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ABSTRACT 
 
The Cancer Stem Cell model supported the notion that leukemia was initiated and 
maintained in vivo by a small fraction of leukemia-initiating cells (LICs). Previous studies 
have suggested the involvement of Wnt signaling pathway in Acute Myeloid Leukemia 
(AML) by the ability to sustain the development of LICs. A novel hematopoietic stem and 
progenitor cell marker, monoclonal antibody AC133, recognizes the CD34bright CD38- 
subset of human acute myeloid leukemia cells, suggesting that it may be an early marker 
for the LICs. During the first part of my phD program we previously evaluated the ability 
of leukemic AC133+ fraction, to perform engraftment following to xenotransplantation in 
immunodeficient mouse model Rag2-/-γc-/-. The results showed that the surface marker 
AC133 is able to enrich for the cell fraction that contains the LICs. In consideration of our 
previously reported data, derived from the expression profiling analysis performed in 
normal (n=10) and leukemic (n=33) human long-term reconstituting AC133+ cells, we 
revealed that the ligand-dependent Wnt signaling is induced in AML through a diffuse 
expression and release of WNT10B, a hematopoietic stem cells regenerative-associated 
molecule. In situ detection performed on bone marrow biopsies of AML patients, showed 
the activation of the Wnt pathway, through the concomitant presence of the ligand 
WNT10B and of the active dephosphorylated β-catenin form, suggesting an autocrine / 
paracrine-type ligand-dependent activation mechanism. In consideration of the link 
between hematopoietic regeneration and developmental signaling, we transplanted 
primary AC133+ AML A46 cells into developing zebrafish. This biosensor model 
revealed the formation of ectopic structures by activation of dorsal organizer markers 
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that act downstream of the Wnt pathway. These results suggested that the 
misappropriating Wnt associated functions can promote pathological stem cell-like 
regeneration responsiveness. The analyses performed in situ retained information on 
the cellular localization, enabling determination of the activity status of individual cells 
and allowing the tumor environment view. Taking this issue into consideration, during 
the second part of my phD program, I set up the application of a new in situ method for 
localized detection and genotyping of individual transcripts directly in cells and tissues. 
The mRNA in situ detection technique is based on padlock probes ligation and target 
priming rolling circle amplification allowing the single nucleotide resolution in 
heterogenous tissues. The mRNA in situ detection performed on bone marrow biopsies 
derived from AML patients, showed a diffuse localization pattern of WNT10B molecule 
in the tissue. Conversely, only the AC133bright cell population shows the Wnt signaling 
activation signature represented by the cytoplasmatic accumulation and nuclear 
translocation of the active form of β-catenin. In spite of this, we previously evidenced 
that the regenerative function of WNT signaling pathway is defined by the up-regulation 
of WNT10B, WNT10A, WNT2B and WNT6 loci, we identified the WNT10B as a major 
locus associated with the regenerative function and over-expressed by all AML patients. 
By the molecular evaluation of the WNT10B transcript, we isolated the WNT10BIVS1 
aberrant splicing variant, that identify Non Core-Binding Factor Leukemia (NCBFL) class 
and whose potential role is discussed. Moreover, we demonstrate that the function of 
"leukemia stem cell", present in the cell population enriched for the marker AC133bright, 
is strictly related to regenerative function associated with WNT signaling, defining the 
key role of WNT10B ligand as a specific molecular marker for leuchemogenesis. This 
thesis defines the new suitable approaches to characterize the leukemia-initiating cells 
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(LICs) and suggests the role of WNT10B as a new possible target for AML. 
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1. INTRODUCTION
1.1 ACUTE MYELOID LEUKEMIA “MOLECULAR”; THE STATE OF 
THE ART 
The term leukemia (from ancient greek: leukós haima, “white blood”) was originally 
described by Rudolf Virchow (Virchow, 1856). The first case to be described in medical 
literature dates to 1827 when a French Doctor Velpeau described a patient who 
developed the symptoms such as fever, weakness, urinary stones, enlargement of the 
liver and spleen. He noticed that the blood of this patient had a consistency like “gruel”. 
Rudolf Virchow was the first to describe the abnormal amount of white blood cells in 
patients and called the disease “leukemia” in 1856. In 1889, Wilhelm Ebstein presented 
the name “acute leukemia” to the leukemias that are rapidly progressive and fatal. 
Finally, in 1900 Naegeli divided leukemias into myeloid and lymphocytic based on cell 
specificity. Nowadays leukemias are divided into several major groups: acute myeloid 
leukemia (AML), chronic myelogenous leukemia (CML), acute lymphocytic leukemia 
(ALL) and chronic lymphocytic leukemia (CLL). Molecularly, leukemias are a 
heterogeneous disease entity with different rearrangements and dysregulations of genes 
with important functions in cellular growth, differentiation, and death (apoptosis). At 
the cellular level, acute leukemias are characterized by an expansion of immature white 
blood cells (blasts) in the bone marrow and blood, where a lack of mature blood cells 
together with a suppression of normal residual hematopoiesis, eventually leads 
toanemia, thromobocytopenia, and leukopenia, which result in fatigue, bleeding, and 
infections. Deregulated hematopoiesis ultimately leading to leukemia is a consequence 
of acquisition of genetic and epigenetic changes in blood stem and progenitor cells, 
which otherwise produce the huge numbers of mature, red and white blood cells. These 
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so-called blast cells have lost their ability to differentiate and response to normal 
regulation of proliferation and survival, and progressively displace normal blood cells in 
the bone marrow (BM) with the result of fatal infections, bleedings, and infiltration of 
other organs (Tenen, 2003). Depending on which blood cell lineage is affected, leukemia 
is subdivided into lymphoid or myeloid leukemia. Furthermore, chronic and acute 
leukemia are distinguished by the amount of blast cells in the (BM). The occurrence of 
more than 20 percent blasts in the BM is considered as acute leukemia. AML is 
diagnosed as a result of a complete blood count showing decreased numbers of red 
blood cells (anemia), platelets (thrombocytopenia) and neutrophil granulocytes 
(neutropenia) whereas the total white blood count are most commonly increased 
(leukocytosis) due to an accumulation of leukemic blast cells. For identification of blasts 
an examination of peripheral blood analysis can be carried out, but definitive diagnosis 
requires a BM sample, which is analyzed morphologically by microscopy and flow 
cytometry to diagnose the presence of leukemic blasts and to differentiate from other 
types of leukemia. In addition, cytogenetic analysis is carried out to identify 
chromosomal abnormalities and translocations which can have prognostic significance. 
The classification of AML is complex due to the diversity of cytology, clinical prognosis, 
and genetic diversity. Two main classifications for AML have been defined over the years. 
The earliest was designed by a French-American-British cooperative group (FAB) in 
1976, and was based on cytological and cytochemical criteria assessing lineage of origin 
of leukemic cells and stage of differentiation block. The AMLs were divided into 8 groups 
from M0 to M7 with later groups presenting more differentiated cells than the earlier 
ones. A new leukemia classification was introduced by the World Health Organization 
(WHO) (Jaffe, 2009; Vardiman, 2010; Vardiman et al., 2002; Vardiman et al., 2009). This 
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classification is not limited to cytological or cytochemical characteristics of the cells, but 
was designed to include all currently available information, including morphology, 
cytochemistry, immunophenotype, genetics, and clinical features in order to define 
clinically relevant diseases (Vardiman et al., 2009). The latest WHO classification 
includes a number of entities that are defined by the common genomic rearrangements 
rather than other cellular characteristics. Two provisional entities were included that 
are defined based on mutations in CCAAT/enhancer binding protein α (CEBPA) and 
nucleophosmin (NPM1) genes. Although FLT3 mutations did not define a separate 
category, screening was recommended due to their profound effect on prognosis. 
Separate entities include myeloid neoplasms with therapy-related changes, as they have 
significantly different complete response, overall survival and response to treatment. 
Another interesting change was the introduction of a separate group for myeloid 
proliferations related to Down syndrome that are often associated with mutated GATA-1. 
As for not otherwise specified AMLs (AML, NOS), they generally incorporate FAB 
classification based on stage of maturation of myeloid leukemia cells.  
 
The molecular pathogenesis of AML 
A key characteristic of hematopoietic stem cells (HSC) is the ability to self-renew. 
According to Rizo et al., the processes of self-renewal and differentiation, are based on 
the relationship between stem cell and microenvironment (Rizo et al., 2006). The 
characteristics of quiescence, self-renewal and differentiation of hematopoietic stem cell 
(HSC) are regulated by intrinsic mechanisms, such as chromatin remodeling and 
extrinsic mechanisms, mainly driven by the microenvironment of the niche, which 
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guides the fairies of the stem cell. Several genes and signaling pathways control the fine 
balance between self-renewal and differentiation in HSC and potentially also in leukemic 
stem cells. Besides pathways such as Wnt signaling, Hedgehog signaling and Notch 
signaling, transcription factors (FoxOs) and cell fate determinants may also play a role in 
stem cells. While some of these pathways seem to be dispensable for maintenance of 
adult HSC, there may be a distinct requirement in leukemia stem cells for leukemic self-
renewal. Genetic changes involving tyrosine kinases, important regulators in basic 
cellular processes such as proliferation, survival and differentiation, are frequent in 
leukemia. Deregulation of signaling pathways, including those involving tyrosine kinase 
signaling, have been connected to leukemogenesis and progression of leukemic disease, 
thereby making them attractive targets in antileukemic drug discovery (Chase & Cross, 
2006; Stapnes et al., 2009). The molecular pathogenesis of acute myeloid leukemia (AML) 
has not yet been completely defined. Recurrent chromosomal structural variations (e.g., 
t(15;17), t(8;21), inv(16), t(9;21), t(9;11), del5, del7) are established diagnostic and 
prognostic markers, suggesting that acquired genetic abnormalities play an essential 
role in leukemogenesis (Betz and Hess, 2010). However, nearly 50% of AML cases have a 
normal karyotype (NK), and many of these lack recurrent structural abnormalities, even 
with high density comparative genomic hybridization (CGH) or SNP arrays (Bullinger et 
al., 2010; Suela et al., 2007; Walter et al., 2009). Targeted sequencing efforts have 
identified several mutations that carry diagnostic and prognostic information, including 
mutations in FLT3, NPM1, KIT, CEBPA, and TET2 (Bacher et al., 2009; Stirewalt & Radich, 
2003). The advent of massively parallel sequencing enabled the discovery of recurrent 
mutations in DNMT3A (Ley et al., 2010; Yamashita et al., 2010) and IDH1 (Mardis et al., 
2009). Despite these efforts, more than 25% of AML patients carry no mutations in the 
 20 
known leukemia-associated genes (Shen et al., 2011). Furthermore, defining the 
molecular consequences of recurring mutations (e.g., whether a mutation is an initiating 
or a cooperating event) has been challenging. 
 
1.1.1 DANCING TO THE TUNE OF DANGER SIGNALING 
Historically, the signaling cascades have been described as pathways, based on 
biochemical and genetic evidence placing some signaling intermediates “downstream” of 
others. One of the first pathways to be described from the activation of RTKs to the 
alteration of transcription in the nucleus was the Ras-MAPK pathway, where the small 
GTPase Ras is activated via several intermediate steps. Activated, GTP-bound Ras in turn 
activates a cascade of dual specificity and serine/threonine kinases that finally activate a 
group of mitogen activated protein kinases, the MAPK. These kinases phosphorylate 
important transcriptional regulators of cell cycle progression and thus induce a 
proliferative response of the target cell. Another signaling pathway that recently 
received much attention is the PI3- Kinase/Akt pathway that can be activated directly by 
binding and phosphorylation of a regulatory subunit of PI3-Kinase to an activated RTK 
or indirectly by several mechanisms involving the activation of Src-family kinases or the 
binding of adaptor proteins to activated kinases. PI3-Kinase generates a small lipid 
second messenger that activates several serin/threonine-kinases like Akt or the 
mammalian target of Rapamycin mTOR. These proteins are involved in the regulation of 
apoptosis, proliferation and, through a direct effect on protein translation, in the control 
of cell size. Alterations of signal transduction increase proliferation and survival 
potential of hematopoietic stem and progenitor cells, often through constitutive 
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activation of protein tyrosine kinases (PTKs) but normally do not affect cellular 
differentiation. Examples include gain-of-function mutations of ABL, JAK2, FLT3, PDGFR, 
KIT, activating mutation of the RAS family members, as well as loss-of-function 
alterations of NF1 or PTPN11. Activating JAK2 mutations are found in chronic 
myeloproliferative neoplasms and in more than 95% of patients with polycythemia vera 
(PV). Activating mutations of FLT3, KIT and RAS are present in more than 50% of AML 
patients. FLT3 is the most commonly mutated gene in approximately one third of AML. 
In 20%–25% of cases of AML, internal tandem duplications (ITD) in the juxtamembrane 
domain of FLT3 results in loss of an autoinhibitory domain leading to constitutive 
activation. Other FLT3 mutations consist of substitutions, small deletions, or insertions 
within the activation loop of the second kinase domain found in 5% to 10% of AML 
patients. The overall consequence of these FLT3 mutations is ligand- independent 
receptor dimerization and/or constitutive activation of its tyrosine kinase activity, 
leading to uncontrolled activation of several downstream signaling pathways, such as 
RAS, MAPK, and STAT5 pathways. The RAS/MAPK signal transduction pathway is a 
critical regulator of proliferation and survival of hematopoietic progenitors. Leukemic 
blasts from about 40% of AML patients showed constitutive activation of RAS signaling. 
However, expression of most class I mutations in murine bone marrow generally leads to 
a lethal myeloproliferative disease (MPD), but not acute leukemia. In addition, most of 
these disorders such as the FLT3-ITD induced MPD are not transplantable into 
secondary recipient mice suggesting that the class I mutations do not confer self-
renewal potential to the transformed cells. JAK/STAT pathway is also involved in 
oncogenesis, as JAK2 mutations are commonly found in CML and MDS (Reuther, 2008). 
JAK is an intracellular kinase that is activated by different receptors and in turn 
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phosphorylates STAT proteins. The phosphorylated STAT TFs dimerize, are transported 
into nucleus and become active as regulators of transcription. Among different genes 
regulated by STAT is anti-apoptotic BCL family member BCL-xL. STAT5 also promotes 
cell survival by inducing PIM1 expression (Steelman et al., 2008). Additionally, it is 
shown that activation of STAT5 by mutant FLT3 increases proliferation and alters 
differentiation of hematopoietic stem cells (Moore et al., 2007). Activation of STAT5 may 
be enhanced by ERK phosphorylation, indicating a possible cross-talk between 
JAK/STAT and MAPK pathways (David et al., 1995; Winston & Hunter, 1995). The most 
commonly mutated genes found in human AMLs, as well as many of the genes constantly 
upregulated in AMLs, are involved in the described pathways. C-KIT RTK, which is 
almost ubiquitously expressed on AML cells, results in direct activation of PI3K/AKT 
pathway and activates STAT3 (Ning et al., 2001a). RAS GTPases are also directly activated 
by c-KIT receptor, leading to upregulated RAF/MEK/ERK cascade (Scholl et al., 2008a). 
FLT3-ITD and other activating mutations of FLT3 activate AKT phosphorylation, 
RAS/RAF/MEK/ERK and STAT5 in AML cells (Brandts et al., 2005; Hayakawa et al., 2000; 
Kim et al., 2005; Mizuki et al., 2000; Spiekermann et al., 2003). JAK2, as described above, is 
a member of JAK/STAT oncogenic pathway. Commonly mutated in AML RAS proteins are 
downstream targets of type III RTKs (including c-KIT and FLT3) and activators of 
RAF/MEK/ERF pathway. Finally, a major player in PI3K/AKT pathway AKT is 
overexpressed in a large human AML (Tamburini et al., 2007). Many of these players of 
leukemic transformation are targets for specific inhibitors therapy, although cross-talks 
between the pathways and autoregulatory feedback loops make a task of cancer 
prevention by signaling inhibition challenging (Breitenbuecher et al., 2009; Chu & Small, 
2009; Huang et al., 2003; Huang & Houghton, 2001). Mutations in components of the RTK 
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signaling pathway are the most common mutations found in CBF leukemias (Haferlach et 
al., 2010). The KIT and FLT3 genes play crucial roles in proliferation and survival of 
hematopoietic progenitors (Ikeda et al., 1991; Pollard et al., 2010; Wang et al., 1989; 
Yokota et al., 1997). The oncogenic mutations that activate the FLT3 receptor are found in 
5% to 7% of CBF AML cases, including the ITD and TKD mutations (Boissel et al., 2006b; 
Care et al., 2003; Schnittger et al., 2002; Shih et al., 2008), and have an unfavorable 
prognosis (Döhner et al., 2010; Mrózek et al., 2007). The activating mutations in KIT (the 
most common are D816V and N822K) are found in approximately 25% of CBF AML and 
are rare in other AMLs (Beghini et al., 2000a; Cairoli et al., 2006; Boissel et al., 2006b; Care 
et al., 2003; Goemans et al., 2005; Paschka, 2008; Shih et al., 2008). It was also proven by 
using mouse models that both FLT3-ITD (Kim et al., 2008; Schessl et al., 2005b) and 
mutant KIT (Wang et al., 2011a) cooperate with CBF fusions in leukemia development in 
mice. The CBF AMLs can also present oncogenic mutations in NRAS and KRAS, but rarely 
in HRAS (Neubauer et al., 2008). Rat sarcoma (RAS) genes encode membrane anchored 
GTPases that are involved in multiple signaling pathways and were shown to have 
oncogenic activity (McCubrey et al., 2007). In inv(16) AML cases around 30% harbored 
constitutively active mutated RAS genes with the most commonly mutated NRAS. The 
incidence of RAS mutations in t(8;21) AML cases is around 10% (Boissel et al., 2006b; 
Care et al., 2003; Goemans et al., 2005; Shih et al., 2008). It is noteworthy that KIT, FLT3 
and RAS mutations in inv(16) and t(8;21) human AML cases were mutually exclusive, 
thus supporting the idea that they act as class I mutations in the “two hit” model for 
leukemia development (Care et al., 2003; Shih et al., 2008). Approximately 8 to 10% of 
t(8;21) AML cases show oncogenic mutations in the tyrosine kinase Janus kinase 2 
(JAK2) gene, frequently at residue V617F (Dohner et al., 2006; Schnittger et al., 2007a), 
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but this occurs less frequently in inv(16) AML. Interestingly, these mutations in JAK2 are 
often found in CML and MDS, but are rare in non-CBF AMLs (Illmer et al., 2007). 
 
1.1.2 MAKING THE CUT: THE CORE BINDING FACTOR STORY 
 
The Core Binding Factor (CBF) is a master regulator of hematopoietic development, 
maintenance and differentiation, in embryonic and adult hematopoiesis. CBF is a 
heterodimeric TF that consists of subunits called α and β (Kamachi et al., 1990). In 
mammals, the α-subunit is encoded by three alternative genes with high level of 
homology (over 90% identity at the amino acid level) called Runt-related transcription 
factors RUNX1, RUNX2 and RUNX3. The nomenclature of the CBF factors has been 
confusing due to its history until the year 2004 when researchers from these fields 
working with the CBF proteins proposed a unified nomenclature in which the 
mammalian homologs of the Drosophila gene runt would be officially called RUNX1, 
RUNX2, and RUNX3, while the cofactor would remain with the name given in the 
developmental field as CBFB (van Wijnen et al., 2004). Interaction between RUNX1 and 
CBFβ subunits is critical for CBF function (Wang et al., 1996b). The RUNX protein binds 
to the DNA consensus sequence YGYGGTY in promoters, enhancers and silencer regions 
(Wang & Speck, 1992). This binding is dependent on heterodimerization with CBFβ, as 
CBFβ increases RUNX affinity to DNA over five-fold (Golling et al., 1996; Wang et al., 
1993), and protects it from proteasomal degradation (Huang et al., 2001). All three RUNX 
proteins share similar conserved domains with defined functions. The highly conserved 
Runt-homology domain (RHD) between amino acids 50 and 177 is responsible for 
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binding to DNA and CBFβ (Golling et al., 1996). The RHD also participates in RUNX 
binding a variety of cofactors. For example, the v-Ets avian erythroblastosis virus E26 
oncogene homolog 1 (ETS1) TF binds to the RHD as RUNX1 recruits it to the T-cell 
receptor a (TCRa) enhancer in T cells (Giese et al., 1995).  
 
Core Binding Factor Leukemias 
 
Approximately 20-25% of AML cases are associated with genomic alterations involving 
CBFB or RUNX1 genes (Look, 1997). Specifically, 12% of cases of AML have chromosomal 
inversion inv(16)(p13q22), disrupting the CBFβ gene and fusing it inframe with the 
second half of the Myosin heavy chain 11(MYH11) gene that encodes the Smooth muscle 
myosin heavy chain (SMMHC) protein. The resulting gene is called CBFβ -MYH11, and its 
encoded fusion protein is called CBFβ-SMMHC (Liu et al., 1993). In 12% of AML cases the 
translocation t(8;2l)(q22;q22) results in the creation of the RUNX1-ETO fusion gene that 
fuses RUNX1 in exon 5 with Eight Twenty One (ETO, also known as RUNX1T1) gene 
starting from exon 2 (Rowley, 1973). In addition to these rearrangements, AML samples 
can also harbor point mutations in RUNX1 that create a protein with dominant negative 
or hypomorphic function (Schnittger et al., 2011; Silva et al., 2009). By FAB classification, 
68% of cases associated with the CBFβ-MYH11 fusion gene fall into M4Eo group, while 
20% are M4 and 12% are M2 (Marcucci et al., 2005; Schnittger et al., 2007a). There are 
rare cases of myelodysplastic syndrome and chronic myeloid leukemia crisis also 
associated with CBFβ-MYH11 expression (Tirado et al., 2010), but these are temporary 
conditions that lead to development of AML. More than 90% of the M4Eo cases carry an 
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abnormality that leads to CBFB-MYH11 expression, whether it is inv(16), t(16;16) or 
del(16)(q22) (Hernandez et al., 2000; Pirc-Danoewinata et al., 2000). However, the fusion 
transcript CBFβ-MYH11 has been detected in all M4Eo cases tested, suggesting the 
presence of micro-rearrangements in some cases. Since the presence of the CBFβ-
MYH11 fusion in AML samples is unique at the molecular and clinical levels, the WHO 
classification defined it as a separate AML subtype (Vardiman, 2010). The CBFβ-MYH11-
expressing AML subtype is considered to have a favorable prognosis, with CR rate 
around 90% and OS rate around 50% (Appelbaum et al., 2006; Delaunay et al., 2003; 
Marcucci et al., 2005). The CR and OS rates were lower in older patients, patients with 
complex genotype and high white blood cell (WBC) counts (Appelbaum et al., 2006). AML 
cases in M4Eo group are characterized by myeloblastic and/or monoblastic infiltration 
into BM, elevated monocytic counts in peripheral blood (PB), and the presence of 
atypical eosinophils in both BM and PB. The eosinophil population usually accounts for 
5% or more of white blood cells and carries the inv (16), being therefore part of the 
leukemic population and not a secondary change in AML (Haferlach et al., 1996). Taken 
together, the data from human patients suggest that CBFβ- MYH11 causes development 
of AML with partial abnormal differentiation into monocytic/myeloid lineage with 
small populations keeping expression of early hematopoietic stem/progenitor markers. 
A majority (91%) of AML cases associated with the fusion gene RUNX1-ETO are in the 
FAB subtype M2, while only 6% are in the less differentiated subtype M1 and 3% in the 
more differentiated subtype M4 (Marcucci et al., 2005). The WHO classification defines a 
separate subtype based on the presence of t(8;21) translocation expressing RUNX1-ETO. 
The AML subtype is considered to have a favorable prognosis, but the OS rate is lower in 
the RUNX1-ETO-related AMLs than in CBFβ-MYH11-related AMLs (Appelbaum et al., 
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2006; Marcucci et al., 2005), being around 45%. The risk factors were similar to those for 
CBFβ-MYH11 subtype: age, WBC count, complex genotype with additional genomic 
alterations. Race was an additional factor that was not found significant in CBFβ- MYH11 
AML subtype, but was significant for OS of patients with RUNX1-ETO AMLs (Marcucci et 
al., 2005) being around45%. 
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1.2 LEUKEMIA INITIATING CELL (LIC): GETTING THE STEM OF 
AML 
 
 
The “stem cell” concept was first proposed by Till and McCulloch following their 
pioneering studies of the blood system regeneration in vivo. Ten days after transplanting 
limiting number of syngenic bone marrow (BM) cells into recipient mice, they observed 
cellular colonies that formed in the spleens of recipient mice. Analysis of these colonies 
revealed that a very small sub-population of the donor BM cells possessed two 
remarkable properties: (1) the ability to generate multiple types of myeloerythroid cells, 
and (2) the ability to self- replicate (Becker et al., 1963; Siminovitch et al., 1963; Till & 
McCulloch, 1961). These findings introduced the two defining criteria of stem cells i.e. 
multi-potency and self-renewal. Hematopoietic Stem Cells (HSCs) are the only cells 
within the hematopoietic system that possess the potential for both multi-potency and 
self-renewal. In the case of HSC, multi-potency is the ability to differentiate into all 
functional blood cells, while self-renewal is the ability to give rise to identical daughter 
HSCs without differentiation. In 1988, the initial prospective purification of 
hematopoietic stem cells from mouse BM was achieved utilizing the relatively new 
technologies of multi-color fluorescence-activated cell sorting and monoclonal 
antibodies (Spangrude et al., 1988). The resultant population of enriched mouse HSCs 
had a surface marker phenotype of Thy-1low Lin- Sca-1+, and represented approximately 
0.05% of the mouse adult BM cells. Spangrude and colleagues demonstrated that these 
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were the only cells in mouse BM capable of transferring long-term reconstitution of the 
entire hematopoietic system when transplanted into lethally irradiated mice (Spangrude 
et al., 1988). A reductionist approach by Uchida et al showed that Thy1.1low, but not 
Thy1.1high or Thy1.1− cells could give rise to donor-derived long-term multilineage 
reconstitution of irradiated hosts; this was true of Sca-1+, but not Sca-1− cells, and of 
Lin−, but not Lin+ cells (Uchida & Weissman, 1992). Since these initial studies, mouse 
HSCs have been more extensively purified by identifying and then utilizing additional 
cell-surface markers to distinguish them from other cells in BM; these included, but were 
not exclusively single cells that could self-renew and give long-term multilineage 
maturation (Uchida & Weissman, 1992; Ikuta and Weissman, 1992). In 1994 the 
population isolated by Spangrude et al was shown to include at least three multipotent 
populations: Long-Term (LT)-HSC, Short-Term (ST)-HSC, and Multi-Potent Progenitor 
(MPP), a cell population that has lost the self-renewal capacity of HSC (Morrison & 
Weissman, 1994). In 1996, HSCs from adult mouse BM were sufficiently enriched to 
conduct single-cell transplantation experiments, and these studies revealed that one in 
three CD34−/low c-Kit+ Sca-1+ Lin− cells showed myelolymphoid long-term 
reconstitution in lethally irradiated recipients after a single cell transplant (Osawa et al., 
1996). Despite the fact that hematopoietic tissues contain both stem and progenitor 
cells, rapid and sustained engraftment of syngenic and even of H2 incompatible allogenic 
hosts can only be achieved with HSC, the time to engraftment depending on the number 
of HSC transplanted (Uchida et al., 1997). While the phenotypic and functional properties 
of HSCs have been extensively characterized (Morrison et al., 1995; Weissman, 2000), a 
fundamental question that remains is how self- renewal is regulated. In most cases, 
combinations of growth factors that can induce extensive proliferation are unable to 
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prevent differentiation of HSCs in long-term cultures. Although progress has been made 
in identifying conditions that maintain HSC activity in culture for a brief period of time 
(Miller & Eaves, 1997), it has proven exceedingly difficult to identify combinations of 
growth factors that cause significant expansion in culture in the number of progenitors 
with transplantable HSC activity. The first one to identify the leukemic stem cell (LSC) 
were Bonnet and Dick in 1997 (Bonnet & Dick, 1997). Until then, there was much conflict 
in reasoning about the identity of the initiating cell in leukemia (Wang & Dick, 2005). It 
was not clear whether the stochastic model or the hierarchical model was applicable, 
and within the hierarchical model it is still not clear whether the normal SC is targeted 
and transformed and/or a progenitor cell initiates leukemia. By using non-obese 
diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice) it was 
shown that cells that are able to initiate leukemia (the SCID leukemia-initiating cells or 
SL-ICs) have the ability to proliferate, self-renew, and differentiate via asymmetrical 
division. The cells identified by Bonnet as the leukemia initiating cells reside in the 
CD34+CD38- immunophenotypic compartment (Bonnet & Dick, 1997). Cancer stem cells 
(CSCs) constitute a subpopulation of malignant cells capable of self renewal and 
differentiation (Al-Hajj et al., 2004; Jordan et al., 2007; Jordan, 2006; Pardal et al., 2003; 
Reya et al., 2001; Rossi et al., 2008; Wang & Dick, 2005). It is now half a century since 
bone-marrow reconstitution experiments, following lethal irradiation in mice, first 
indicated the existence of the haematopoietic stem cell (HSC) a cell first postulated to 
exist by Artur Pappenheim as early as 1917. Although this cell population is still not fully 
characterized, its discovery awakened the field of stem-cell biology. Elegant experiments 
by Philip Fialkow and colleagues, in which they used patterns of inactivation in X-linked 
genes, had previously shown that leukaemias such as chronic myelogenous leukaemia 
 31 
(CML) and AML (Huntly & Gilliland, 2005), together with preleukaemic diseases such as 
the myeloproliferative disorders, are clonal in origin. In a series of seminal experiments 
in 1997 by investigators based at the University of Toronto, where James Till and Ernest 
McCulloch had first shown the radioprotective effects of mouse bone marrow, the LSC for 
AMLwas first identified. The first descriptions of LSC (Leukemia Stem Cell) in human 
AML by Lapidot et al. and Bonnet and Dick from John Dick’s laboratory identified a 
subpopulation of CD34+ CD38− human AML cells that were able to serially transplant 
leukemia in a mouse xenograft model. In contrast, the more committed progenitors 
expressing CD38, lacked this potential. These reports demonstrated that LSC were rare, 
however the frequency of these LSC varied greatly between different AML samples, 
ranging from 1 in 104 to 107 cells. In this xenograft model, LSC were not limited to their 
ability to cause leukemia, but also gave rise to progeny that lost leukemia initiating 
activity, leading to the hypothesis that AML is arranged in a hierarchy with the LSC at the 
apex and the more “differentiated” blasts representing the bulk, non-transplantable 
tumor population. This deterministic model differs from the original stochastic model 
based on observations that only rare cells within tumors randomly possessed or 
acquired the ability to form colonies and transplant disease. Until then, there was much 
conflict in reasoning about the identity of the initiating cell in leukemia. It was not clear 
whether the stochastic model or the hierarchical model was applicable, and within the 
hierarchical model it is still not clear whether the normal SC is targeted and transformed 
and/or a progenitor cell initiates leukemia. By using non- obese diabetic mice with 
severe combined immunodeficiency disease (NOD/SCID mice) it was shown that cells 
that are able to initiate leukemia (the SCID leukemia-initiating cells or SL-ICs) have the 
ability to proliferate, self-renew, and differentiate via asymmetrical division. The cells 
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identified by Bonnet as the leukemia initiating cells reside in the CD34+CD38- 
immunophenotypic compartment. LSC, like their normal HSC counterparts, possess a 
range of characteristics that enable their long-term survival and some of these also 
facilitate their escape from the cytotoxic effects of chemotherapy. For example, LSC 
express the p- glycoprotein multidrug resistance efflux pump, ABCB1 (also known as 
MDR1) that can remove potentially cytotoxic chemotherapeutic agents from the cell. By 
reducing cytotoxic stress, LSC may become a reservoir for the selection of mutants that 
are resistant to targeted or conventional therapy. LSC are characterized by limitless self-
renewal and experimental evidence implicates the primacy of key, developmentally 
conserved self- renewal pathways such as Bmi-1, Wnt/β-catenin and Hedgehog in this 
process. Increased expression of Hox genes, such as HoxA9, has been implicated in the 
pathogenesis of MLL- AF9-induced AML. However, not surprisingly, this dependence may 
be context and oncogene dependent as evidenced by the importance of Hedgehog 
pathway signaling in CML LSC but not in MLL-AF9-induced AML. LSC may also evade 
apoptosis by up-regulation of the pro-survival factor NF-kB or evasion of programmed 
cell death mediated by Fas/CD95 interactions. The development of the NOD/SCID-
leukaemia model allowed the separation of leukaemia cells into subpopulations that 
could be evaluated for engraftment and serial-transplantation potential. Cells derived 
from seven patients representing each subtype of AML (according to French-American-
British classification standards), were separated into CD34+CD38+ and CD34+CD38- 
fractions. These subpopulations were then injected intravenously into sublethally 
irradiated NOD/SCID mice that received regular injections of human cytokines. The mice 
were assessed at 4–8 weeks for engraftment, based on human-specific DNA sequences. 
Human cells from the bone marrow of transplant recipients were then isolated, based on 
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the expression of human form of CD45 and transplanted into secondary recipients. 
These experiments showed that the capacity to transfer human AML to recipient mice 
resided exclusively within the CD34+CD38- cell fraction. Furthermore, these cells had 
the same capacity to induce all subtypes of AML except for M3 acute promyelocytic 
leukaemia. The leukaemias that developed in the secondary recipients closely resembled 
the human cancer, demonstrating that LSCs have long-term self-renewal capabilities and 
also determine the stage of the differentiation block during leukaemogenesis. Based on 
these findings, the authors proposed a hierarchical organization for AML that is similar 
to normal haematopoiesis. In this model, the LSC (or SL-IC, as the authors named it) is 
responsible for both self-renewal and the production of clonogenic leukaemic 
progenitors that have proliferative capacity, but not the capacity of self-renewal. Based 
on similarities in the organization of the respective systems and phenotypic similarities, 
they also proposed that the HSC was the most likely target for transformation into an 
LSC (Bonnet & Dick, 1997). Experiments performed by Craig Jordan and Donna Hogge 
have refined the immunophenotype of the LSC in AML to be CD34+CD38-CD90- 
interleukin 3 receptor (IL-3R)+CD71- human leukocyte antigen (HLA)-DR-CD117-. In 
order to identify the LICs by immunophenotype, Gibbs et al. transplanted into irradiated 
wild-type mice the purified hematopoietic stem/progenitor cells, which express c-kit 
(Lin-kit+), kit+ cells coexpressing lymphoid markers (Lyn+kit+) or myeloid markers 
(Gr1+kit+), and mature myeloid cells (Gr1+kitlow) from HoxA9-Meis1 (H9M) mice. All 
transplanted cell fractions generated leukemia in the recipients except the Gr1+kit cells. 
These findings show that the LICs represent malignant hematopoietic progenitors that 
are immunophenotypically heterogeneous. Furthermore, each immunophenotype of LIC 
from primary leukemias could recapitulate all the LIC immunophenotypes in secondary 
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recipients. Because the three distinct LIC populations seemed to share developmental 
lineage potential, Gibbs et al. suggested that they may possess common cell signaling and 
genetic properties. In human leukemias, it has also been difficult to find exact 
immunophenotypic markers that characterize all LICs. For example, Goardon et al. and 
Sarry et al. found that LICs represented hematopoietic progenitors with several different 
immunophenotypes (Goardon et al., 2011; Sarry et al., 2011). Goardon et al. examined a 
large group of primary AML patients and found two different progenitor-like LICs: one 
multipotent population and another representing granulocyte-macrophage progenitors 
(GMPs). Their relationship was hierarchical because the multipotent population could 
generate the GMP-like LICs, but not the other way around. Another recent study also 
reported progenitor-like LICs in primary AML with different immunophenotypes, some 
without expression of lineage markers (Lin-CD38-) and others expressing lineage 
markers CD38 or CD45RA (Sarry et al., 2011) (Figure 1.1).  
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Figure 1.1. Different models for Leukemia-Initiating Cells. (A) A classical 
hierarchical model: leukemia-initiating ability is restricted to a small fraction of 
hematopoietic-stem-cell-like cells, that generate progeny cells that lack tumor-initiating 
ability. (B) An atypical hierarchical model: various types of hematopoietic-stem-cell-like 
or progenitor-like cells comprise leukemia-initiating cells (LICs), and these cells can 
independently generate other LICs with distinct immunophenotypes and therefore 
exhibit an atypical hierarchy. Hence it is not possible to identify LICs with a single 
immunophenotype. (C) A signaling network model: LICs with different 
immunophenotypes exhibit activation of common signaling pathways. Cell bodies in blue 
are LICs, while the orange cells do not have leukemia-initiating activity. Figure from 
Miharada & Karlsson, 2012. 
 
 
 
In recent study, the capacity of various strains of immunodeficient mice [NOD/it-SCID 
and NOD/Shi-SCID, NOD/it-SCID/IL-2Rγnull (NSG), and NOD/Shi-SCID/IL-2Rγnull 
(NOG)] to act as recipients for human HSCs was compared, showing that both NSG and 
NOG improved the engraftment in peripheral tissues compared to the parental strains of 
NOD/SCID mice. NSG mice provide greater human engraftment in bone marrow 
(McDermott et al., 2010). The NOD/SCID repopulating assay demonstrated that human 
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HSCs are present in the CD34+CD38− fraction of human hematopoietic cells (Bhatia et 
al., 1997; Civin et al., 1996). Using NOD/SCID mice strains with enhanced 
immunosuppression as recipients, it was shown that the CD34+/CD38+ cell fraction also 
possesses some repopulating activity (Hogan et al., 2002; McKenzie et al., 2006). 
However, CD34+/CD38+ cells possess only a short-term SCID-repopulating activity, 
while the long-term repopulating activity is limited to the CD34+/CD38− cell population 
(Hogan et al., 2002). It is important to mention that several studies have characterized a 
rare SCID-repopulating population observed at the level of CD34−Lin− cells: these cells, 
like CD34+/CD38− cells, possess a long-term repopulating capacity (Wang et al., 2003; 
Kitamura et al., 2007; Kitamura et al. 2010). Importantly, CD34− HSCs are able to 
generate in vivo CD34+ HSCs (Kitamura et al., 2010). According to their capacity of 
repopulating hematopoiesis, the hematopoietic stem cell pool can be subdivided into 
three groups: short-term HSCs, capable of generating clones of differentiating cells for 
only 4–6 weeks; intermediate-term HSCs, capable of sustaining a differentiating cell 
progeny for 6–8 months before becoming exinct; and long-term HSCs, capable of 
maintaining hematopoiesis undefinitely (Benviste et al., 2010). Initial studies have shown 
that the leukemia-initiating cells, as assayed in the NOD/SCID assay model, are detected 
only within the CD34+/CD38− fraction of the majority of AML samples, but none were 
found in any other fraction, including CD34+/CD38+ fraction (Lapidot et al., 1994; 
Bonnet & Dick, 1997; Ailles et al., 1999). Since AML-CFUs are contained only in the 
CD34+/CD38+ fraction, these studies provided a direct experimental proof that the AML 
clone is organized as a hierarchy that originates from leukemia-initiating cells, which 
generate a cell progeny initially composed by AML-CFU and then by leukemic blasts 
arrested at various stages of differentiation. Serial transplantation studies in NOD/SCID 
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mice provided evidence that the pool of AML-initiating cells, like normal HSCs, is 
composed of distinct leukemia stem cells that differ in their repopulating leukemia 
capacity and self-renewal capacity (Hope et al., 2004). However, some recent studies 
have shown that leukemia stem cells are present also in the CD34+/CD38+ fraction. In 
fact, it was shown that, in a significant proportion of AMLs, cells contained in the 
CD34+/CD38+ fraction are capable of initiating and maintaining the leukemic process 
when grafted to NOD/SCID mice (Taussig et al., 2008). Interestingly, in some AMLs in 
which the CD34+/CD38− fraction was unable to initiate leukemia after injection in 
NOD/SCID mice, the CD34+/CD38+ fraction was able to do it (Taussig et al., 2008). The 
discrepancy between these observations and previous studies relies in the observation 
that the anti-CD38 monoclonal antibody used for cell fractionation studies has a marked 
negative effect on the engraftment of AML repopulating cells in NOD/SCID mice (Taussig 
et al., 2008). Very recently, it was shown that, in a significant proportion of AMLs, 
leukemia-initiating cells are observed within the CD34− fraction. These studies were 
based on the analysis of SCID leukemia-initiating cells in a group of patients bearing 
nucleophosmin mutations using the most immunodeficient SCID mice available. These 
AMLs are classified as a separate entity and are characterized by a low CD34 expression. 
In half of these AMLs, the CD34− fraction contained leukemia-initiating cells, while the 
CD34+ fraction gave rise to normal multilineage hematopoiesis. In the remaining half of 
the patients, leukemia-initiating cells are observed among both CD34+ and CD34− AML 
cells (Taussig et al., 2010). The AMLs with exclusively CD34− leukemia initiating cells 
may have arisen either from CD34+ stem/ progenitor cells that have lost CD34 
expression through the leukemia-transforming events or from CD34− stem cells. These 
observations further reinforce the concept that the membrane phenotype of leukemia-
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initiating cells is heterogeneous in various AMLs. While cell surface characteristics may 
not define LICs, recent studies have identified several cell surface markers that predict 
the ability of LICs to grow and metastasize. For example, antibodies against CD44 
expressed on LICs could markedly deplete human LIC engrafted in NOD/SCID mice. 
Similarly, in HOXA10-Meis1 induced murine leukemia, prevention of secondary 
leukemias was achieved upon treatment of the recipients with antibodies against CD44 
(Jin et al., 2006; Quere´ et al., 2011). Increased protein levels of CD44 were discovered by 
screening the LICs by proteomics, indicating that expression profile analysis may not 
always be sufficient to find key molecules that are dysregulated in LICs (Quere´ et al., 
2011). Interestingly, Hertweck et al., evidenced that CD44 plays two pivotal roles in early 
hematopoiesis: (1) mediation of the interaction of the progenitor cells with their 
respective niche in the bone marrow (BM), (2) stimulation of cell proliferation and 
differentiation by regulation of local cytokine secretion (Hertweck et al., 2011). CD44 
signaling plays a pivotal role in acute myeloid leukemia (AML), depicting three different 
putative points of attack: differentiation arrest, bone marrow niche dependency of 
leukemia-initiating cells (LIC), and acquired therapy resistance. The authors focused on 
hematological neoplasias where CD44 has three main functions: first, its role as 
prognostic marker; second, its potential role for diagnosis; and third, its role as a 
promising therapeutic target. Distinguishing between different prognostic subtypes of 
one neoplastic disease entity is of great advantage. For preventing secondary 
malignancies induced by too aggressive treatment regimes a deliberate risk stratification 
based on the expected tumor prognosis is imperative. Another example gives the 
observed treatment resistance to several standard therapeutics associated with CD44 
expression in a limited group of patients with DLBCL (diffuse large B-cell lymphoma). 
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This provides the possibility of improved individual treatment decisions, which have 
been a big aim in cancer therapy in the last years. More and more, CD44 is considered 
being of diagnostic use. 
 
1.3 THE AC133 ANTIGEN: OLD DOG NEW TRICKS?  
The pentaspan membrane protein CD133 (Prominin-1) was first identified by Huttner 
and colleagues in embryonic and adult mouse epithelial cells (Weigmann et al., 1997), 
and it was charachterized in human hematopoietic stem and progenitor cells by Miraglia 
and colleagues (Miraglia S et al., 1997). CD133was found to be enriched at subdomains 
of the cell surface, such as microvilli of neuroepithelial cells and in cell protrusions, like 
filopodia, lamellipodia and microspikes in non-epithelial cells. Due to its specific location 
on the cell surface, this protein was termed´Prominin`, from the Latin word “prominere”, 
which means to stand out, to be prominent. In the same year, the homolog of mouse 
CD133 was detected in human CD34-positive hematopoietic stem cells, by using an 
antibody against the surface antigen AC133 (Yin et al., 1997). In the mouse, CD133 is 
encoded by the Prom1 gene on chromosome 5 (location 5 B3). In 1997, Yin et al., 
produced a novel monoclonal antibody (MAb) that recognized the AC133 antigen, a 
glycosilation-dependent epitope of CD133. Prominin-1 is a product of a single-copy gene 
on chromosome 4 (4p15.33) in humans or chromosome 5 (5 B3) in mice. Both the 
mouse and human genes have similar genomic organizations, consisting of at least 37 
(human) and 34 (mouse) exons spanning approximately 160 kb. The transcript size is 
about 4.4 kb in both humans and mice. Human Prominin-1 is a transmembrane 
glycoprotein of 865 amino acids (aa) with a total molecular weight of 120 kDa (858 aa, 
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115 kDa in mouse). Prominin-1 has a unique structure consisting of an N-terminal 
extracellular domain, five transmembrane domains with two large extracellular loops, 
and a 59 aa cytoplasmic tail (Figure 1.2).  
 
 
 
Figure 1.2 Structure of AC133 antigen. Adapted from Fargeas et al., 2004.  
 
Human and mouse Prominin-1 share roughly 60% homology. Phylogenetically 
conserved, Prominin-1 can also be found in C. elegans, Drosophila and Zebrafish. 
Prominin-2, a recently discovered second member of the Prominin family, shares about 
26% and 29% homology with human and mouse Prominin-1, respectively (Fargeas, et 
al., 2003). A number of alternatively spliced isoforms of Prominin-1 have been identified 
in mice and humans, with tissue-specific distribution (Corbeil, et al., 2001; Shmelkov et 
al., 2004; Yu, et al., 2002). CD133 has five putative transmembrane domains with two 
extracellular loops which contain more than 250 aminoacids each, an extracellular N-
terminal and a cytoplasmic C-terminal domain. Eight potential N-gycosylation sites are 
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located at the extracellular loops (Fargeas et al., 2003). Several splice variants are 
identified so far (in the mouse variant s1-s8) and their expression seems to be tissue-
specific and developmentally regulated (Fargeas et al., 2007) (Figure 1.3). Murine 
prominin-1 was identified as a novel marker of neuroepithelial cells, primary progenitor 
cells of the mammalian central nervous system, whereas its human counter part 
constituted a new hematopoietic stem and progenitor cell (HSPC) marker (initially 
referred to as AC133 antigen).  
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Figure 1.3 Schematic representation of the 5′ region of CD133. CD133 has five 
alternative promoters, each containing one or multiple corresponding exons. Adapted 
from Kemper et al., 2010; Xin et al., 2008.  
As a cell surface marker, prominin-1 is now used for somatic stem cell isolation. CD133+ 
stem and progenitor cells might become clinically important, particularly with regard to 
brain injury/disease and bone marrow transplantation. It is important to note that, 
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although various stem and progenitor cells express prominin-1, its expression is not 
limited to primitive cells. For instance, prominin-1 is detected in several epithelia in 
adult mice and humans where it appears to be restricted to the apical (luminal) side. 
Additionally, prominin-1/ CD133 is often used for the identification and isolation of 
putative cancer stem cell populations from malignant tumors of brain, prostate, liver, 
pancreas, lung, and colon (Yin et al., 1997; Kania et al., 2005; Miraglia et al., 1997; 
Weigmann et al., 1997). Its expression in cancer stem cells has broadened its clinical 
value, as it might be useful to outline new prospects for more effective cancer therapies 
by targeting tumor initiating cells. Cell biological studies of this molecule have 
demonstrated that it is specifically concentrated in various membrane structures that 
protrude from the planar areas of the plasmalemma. Prominin-1 binds to the plasma 
membrane cholesterol and is associated with a particular membrane microdomain in a 
cholesterol-dependent manner. Although its physiological function is not yet fully 
determined, a recent finding has shown that transgenic mice carrying human mutation 
for the prominin-1 gene (PROM1) undergo progressive photoreceptor degeneration in 
the retina consistent with that found in human patients, suggesting a functional role for 
prominin-1. Prominin-1 is expressed on a subpopulation of CD34+ HSPCs derived from 
various sources including fetal liver and bone marrow, adult bone marrow, cord blood 
and mobilized peripheral blood. Interestingly, an immunomagnetic selection of CD133+ 
HSPCs allowed the enrichment of a sufficient amount of cells to perform hematopoietic 
stem cell transplantation, and pilot trials with leukemic children have proven the 
feasibility of CD133+ selection for allogeneic transplantation. Other studies have shown 
the successful transplantation of haploidentically mismatched peripheral blood stem 
cells using CD133+ purified stem cells. Thus, the immunomagnetic isolation procedure 
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of HSPCs based on prominin-1 appears to be an interesting alternative to CD34. 
Moreover, accumulating studies illustrate that prominin-1/CD133+ progenitor cells can 
exert beneficial effects in treating of different pathological disorders, including cardiac 
and hepatic malignancies Although its physiological function in stem cells remains 
elusive, Bauer et al., observed that during the cell division of neural and HSPCs 
prominin-1 was either symmetrically or asymmetrically distributed between the two 
nascent daughter cells (Bauer et al., 2008; Fargeas et al., 2006; Kosodo et al., 2004). 
Prominin-1 containing lipid rafts might host key determinants or players necessary to 
maintain stem cell properties, their quantitati\ve reduction or loss might result in 
differentiation (Fargeas et al., 2006; Marzesco et al., 2005). In agreement with this, 
Kosodo et al could demonstrate that neurogenic cell divisions of neural progenitors, but 
not proliferative ones, involve such an asymmetric distribution of prominin-1 (Kosodo et 
al., 2004). Additionally, in the developing embryonic mouse brain, prominin-1 is released 
from neural progenitor cells into the lumen of the neural tube during the early phase of 
neurogenesis (Marzesco et al., 2005). Therein, prominin-1 is associated with small (50–
80 nm) membrane vesicles that were distinct from exosomes and appeared to bud from 
microvilli and/or primary cilium (Dubreuil et al., 2007; Marzesco et al., 2005). Such 
prominin-1 containing membrane vesicles (prominin-1-CMV) were also found in human 
cerebral fluids, and remarkably appear to be up-regulated in glioblastoma patients 
suggesting that putative cancer stem cells might release them as well (Huttner et al, 
2008). Intriguingly, we demonstrated that, in contrast to other prominin-expressing cell 
types studied so far, e.g. epithelial cells (Karbanova´ et al, 2008; Weigmann et al, 1997), 
HSPCs contain an important intracellular pool of prominin-1 in addition to the cell 
surface one. Inside the cell, prominin-1 is located primarily in membrane vesicles within 
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multivesicular bodies. Taken together, the release of prominin-1-containing exosomes 
concomitant with cellular differentiation may represent an alternative mechanism of 
externalization of stem/progenitor properties-containing lipid rafts, in addition to the 
budding mechanism underlying the release of prominin-1 from plasma membrane 
protrusions (i.e. microvillus and primary cilium) of neural progenitors (Ettinger et al., 
2011; Corbeil et al., 2010; Dubreuil et al., 2007; Marzesco et al., 2005, 2009). Thus, the 
concept of ‘stem cell-specific lipid rafts’ holding molecular determinants necessary to 
maintain the stem cell properties is attractive in this context (Fargeas et al., 2006; 
Marzesco et al., 2005) and the characterization of those containing prominin-1 including 
their proteome and lipidome may reveal new aspects of stem cell biology. Along the 
same line, it will be of interest to determine whether similar phenomena occur in 
cancerous tissues other than the brain (Huttner et al., 2008) given that the expression of 
prominin-1 is often associated with transformed, treatment-resistant cells exhibiting 
tumour initiating properties (Bao et al., 2006; Liu et al., 2006).  
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1.4 WNT RECEPTOR SIGNALING: PROCESSING, SECRETION 
AND RECEPTION  
 
The Wnt pathway, like several other signaling systems, is a major molecular mechanism 
that controls animal development. Moreover, deregulation of Wnt signaling is tightly 
linked to human disease, such as multiple forms of cancer and bone malformation 
(Clevers, 2006; Klaus & Birchmeier, 2008). In sporadic colorectal cancer, the mostcommon 
form of intestinal cancer, mutations in multiple Wnt signaling components have been 
found, ectopically activating the Wnt pathway. This is best illustrated by the gene 
adenomatous polyposis coli (APC) which is mutated in more than two-thirds of the cases 
(Segditsas & Tomlinson, 2006). More recently, Wnt signaling received additional attention 
for its important role in specification and maintenance of stem cells in various tissues 
and organs (Wend et al., 2010). Therefore, it is of critical importance to have a good 
understanding of this pathway. Over the last few decades much work has focused on the 
different signal transduction mechanisms initiated by binding of the Wnt ligand to 
receptors of Wnt responsive cells. More recently, also the Wnt posttranslational 
modifications and the secretion mechanismin the Wnt producing cells have received 
much attention. Wnt proteins were originally identified in Drosophila (Nusslein-Volhard 
& Wieschaus, 1980) and mice (Nusse & Varmus, 1982), which were called Wingless(Wg) 
and Int1, hence the name Wnt. Wnt proteins are secreted lipid-modified glycosylated 
signaling molecules that are essential in various developmental processes. Wnt proteins 
contain an N-terminal signal sequence and are palmitoylated on a conserved cysteine 
residue. The palmitate is added in the endoplasmatic reticulum by the protein Porcupine 
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(Porc) and is essential for signaling. These proteins are characterized by a high number 
of conserved cysteine residues and are glycosylated and lipid modified at two conserved 
residues, which makes Wnt proteins highly hydrophobic. Surprisingly, however, Wnt 
proteins have been shown to diffuse over several cell diameters in the extracellular 
space. Additional factors in the extracellular space are able to regulate the activity of the 
Wnt morphogenetic gradient. Proteins of the secreted frizzled related protein (SFRP) 
family and the Wnt interacting factor 1(Wif1) can bind Wnts and are therefore seen as 
Wnt inhibitors. Other factors act at the level of the Wnt receptors such as the Wnt 
signaling inhibitor Dickkopf (Dkk) and Wnt activator R-spondin. Wnt receiving cells can 
induce several signaling cascades in response to the morphogenetic Wnt gradient. The 
best studied signal transduction mechanism is the Wnt/β-catenin pathway, which is 
also known as the canonical Wnt pathway (Clevers, 2006). Here, binding of Wnt to its 
receptors induces the stabilization of β-catenin, which is otherwise targeted for 
proteasomal degradation. Stabilized β-catenin translocates into the nucleus and 
activates TCF-LEF depended transcription of Wnt target genes (Figure 1.4). 
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Figure 1.4 Activation of Wnt signaling pathway. In the absence of Wnt ligands, β-
catenin binds to a destruction complex containing APC, Axin, and the CK1 and GSK3 
kinases and is marked for proteolytic destruction (“off”). Wnt signaling promotes CK1γ 
and GSK3β mediated hyperphosphorylation of LRP5/6 and enhances Dsh 
phosphorylation, which jointly recruit Axin to the receptor complex at the plasma 
membrane (“on”), where it undergoes proteolytic degradation. Unphosphorylated β-
catenin is no longer rapidly degraded and enters the nucleus. Many of the β-catenin 
destruction complex components are shuttling proteins that distribute both in the 
cytoplasm and the nucleus, and some of these, such as APC, Axin, and Bcl-9/Lgs, are 
required for the accumulation or retention of β-catenin in the nucleus. Adapted from 
Willert and Jones, 2006.  
 
 
Wnt- signalling participates in embryogenesis, stem cell biology, and human cancer. At 
present there are 19 Wnt genes identified encoding unique ligands (Cadigan & Nusse, 
1997.). Wnt- β-signalling has been classified in two major pathways, canonical and non-
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canonical. Wnts induce intracellular signalling in both pathways by binding to Frizzled 
receptors (Bhanot et al., 1996; He et al., 1997; Yang-Snyder et al., 1996; Strutt, D. 2003.). 
Six Frizzled genes have been identified so far. The Wnt- non-canonical pathway can be 
further divided in two different signal transduction pathways. The Wnt/PCP pathway, 
which affects planar cell polarity through rearrangements of the cytoskeleton involving 
JNK and ROCK, and the Wnt/Ca2+ pathway affecting NF-AT transcription activity, 
through calcineurin, PKC and PLC. In the canonical pathway, the Wnt co-receptors 
LRP5/6 are also required for signal induction (Pinson et al., 2000). Canonical Wnt- β 
signalling involves activation of β -catenin, the key effector of this pathway, which is a 
ubiquitously expressed multifunctional protein. β-catenin links E-cadherin to the actin 
cytoskeleton and thus has an important function in cell-cell adhesion. In the nucleus, β-
catenin functions as a transcription cofactor regulating cell proliferation and 
differentiation (Gumbiner et al., 1995).  
 
1.4.1 CANONICAL WNT SIGNALING: COLLABORATION AND 
CONNIVANCE 
 
Signaling pathways are a fundamental aspect of how cells communicate with one 
another and respond to their environment, influencing cell growth, cellular 
differentiation and apoptosis (Clevers, 2006; Logan & Nusse, 2004). In the simplest form, 
a signaling pathway functions through the binding of a ligand to its specific receptor 
which in turn activates the receptor in order to elicit an intracellular response (Figure 
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1.5).  
 
 
 
 
 
 
 
 
 
Figure 1.5 Model for the activation of the Wnt/β-catenin pathway. (A) In absence 
od WNT ligand. (B) On binding of Wnt to the receptors, FZD and LRP, Dvl binds to FZD 
and recruits the destruction complex through interaction with axin. Subsequently, LRP is 
phosphorylated and acts as docking site for axin. (C) Binding of axin to LRP leads to 
inhibition of the destruction complex and stabilization of β-catenin. (Fuerer and Nusse, 
2008).  
 
 
The Wnt family of secreted glycoproteins are the ligands which promote cell 
proliferation, cell polarity, neural differentiation, and cell fate determination during 
embryonic development and tissue homeostasis (Clevers 2006; MacDonald et al., 2009). 
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β-catenin is a fundamental player in the canonical Wnt pathway. In the presence of 
ligand, β-catenin is bound to the destruction complex which is composed of several 
proteins including a scaffolding protein Axin, adenomatous polyposis coli (APC), casein 
kinase 1α (CK1), and glycogen synthase kinase 3β (GSK3β). When bound, β-catenin is 
phosphorylated on Serine (Ser) 45 by CK1α which primes β-catenin for the sequential 
phosphorylation of Threonine (Thr) 42, Ser 39, and Ser 37 by GSK3β. This 
phosphorylation of β-catenin promotes the recognition by β-TRCP, an E3 ubiquitin 
ligase, which leads to the ubiquitination of β-catenin and proteasomal degradation. This 
continuous degradation prevents cytoplasmic β-catenin from translocating into the 
nucleus, binding to transcription factors T‐cell factor and lymphoid enhancer factor 1 
(TCF/LEF-1), and stimulating Wnt responsive genes. In the presence of Wnt 
glycoproteins, Wnts bind simultanously to the seven-pass transmembrane Frizzled 
receptors (Fzd) and the lipoprotein receptor-related protein 5 or 6 (LRP5/6) co-
receptor. Proteoglycans, such as Dally (Lin and Perrimon, 1999) or Syndecan 1, 
concentrate Wnt ligands at cell surfaces where they can bind to LRP5/6 and Fz receptors 
to mediate their interaction. β-catenin is the key player in this pathway and is degraded 
by the proteasome in the absence of an activating Wnt signal. The E3-ubiquitin-ligase β-
transducin-repeat-containing protein  (β -TRCP) targets β-catenin for proteasomal 
destruction, but only recognizes its substrate in a phosphorylated state. β-catenin is 
phosphorylated by the destruction complex, which is composed of at least the Axis 
inhibition protein 1 (Axin1), adenomatous polyposis coli (Apc), casein kinase 1 (CK1) 
and glycogen synthase kinase 3β (GSK-3β). Axin1 interacts directly with all the other 
members of the destruction complex and functions as a scaffold protein. The two 
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serine/threonine kinases CK1 and GSK3βphosphorylate β-catenin, which is then 
ubiquitinylated by βTRCP and degraded by the proteasome. Signals induced by Wnt 
proteins interrupt the formation of the degradation complex, there by preventing the 
phosphorylation and destruction of β-catenin .  
WNT proteins 
  
Wnt proteins bind to the extracellular N-terminal cysteine-rich domain of the Frizzled 
(Fz) receptor, which is in a complex with the low density lipoprotein receptor-related 
protein 5 or 6 (LRP5/6). After an activating Wnt signal the protein Dishevelled (Dvl) is 
recruited to the receptor complex and the cytoplasmic tail of LRP5/6 is phosphorylated 
by CK1 and GSK3β. This provides a docking site for Axin1, which is then recruited to the 
receptor complex. Axin1 is sequestered and assembly of the destruction complex is 
disrupted. β-catenin will accumulate in the cytoplasm and translocate to the nucleus, 
where it initiates transcription by activating T cell factor/lymphoid enhancer factor 
(TCF/LEF) transcription factors. In the absence of β-catenin TCF forms a 
transcriptional repressor complex with Groucho. Groucho is physically displaced by β-
catenin and Pygopus and Legless are recruited to assemble a transcriptional activator 
complex (Clevers, 2006; Logan & Nusse, 2004; MacDonald et al., 2009; Mosimann et al., 
2009; Staal & Clevers, 2005). β-catenin is rapidly turned over by ubiquitination and 
degradation by the proteasome pathway under unstimulated conditions. This requires 
phosphorylation of β-catenin by a “degradation complex” consisting of APC, Axin, 
GSK3, and CK1, followed by binding of β -Trcp (Rubinfeld et al., 1996; Munemitsu et al., 
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1995). Mutations in components of the “degradation complex” lead to constitutive 
accumulation of β-catenin in a number of cancers. APC mutations are common in 
colorectal cancers (Kinzler & Vogelstein, 1997). Axin1 mutations have been reported in 
hepatocellular carcinomas (Satoh et al., 2000) while β-Trcp mutations have been 
reported in prostate cancers (Gerstein et al., 2002).  
 
1.4.2 THE MANY FACES OF THE CANONICAL WNT PATHWAY 
  
Wnt proteins are characterized by a high number of conserved cysteine residues (Miller, 
2002) and are post-translationally glycosylated and lipid modified. Secreted Wnt 
proteins form concentration gradients in the extracellular space, to which cells 
expressing the appropriate receptors respond in a concentration dependent manner. 
Although much research has focused on the signaling cascades that are triggered by Wnt 
proteins, the importance of Wnt producing cells in the Wnt signaling pathway is only 
recently becoming apparent. With the identification of several components required in 
the Wnt producing cells for Wnt signaling, the idea evolved that the production and 
secretion of Wnt molecules requires a specialized secretory machinery that offers an 
additional layer of control to the Wnt signaling pathway. When Wnt proteins were first 
isolated, a surprising finding was that they are highly hydrophobic (Bradley & Brown, 
1990). This was explained by the identification of two lipid modifications; a saturated 
acyl chain, palmitate, attached to a conserved cysteine residue (C77 in mouse Wnt3a) 
(Willert et al., 2003) and a mono-unsaturated acyl chain, palmitoleate, on a conserved 
serine residue (S209 in mouse Wnt3a) (Takada et al., 2006). Mutating the C77 position in 
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Wnt5a also led to a loss of hydrophobicity, suggesting that the lipid modification on this 
residue is conserved (Kurayoshi et al., 2007), although it is not known whether the same 
type of acyl chain is used. Mutational analysis has shown that lipid modifi cation is 
required for the secretion as well as the signaling activity of Wnt proteins. In mammalian 
Wnt proteins, mutating C77 to alanine strongly interferes with signaling activity, while 
secretion is largely unaffected (Galli et al., 2007; Komekado et al., 2007; Kurayoshi et al., 
2007; Willert et al., 2003). Mutating the S209 residue, on the other hand, has a strong 
effect on secretion, resulting in accumulation of the mutant Wnt protein in the 
endoplasmic reticulum (ER) (Takada et al., 2006). The effect of mutating the lipid 
modified residues is however less clear in Drosophila. In S2 tissue culture cells, both C77 
and S209 mutants of the Wnt protein Wg are secreted, while in transgenic animals, there 
is accumulation of the C77A mutant Wg protein in the ER (Franch-Marro et al., 2008a). 
Despite these discrepancies, the current consensus is that lipidation is important for the 
exit of Wnt from the ER. The observed accumulation of Wnt proteins in the ER might be 
the result of defects in the folding of the mutated protein. Alternatively, membrane 
tethering might be required for the interaction of Wnt with the ER exit machinery. It 
cannot be excluded, however, that the ER accumulation is caused by overexpression of 
the mutated protein. Therefore, to better understand these results, it will be important 
to analyze these mutant Wnt proteins under physiological conditions. In C. elegans as 
well as in Drosophila , alleles of Wnt were isolated in which the C77 residue is mutated. 
This leads to a strong loss of Wnt signaling, although not as severe as observed in Wnt 
null mutants (Coudreuse et al., 2006; Couso & Martinez Arias, 1994; Willert et al., 2003), 
suggesting that C77 mutated Wnts still have residual signaling activity. The subcellular 
distribution of the mutated Wnt proteins has however not been studied. Interestingly, 
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genetic screens have not recovered mutants with mutations in the S209 residue. The 
only functional data to compare the two lipid modification mutants is the above 
mentioned S2 cell secretion assay (Franch-Marro et al., 2008a). Here it was found that, in 
agreement with the C. elegans and Drosophila mutants, the C77 mutant has only residual 
activity, while the S209 mutant has retained more activity. Another interesting question 
is the biological significance of the S209 acylation with a mono-unsaturated fatty acid. 
The resulting double bond will induce a kink in the acyl chain, which may negatively 
influence the interaction with lipid ordered membrane domains (Moffett et al., 2000). It 
was shown for proteins such as Fyn, Annexin II and Gai that acylation with unsaturated 
fatty acids results in displacement of proteins from membrane domains with ordered 
lipid structure (Liang et al., 2001; Moffett et al., 2000; Zhao & Hardy, 2004). Therefore, 
this unsaturated lipid modification could play an important role in targeting of Wnt to 
specific membrane domains during secretion. Furthermore, modification with an 
unsaturated acyl chain will slightly decrease membrane affinity compared to a saturated 
acyl chain, which may be important for the extracellular spreading of the secreted Wnt 
protein. A good candidate for mediating the lipid modification of Wnt is Porcupine 
(Porc), which was originally identified as a segment polarity gene in Drosophila (van den 
Heuvel et al., 1993) and encodes a member of the membrane-bound O-acyltransferase 
(MBOAT) family. Porc localizes to the ER, where Wnts are thought to be lipid modifi ed 
(Zhai et al., 2004), and interacts with Wnts in a region that includes the C77 residue 
(Tanaka et al., 2002; Tanaka et al., 2000). Depletion of Porc leads to a complete block in 
Wnt secretion and accumulation of Wnt in the ER (van den Heuvel et al., 1993), similar as 
observed with the murine Wnt3a (S209) mutant. Furthermore, Porc depletion strongly 
reduces the hydrophobicity of Wnts (Zhai et al., 2004), whereas Porc overexpression 
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increases hydrophobicity (Galli et al., 2007). Given the similarity in phenotype, it is likely 
that Porc is responsible for the S209 O-esterification of Wnt with palmitoleic acid. 
Whether Porc is also responsible for the C77 lipid modification is less clear, since this 
might be masked by the S209 modification and subsequent ER retention. Furthermore, 
one might question whether a single enzyme can specifically catalyze both oxyester 
(S209) as well as thioester (C77) formation using two different substrates (palmitoyl 
and palmitoyleoyl CoA) (Jing and Trowbridge 1987; Rose et al., 1984). A possible 
explanation could be that Porc is responsible for the S209 acylation of Wnt and that 
subsequent C77 acylation is dependent on a different enzyme. Another explanation 
could be that both C77 as well as S209 get palmitoylated by Porc and that the S209 
palmitate gets de-saturated to palmitoleate by another enzyme. Experimental evidence 
for this possibility is however lacking. In addition to a role in Wnt maturation and 
secretion, lipidation is also important for the signaling activity of Wnt proteins, as 
illustrated by the S2 reporter assays and genetic mutants discussed above and by the 
observation that enzymatic de-lipidation of purified secreted Wnt strongly inhibits 
signaling activity. Lipid modification is thought to restrict the spreading of Wnt in the 
extracellular environment and to concentrates it at the membrane for signaling. In 
addition, the lipid modifications are also required for the interaction with its receptors, 
as de-lipidation or mutation of C77 also results in a strong reduction in the affinity of 
Wnt for the Wnt binding domains of its receptors LRP and Frizzled (Cong et al., 2004; 
Franch-Marro et al., 2008a; Komekado et al., 2007; Kurayoshi et al., 2007). Wnts are 
modified by multiple N-linked glycosylations, which, like the lipid modifications, are not 
well understood and are likely involved in regulating both secretion and signaling. For 
example, upon enzymatic de-glycosylation of secreted Wnt, signaling activity is strongly 
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reduced, even though it still interacts with the Frizzled receptor (Komekado et al., 2007). 
Moreover, mutating the presumed modified residues or inhibiting the modification by a 
glycosylation inhibitor strongly affects Wnt secretion (although this may not be the case 
for all Wnts) (Komekado et al., 2007; Kurayoshi et al., 2007). These effects on secretion 
could be caused by folding defects, as one of the functions of glycosylation is to facilitate 
the folding of proteins in the ER (Caramelo & Parodi, 2007). Surprisingly, overexpression 
of Porc stimulates both lipidation and glycosylation and Porc depletion was reported to 
decrease glycosylation (Galli et al., 2007; Tanaka et al., 2002). It seems unlikely that Porc 
is directly responsible for the glycosylation of Wnt. It may, however, be involved in the 
recruitment of the oligosaccharide transferase (OST) complex. Alternatively, Porc 
overexpression may facilitate glycosylation by promoting membrane tethering of Wnt, 
making it better accessible to the OST complex. Three independent groups identified the 
multi-pass transmembrane protein Wls (also known as Evenness interrupted/Evi or 
Sprinter) as a critical component of the Wnt secretion machinery (Banziger et al., 2006; 
Bartscherer et al., 2006; Goodman et al., 2006). Wls is specific for Wnt secretion, since its 
depletion does not affect other secreted proteins. It is a highly conserved multi-pass 
transmembrane protein that binds Wnt in co-immunoprecipitation experiments 
(Banziger et al., 2006; Coombs et al., 2010; Fu et al., 2009). Wls localizes most 
prominently to the Golgi, the plasma membrane and endosomes (Banziger et al., 2006; 
Bartscherer et al., 2006; Belenkaya et al., 2008; Franch-Marro et al., 2008b; Port et al., 
2010; Yang et al., 2008), indicating that it functions downstream of Porc in the secretory 
pathway. Analysis of Wls mutants in Drosophila showed that in the absence of Wls, Wnt 
accumulates in the Golgi, suggesting that Wls functions as a sorting receptor that 
transports Wnt from the Golgi to the cell surface for release. It was found that upon 
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inhibition of clathrin mediated endocytosis (by depletion of the AP2μ subunit DPY-23 
in C. elegans or dynamin in Drosophila ) Wls accumulates at the plasma membrane 
(Belenkaya et al., 2008; Pan et al., 2008; Yang et al., 2008). As this leads to a strong defect 
in Wnt signaling, it was proposed that Wls is endocytosed and is recycled to take part in 
multiple rounds of Wnt secretion (through a pathway that will be discussed below). In 
this model, Wls plays a central role in the Wnt secretion pathway. Regulation of the 
trafficking of Wls therefore represents a mechanism to closely control Wnt secretion. A 
key question that remains to be addressed is how Wnt is released from Wls. It has 
recently been shown that endosomal acidification is essential for the dissociation of Wnt 
form Wls, as inhibition of acidification by treatment with bafilomycin, a V-ATPase 
inhibitor, interferes with Wnt secretion (Coombs et al., 2010). Intracellular and plasma 
membrane levels of both Wnt and Wls were increased and importantly, Wnt and Wls 
remained in complex together. This suggests that vesicular acidification is somehow 
involved in the release of Wnt from Wls. However, a decrease in pH was not enough to 
dissociate a purified Wls-Wnt complex in vitro. The Wnt binding domain of Wls was 
mapped to the first intraluminal loop and modeling of the structure of this domain 
revealed that it may fold into a lipocalin-like structure (Coombs et al., 2010). Lipocalins 
are a family of secreted proteins that can bind a range of hydrophobic molecules, 
including palmitate (Flower, 1996), indicating that the lipocalin-like domain of Wls might 
bind to the Wnt lipid modifications. In support of this possibility is the recent 
observation from the Nusse laboratory that soluble Wnt isolated from tissue culture 
medium is in complex with the lipocalin family member Swim (Nusse et al., 2008). It was 
shown that the S209 lipid modification is essential for the binding of Wnt to Wls, 
whereas the palmitoylated C77 residue is not (Coombs et al., 2010), indicating that in the 
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case of Wls the lipocalin domain may bind the mono-unsaturated palmitoleic acid 
residue instead of the palmitate residue. Interestingly, it has been shown that a plant 
lipocalin family member dimerizes upon vesicular acidification (Arnoux et al., 2009). 
This suggests the intriguing possibility that vesicular acidification en route to the plasma 
membrane induces the release of Wnt from Wls by triggering dimerization of the Wls 
Wnt binding domains. A recent study provides an example where Wnt may be required 
to traffic through the endocytic pathway for release. The idea that the Wnt producing cell 
itself might promote Wnt spreading by regulating its own plasma membrane 
composition is appealing. Another mechanism that may assist the release and spreading 
of Wnt depends on Reggie-1/flotillin, which is a major component of membrane 
microdomains (Katanaev et al., 2008). Overexpression of Reggie-1 strongly expands the 
signaling range of Wnt by facilitating the capacity of Wnt to diffuse in the tissue. The 
mechanism by which Reggie-1 achieves this increase in Wnt spreading is however still 
unknown. Since Wnt signaling is such a key mechanism of development and adult tissue 
homeostasis, close regulation of Wnt signaling is essential. It is clear that there are 
several layers of regulation of the Wnt secretion process. First, there is transcriptional 
control of Wnt, but also of Wnt secretion factors. This is illustrated by Wls in the mouse, 
which is a target of the canonical Wnt/β-cateninpathway. This suggests a positive 
feedback mechanism in which Wnt stimulates Wnt secretion through an autocrine or 
paracrine mechanism (Fu et al., 2009). The induction of Wls expression by canonical Wnt 
signaling is however not evolutionarily conserved, as constitutive activation of canonical 
Wnt/ β-catenin signaling in the Drosophila wing disc did not alter Wls levels (Port et al., 
2008).  
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Frizzled (FZD) receptors  
Wnt ligands interact with the cell surface receptor, Frizzled (FZD). The initial connection 
between seven-transmembrane-span proteins of the Fz family and Wnt proteins came 
from studies in Drosophila cell culture. Transfection of Drosophila frizzled 2 (fz2) 
confers the ability to bind Wingless (Wg; a fly Wnt) and stabilize Armadillo (Arm; the fly 
β-catenin) upon cells that do not express Fz2 and are unresponsive to Wg (Bhanot et al., 
1996). Additional evidence implicating Fzs in Wnt signaling came from mis-expression 
studies in Xenopus (Yang-Snyder et al., 1996; He et al., 1997) and the finding that a 
mutation in lin-17, which encodes a Fz, affects T-cell polarity in Caenorhabditis elegans 
(Sawa et al., 1996), which is controlled by LIN-44, a Wnt (Herman et al., 1995). FZD 
receptors are seven-pass transmembrane receptors which have cycteine-rich domains 
(CRD) in their N-terminus. Through the CRD, FZD receptor binds Wnt ligands. In general, 
it is thought that a monomeric FZD receptor transmit signals downstream upon binding 
with Wnt ligand, however, the crystallographic resolution of the structure of the mouse 
FZD8 and sFRP3 CRD domains suggested that CRDs might be able to homodimerise or 
heterodimerise. Furthermore, there are reports showing that dimerisation of FZD 
receptor activates the Wnt/β-catenin pathway and that FZD form specific homo-and 
hetero-oligomers. These reports suggest the wide possibility of the signal transmission 
mechanism downstream of FZD receptor. Upon the binding of Wnt to FZD receptor, the 
intracellular amino sequences, K-T-X-X-X-W directly binds to Dishevelled proteins. 
There are 10 reported human frizzled receptors. Phylogenetically, the Frizzled receptors 
fall into four groups. Frizzled-1, 2 and 7, and Frizzled-3 and 6 make up two related 
groups, while Frizzled-5 and 8 comprise a third group, and Frizzled-4, 9 and 10 generate 
a distant fourth group (Carron et al. 2003 ).  
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LRP5, LRP6 
There also exist co-receptors of FZD receptor. A genetic study using flies showed that a 
single-pass trans-membrane receptor, Arrow, is required to establish a segment polarity 
triggered by Wg signaling. Arrow is homologous to two members of the mammalian low-
density lipoprotein receptor (LDLR)-related protein (LRP) family, LRP5 and LRP6. 
LRP5/6 function as co-receptors of FZD receptor and binding of Wnt ligand to both FRZ 
receptor and LRP5/6 co-receptor activates Wnt/β-catenin pathdway. LRP5 was first 
cloned as an apolipoprotein E binding receptor in hepatocytes and adrenal cortex (Kim 
et al., 1998; Hey et al., 1998; Brown et al., 1998). The gene is highly conserved among 
different species (Houston & Wylie et al., 2002) and is designated “arrow” in 
invertebrates (Wehrli et al., 2000). LRP5 was later associated to type 1 diabetes 
(Figueroa et al., 2000; Twells et al., 2003), and being essential in cholesterol metabolism 
and glucose-induced insulin secretion (Fujno et al., 2003: Magoori et al., 2003). LRP5 was 
shortly thereafter identified as an essential component in Wnt signalling (Tamai et al., 
2000; Wehrli et al., 2000). LRP5 functions as a coreceptor and binds Wnt ligands together 
with Frizzled receptors, with subsequent activation of the β -catenin dependent Wnt 
signalling pathway (Schweizer & Varmus, 2003; Holmen et al., 2002). Phosphorylation of 
LRP5/6 by CK1 gamma and GSK-3 transduce activating signals (Davidson et al., 2005), 
while CK1 epsilon phosphorylation has an inhibitory effect (Swiatek et al., 2006). 
Receptor phosphorylation leads to Axin binding and subsequent stabilisation of β-
catenin (Tamai et al., 2004). LRP5 activity is inhibited by DKK1 through binding to 
kremen (Mao et al., 2002). Using live imaging of vertebrate cells expressing fluorescently 
tagged Axin and LRP6, (Bilic et al. 2007) demonstrated that Wnt signaling induces 
plasma membrane-associated LRP6 aggregates. In unstimulated cells, Axin localizes to 
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intracellular punctate while LRP6 uniformly stains at the cell membrane. Wnt 
stimulation results in the rapid formation of LRP6 punctate, referred to as “LRP6 
signalosomes.” This event is followed by Axin recruitment to the aggregates. The Tp1479 
antibody was used to show that the punctae are enriched for CKIγ-mediated 
phosphorylated LRP6, and that these structures also contain Fz8, Dvl2, GSK, and Axin 
(Bilic et al., 2007).  
  
Kremen, Ror2 and Ryk 
  
A single-pass trans-membrane receptor, Kremen, was initially identified as a binding 
partner of a negative regulator of Wnt/β-catenin signaling, Dkk1. Upon binding to 
Dkk1, Kremen is internalized by endocytosis with LRP5/6, leading to a suppression of 
Wnt/β-catenin pathway (Mao et al., 2002). The Ror family of receptor tyrosine kinases 
(RTK) consists of two structurally related proteins, Ror1 and Ror2. They have an 
extracellular CRD, a membrane proximal kringle (KR) domain, and intracellular 
cytoplasmic tyrosine kinase domain and a proline-rich domain near the c-terminus 
(Forrester er al., 1999). Ror2 has been shown to act as an alternative receptor or co-
receptor for Wnt5a (Mikels & Nusse, 2006). In addition to its ability to bind Wnt5a, Oishi 
and colleagues reported the ability of Ror2 to bind some FZD receptors as well (Oishi et 
al., 2003), suggesting that Ror2 might play a role as a co-receptor. The extracellular 
domain of Ror2 associates with Wnt5a but not with Wnt3a. Furthermore, Ror2 mediates 
Wnt5a signaling by activating the Wnt/JNK pathway and/or inhibiting the β-
catenin/Tcf pathway. It has also been shown that Ror2 interacts with filamin A and that 
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it mediates Wnt5a-dependent cell migration (Nishita et al., 2006). Ryk is a single-pass 
transmembrane RTK and Ryk can interact at least with Wnt1 and Wnt3a (Lu et al., 2004). 
Ryk family members have been shown to be required for Wnt signaling in several 
contexts. For example, knockdown of Ryk reduces the Wnt1-dependent TCF activation in 
HEK-293 cells (Lu et al., 2004). However, whether Ryk mediates Wnt signaling in concert 
with Fz-LRP5/6 or independently is not clear and also how Ryk activates the 
intracellular signaling cascade after binding to Wnt ligands has not yet been uncovered.  
  
WNT negative regulators sFRPs (Secreted Frizzled-Related Proteins) 
  
The sFRPs are a group of Wnt-binding glycoproteins that resemble the transmembrane 
receptor FZD. Their actions are mainly considered to be inhibitory to Wnt activity, 
however, there are also some reports showing their actions stimulatory to Wnt activity 
at low concentrations (Uren et al., 2000). There are presently eight known members of 
the family, sFRP1 to sFRP5, Sizzled, Sizzled2 and Crescent. On the basis of sequence 
homology, sFRP1, sFRP2 and sFRP5 form a subgroup, as do sFRP3 and sFRP4, which are 
quite distantly related to the other sFRPs. Sizzled, Sizzled2 and Crescent form a third 
group, but they have not been identified in mammals and Drosophila (Kawano & Kypta, 
2003). All sFRPs are secreted and derived from unique genes and none are alternate 
splice forms of the FZD family (Jones & Jomery, 2002). They share sequence similarity 
with the Frizzled receptor CRD (cysteine rich domain), but lack the transmembrane and 
intracellular domains (Leyns at al., 1997; Wang et al., 1997; Finch et al., 1997). Through 
its CRD, sFRP exhibits the ability to bind Wnt. Furthermore, the CRD of sFRP1 also 
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appears to interact with itself to make dimmers or multimers and with FZD (Bafico et al., 
1999). Thus, sFRPs may block Wnt signaling either by interacting with Wnt proteins to 
prevent them from binding to FZD receptors or by forming nonfunctional complexes 
with FZD receptors (Rattner et al., 1997; Lin et al., 1997; Bafico et al., 1999). Human 
sFRP1 is also known as SARP2 (secreted apoptosis-related protein 2) and FrzA (Frizzled 
in aorta). sFRP1 has been reported to bind to Wnt1 (Dennis et al., 1999; Bafico et al., 
1999), Wnt2 (Bafico et al., 1999; Xu et al., 1998), Wnt8 (Jaspard et al., 2000), Wnt4 and 
Wnt3a (Hussain et al., 2004). However, it does not bind to Wnt5a (Dennis et al., 1999; Xu 
et al., 1998). In any event, in binding to Wnts, sFRP1 would seem to act primarily as an 
inhibitor of Wnt signaling (Dennis et al., 1999; Uren et al., 2000). sFRP1 binding to Wnt1 
is reported to be antagonistic to Wnt activity (Bafico et al., 1999). sFRP1 also has been 
reported to protect cells from apoptosis, but this may be context dependent (Barandon 
et al., 2003; Hussain et al., 2004; Roth et al., 2000; Dufourcq et al., 2002). Other functions 
associated with sFRP1 include endothelial cell migration and capillary tube formation 
(Dufourcq et al., 2002), myofibroblast recruitment and collagen deposition, and a sFRP-
induced decrease in MMP-9 activity (Barandon et al., 2003).  
 
WIF1 (Wnt-inhibitory factor 1) 
  
WIF1 is a Wnt binding protein secreted by variety of tumors and embryonic tissues. 
WIF1 has an N-terminal signal sequence, a unique WIF domain (WD) that is highly 
conserved across species, and five EGF-like repeats. Although WIF1 does not share any 
sequence similarity with the CRD domain of FZD or sFRPs, it can bind to Wnt ligands 
 65 
(Kawano & Kypta, 2003). It apparently does so by forming a non-covalent complex with 
Wnt8 and Wnt1 (Hsieh et al., 1999).  
  
Dkks (Dickkopfs) 
  
The Dkk family comprises four structurally-related members (Dkk1 to Dkk4) and a 
unique Dkk3-related protein named Soggy (Sgy), which possesses homology to Dkk3. 
Dkks contain two characteristic cysteine-rich domains separated by a linker region of 
variable length (Glinka et al., 1998; Krupnik et al., 1999). Dkk1 is a negative regulator of 
Wnt-mediated LRP signaling. Dkk1 interacts with LRP5/6 and a single-pass 
transmembrane proteins Kremen1 (Krm1) and Kremen2 (Krm2), which are 
endocytosable molecules (Mao et al., 2002). Using these interactions, Dkk1 can form a 
“bridge” between LRP and Kremen leading to the endocytosis of Kremen accompanied 
by internalization of Dkk/LRP. This internalization blocks LRP 
deactivation/destabilization of axin and results in the phosphorylation / degradation of 
β-catenin (Kawano & Kypta, 2003; Caricasole et al., 1999; Nakamura et al., 2001). Thus, 
Dkk1 acts as a negative regulator of Wnt/β-catenin signaling, but not PCP signaling or 
calcium signaling.  
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β-catenin (CTNNB1) 
  
In the late 1980s, β-catenin was independently discovered twice, on the basis of its 
different functions: structural and signalling. The group of Rolf Kemler isolated β-
catenin, together with two other molecules (α-catenin and γ-catenin/plakoglobin), as 
proteins associated with E-cadherin, the key molecule of Ca2fl-dependent cell adhesion. 
These proteins were named catenins (in Latin catena means chain) to reflect their 
linking of E-cadherin to cytoskeletal structures (Ozawa et al, 1989). The signalling 
potential of β-catenin was exposed through its Drosophila orthologue Armadillo: the 
armadillo gene was discovered in the seminal screens for mutations affecting 
segmentation of the Drosophila embryo, performed by Eric Wieschaus, Christiane 
Nusslein-Volhard, and Gerd Jurgens (Wieschaus et al, 1984). Epistatic analysis 
determined that the armadillo segmentation function is regulated by Wingless 
(Riggleman et al, 1990). This finding was a key step in the subsequent characterization of 
the Wnt/β-catenin (or Wingless/ Armadillo, respectively) signalling cascade, and of the 
functions and mutual interactions of its individual components. Another important part 
of this mosaic was revealed by the description of the basic pathway leading from the 
Wingless ligand through Dishevelled to regulation of Armadillo stability by 
Shaggy/Zeste-white-3 (GSK3 in vertebrates) (Siegfried et al, 1994). Finally in the mid-
1990’s several groups independently found that the signalling function of β-
catenin/Armadillo in the nucleus is mediated via T-cell factor (TCF)/Lymphoid 
enhancer-binding factor (Lef) transcription factors, which in association with β-catenin 
trigger Wnt-mediated transcription (Behrens et al., 1996; Huber et al, 1996; Molenaar et 
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al, 1996; Brunner et al, 1997; van de Wetering et al, 1997). The β-catenin protein (781 aa 
residues in humans) consists of a central region (residues 141–664) made up of 12 
imperfect Armadillo repeats (R1–12) that are flanked by distinct N- and C-terminal 
domains, NTD and CTD, respectively. A specific conserved helix (Helix-C) is located 
proximally to the CTD, adjacent to the last ARM repeat (residues 667–683) (Xing et al, 
2008). The NTD and the CTD may be structurally flexible, whereas the central region 
forms a relatively rigid scaffold. This scaffold serves as an interaction platform for many 
β-catenin binding partners, at the membrane, in cytosol, and in the nucleus (Huber et al, 
1997). β-Catenin is a founding member of the Armadillo (ARM) repeat protein 
superfamily. Each ARM repeat of its central region comprises B42 residues, forming 
three helices arranged in triangular shape. Together, all ARM repeats form a superhelix 
that features a long, positively charged groove. Biochemical and crystal structure 
analyses revealed that many of β-catenin’s binding partners share overlapping binding 
sites in the groove of the central β-catenin region: consequently, these partners cannot 
bind to β-catenin simultaneously. This mutual exclusivity is certainly valid for the key 
β-catenin interacting molecules: E-cadherin (the main partner in adherens junctions), 
APC (the main partner in the destruction complex), and TCF/Lef (the main partner in 
the nucleus). All these β-catenin interactors bind to the core binding site comprising 
ARM repeats R3–R9, where they form salt bridges with two key amino-acid residues, 
Lys312 and Lys435. Other ARM repeats are also involved, at least in strengthening the 
interaction (Graham et al, 2000; Huber & Weis, 2001; Poy et al, 2001). Free β-catenin is 
recognized by the key scaffold molecules Axin and APC, both of which can directly 
interact with β-catenin and also inter se. The scaffold establishes a platform for 
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associated kinases to phosphorylate β-catenin (Kimelman & Xu, 2006; Roberts et al, 
2011). CK1a phosphorylates β-catenin at Ser45, priming the sequential 
phosphorylation of Thr41, Ser37, and Ser33 by GSK3 (preferentially by GSK3β) (Liu et 
al, 2002; Xing et al, 2003). As a next step, β-catenin bound to APC leaves the destruction 
complex and interacts with the ubiquitin machinery. Ser33 and Ser37 phosphorylated β
-catenin is recognized by β-TrCP and recruited to the Skp1/Cul1/Fbox/ β-TrCP (SCFβ
-TrCP) E3 ubiquitin ligase complex. Ubiquitin-conjugated β-catenin is subsequently 
degraded by the 26S proteasome (Hart et al, 1999). Alternatively, phospho-β-catenin 
can be ubiquitinylated by the single unit E-3 ligase Jade 1 (Chitalia et al, 2008). The 
scaffolding proteins Axin and APC are essential for the GSK3-mediated phosphorylation 
of β-catenin: although GSK3 can modify a plethora of different proteins within a cell as 
a free molecule, it modifies β-catenin only if it is associated with Axin and APC (Hur & 
Zhou, 2010; Wu & Pan, 2010). The rate limiting protein Axin greatly enhances the activity 
of GSK3 on β-catenin (Dajani et al, 2003). APC contributes to the establishment of the 
destruction complex, and stabilizes β-catenin’s phosphorylation status. If N-
terminally phosphorylated β-catenin is not associated with APC, after leaving the 
destruction complex, then it is immediately dephosphorylated by PP2A (Su et al, 2008). 
Activation of Wnt signalling leads to the disassembly of the β-catenin destruction 
complex and GSK3 activity is blocked. The ubiquitously expressed multi-functional 
protein and proto-oncogene β-catenin fulfils important functions in cell-cell adhesion 
by linking E-cadherin to the actin cytoskeleton, and in the canonical Wnt-signalling 
pathway by regulating cell proliferation and differentiation (Funayama et al., 1995; 
Aberle et al., 1994). β-catenin also plays an important role in interactions between 
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cadherins and transmembrane proteins, such as the epidermal growth factor receptor. 
In the absence of growth or differentiation signals free cytoplasmic β - catenin is rapidly 
turned over, initiated by phosphorylation of its amino terminus (Ser-33, Ser-37, Thr-41, 
Ser-45). A multiprotein complex consisting of GSK-3/APC/Axin and other components 
regulates this phosphorylation and promotes subsequent binding of β-Trcp, 
ubiquitination and degradation of β-catenin by the proteasome pathway (Rubinfeld et 
al., 1996; Munemitsu et al., 1996). In melanoma cells, mutations of the β-catenin 
phosphorylation sites in exon 3 (Ser-33, Ser-37, Thr-41, Ser-45) resulted in stabilisation 
of the protein, cytoplasmic/nuclear accumulation and activation of transcription 
(Rubinfeld et al., 1996). Aberrant activation of the Wnt-signalling pathway, by stabilising 
β-catenin mutations in exon 3 was first described in sporadic colorectal cancers and 
melanomas at a frequency of 6-10%.  
 
The nuclear complex 
  
β-Catenin can dynamically shuttle between the cytoplasm and nucleus. Surprisingly, it 
does not contain any classical nuclear localization signal (NLS) or nuclear export signal 
(NES) within its polypeptide sequence. Indeed nuclear import of β-catenin was shown 
to occur importin-karyopterin independently (Fagotto et al, 1998). Recently, β-catenin 
was shown to directly interact with different nuclear pore complex components (NPCs; 
Shitashige et al, 2008; Sharma et al, 2012). By transiently and sequentially binding to 
different NPCs, β-catenin could pass through the nuclear pores. Of the various NPCs 
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interacting with β-catenin, Nup358 seems to be important for docking/undocking of β
-catenin to nuclear pores during the process of nuclear translocation (Sharma et al, 
2012). ARM repeats R10–12 were revealed as crucial for β-catenin nuclear import (and 
export). Moreover, Tyr654 in the last ARM repeat was supposed to affect β-catenin 
import, as a phospho-mimicking mutation strongly enhances nuclear import, indicating 
yet another way in which (p-Tyr654 can promote the signalling activity of β-catenin at 
the expense of its adhesive function (Sharma et al, 2012). There are a few other 
molecular mechanisms facilitating nuclear translocation of β-catenin. The Forkhead-
box transcription factor FoxM1 was shown to directly interact with the ARM repeats 
R11–12 and thereby promotes β-catenin nuclear import in mammalian cells: 
immortalized neural stem cells or MEF’s lacking FoxM1 display a strong reduction of 
nuclear β-catenin and thus reduced β-catenin signalling activity (Zhang et al, 2011). 
FoxM1 might provide its NLS to β-catenin and bipartite β-catenin–FoxM1 complexes 
could be imported to the nucleus. Alternatively, or additionally, FoxM1 could act as a 
nuclear anchor preventing export of β-catenin out of the nucleus (Figure 1.6).  
 
 
 
 71 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Schematic rapresentation of interactions between different Wnt 
transcriptional regulators. The schematic diagrams indicate the overlapping sites 
within the β-catenin armadillo (ARM) repeats for LEF-1/TCF and APC. Phosphorylation 
of APC by CK1 dramatically enhances its affinity for β-catenin (Ha et al. 2004; Xing et al. 
2004), which would disfavor binding to LEF-1/TCF. Similarly, CK1 phosphorylation of 
LEF-1 has been reported to disrupt binding to β-catenin (Hammerlein et al. 2005). Other 
post-translational protein modifications, potentially including β-TrCP-mediated 
ubiquitination of β-catenin, are likely to regulate the protein interactions within the 
complex; however, the precise mechanism is unknown. The C terminus of β-catenin 
interacts, directly or indirectly, with several distinct chromatin remodeling complexes. 
Sequential interactions with these various complexes is likely to govern transcription 
initiation and elongation at Wnt target genes. (Willert and Jones, 2006). 
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Once in the nucleus β-catenin can activate transcription of Wnt/β-catenin target genes. 
Since β-catenin does not possess a DNA binding domain it needs DNA binding partners 
tobring it to the promoters of its target genes (Huber et al, 1997; Huber et al., 2001; Xing 
et al, 2008). Hence, β-catenin initiates transcription onlyas a member of bipartite or 
multimeric complexes wherein one partner provides association with specific 
responseelements on target genes (e.g., Wnt response elements, WREs) and β-catenin 
acts as the central transcriptional activator. TCF/Lef transcription factors serve as the 
main nuclear partners of β catenin guiding it to specific DNA loci. Within the coactivator 
complex, β-catenin functions as a scaffold to link the LEF-1/TCF proteins to specific 
chromatin remodeling complexes, as well as to the Wnt coactivators, Bcl-9/Lgs and 
Pygopus. The N-terminal armadillo (ARM) repeat of β-catenin interacts directly with 
Bcl-9/Lgs, which forms part of a “chain of adaptors” (Stadeli et al., 2006) that 
connects LEF-1 to the Pygopus (Pygo) PHD finger protein (Belenkaya et al. 2002; Kramps 
et al. 2002; Parker et al. 2002; Thompson et al. 2002). Bcl-9/Lgs and Pygopus are 
implicated in nuclear localization of β-catenin (Townsley et al. 2004) as well as 
transcription (Thompson 2002; Hoffmans et al. 2005). LEF-1/TCF proteins bind to the β-
catenin central ARM repeats in a region that largely overlaps the binding sites for APC or 
E-cadherin. Other β-catenin- interacting proteins include the DNA ATPase/helicase 
TIP49a/Pontin52 (Bauer et al. 2000), which is present in mammalian 
TRRAP/p400/TIP60, INO80, and SWRCAP/SWR1 chromatin remodeling complexes, 
Brg-1, and CBP/p300 (Figure 1.7).  
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Figure 1.7 The TCF/b-catenin transcriptional switch. (A) In an unstimulated (Wnt 
OFF) situation, TCF/Lef transcription factors associated with Groucho and/or CtBP co-
repressors act as transcriptional repressors. (B) The binding of b-catenin displaces co-
repressors, thereby promoting transcriptional derepression (Wray et al., 2011). (C) b-
Catenin converts TCF/Lef into transcriptional activators providing an interacting 
platform for the multitude of dynamically cycling transcriptional co-activators. (D) 
TCF/b-catenin-mediated transcription may also be deactivated by transcriptional 
corepressors, such as Mtgr-1, COOP, or Groucho/TLE kicking off b-catenin. (E) TCF/b-
catenin-mediated transcription may also be deactivated by direct interaction with 
transcriptional co-repressors (Reptin or NCoR/ SMRT) recruiting histone deacetylases. 
(F) Chibby with 14-3-3 protein or APC with CtBP can sequester b-catenin away from 
target promoters and export it out of the nucleus. Binding of ICAT or Chibby blocks the 
interaction between TCFs and b-catenin (Valenta et al., 2012). 
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1.5 HEMATOPOIETIC REGENERATION: TOO MUCH OF A WNT 
THING 
 
Canonical Wnt signaling has been reported to play a major role in the modulation of the 
delicate balance between stemness and differentiationin several adult stem cell niches, 
including hair follicles in the skin, mammary gland, and intestinal crypt. It was reported 
that β-catenin activation is crucial for the development of cancer stem cells in various 
HMs, including AML (Wang et al., 2010), mixed-lineage leukemia (MLL) (Yeung et al., 
2010), and CML (Heidel et al., 2012. Moreover, canonical Wnt signaling plays a crucial 
role in the maintenance and establishment of fetal HSCs, further indicating that the 
signaling pathway sustains LSC development. Evidence from fetal HSC indicates that the 
deletion of β-catenin during the development of these cells results in the impairment of 
self-renewal (Heidel et al., 2012), and very recent studies have revealed that β-catenin is 
also crucial in adult HSC maintenance (Ruiz-Herguido et al., 2012).Along with 
maintaining a steady state of hematopoietic cell production for the lifetime of an 
organism, hematopoietic stem cells(HSCs) also have the ability to proliferate rapidly and 
repair loss of the hematopoietic compartment in response to injury. Loss of cells due to 
events such as chemotherapy, infection, and radiation exposure ablates rapidly cycling 
cells, which includes much of the developing hematopoietic system. In response to such 
injury, HSCs initiate a program of rapid proliferation in order to regenerate the lost 
hematopoietic compartment. Presently, neither the changes in the extracellular 
microenvironment nor the intracellular signals activated by HSCs during the 
proliferative phase of regeneration are known. Furthermore, it is also unknown whether 
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the signals that modulate regeneration after injury are the same as or distinct from those 
implicated in the homeostatic maintenance and growth of HSCs and progenitors. 
Regeneration requires the rapid expansion of HSCs followed by differentiation of these 
cells into mature lineages. This process is mediated by crosstalk between cell intrinsic 
factors and external cues from the microenvironment. Any injury to the hematopoietic 
system results in a significant loss of cells and consequent changes in the 
microenvironmental milieu of HSCs. It is likely that HSCs sense these changes and in turn 
activate intracellular signals to initiate the proliferation process that ultimately leads to 
successful regeneration of the hematopoietic compartment. Studies examining the bone 
marrow environment following injury have revealed changes in mRNA levels of multiple 
growth factors, including stem cell factor, stromal cell derived factor 1, and transforming 
growth factor β1. Congdon et al., demonstrate that following injury the soluble fraction 
of the bone marrow microenvironment develops an enhanced ability to support HSCs 
and examining of the injured bone marrow microenvironment they revealed that both 
hematopoietic and stromal cells specifically upregulate their expression of WNT10B. 
Furthermore, regenerating HSCs show increased activation of the Wnt signaling 
pathway. In consideration that WNT10B functions as an HSC growth factor, Congdon et 
al., proposed that elevated levels of WNT10B after injury may serve to extrinsically 
activate the Wnt pathway in regenerating HSCs. These findings are the first to 
demonstrate that the canonical Wnt cascade is activated by regenerating HSCs and that 
this activation coincides with an increase in the microenvironmental availability of a 
specific Wnt ligand, thus providing novel insight into both the microenvironmental 
changes that occur after injury and how these changes are integrated with the 
regeneration of hematopoietic cells. It’s interesting to note that that renewal signals are 
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reactivated during tissue injury lends support to the proposal that recurrent activation 
of renewal signals during tissue injury may form the basis of oncogenic transformation. 
Wnts are defined as a specific cue that is upregulated early after injury in the bone 
marrow suggests that Wnts and other, similar developmental pathways should be 
investigated as possible players in repair after injury in other organs and tissues as well. 
The Congdon’s et al work, defined that after injury, the microenvironment changes to be 
more supportive of HSCs. According to Bowman’s idea, developmental signal 
transduction pathways, such as BMP and Wnt, are often reactivated during regeneration, 
suggesting that link between the hematopoietic regeneration and developmental 
pathway. In addition, Wnt10b ligand an HSC growth factor, is increased by both stromal 
and hematopoietic cell subsets after an injury induced by Cy/G treatment. Concomitant 
with the increased expression of Wnt ligand, regenerating stem and progenitor cells 
demonstrate increased activation of the Wnt signaling pathway. According to Bowman et 
al., developmental signal transduction pathways, such as BMP and Wnt, are often 
reactivated during regeneration (Bowman et al., 2012).  
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1.6 mRNA IN SITU DETECTION: LOCK AND ROLL 
 
Many of the decisions that cells take concerning survival, growth and differentiation are 
reflected in altered patterns of gene expression. Messenger RNA transcripts, mRNA, play 
an important role in living cells as an intermediate step during the protein synthesis 
process. RNA detection methods span from the specific quantitative detection of a few 
transcripts of interest to the large-scale parallel detection of thousands of different RNA 
molecules. Methods detecting specific RNA transcripts such as northern blot, real-time 
PCR or the invader technique can be used to detect and quantify transcripts present in 
different tissues or cell types. mRNA expression can be studied globally with techniques 
such as reverse transcription quantitative polymerase chain reaction (RT-qPCR) (Bustin 
et al., 2005), microarrays or more recently sequencing technologies (ten Bosch & Grody, 
2008; Wang et al., 2009). In the RT-qPCR the RNA is first reverse transcribed into its 
complementary DNA (cDNA) using a reverse transcriptase enzyme (Chelly et al., 1990). 
The RT-qPCR technology is easy to perform, capable of high-throughput analysis of up to 
hundreds of known transcripts at a time and can combine low LOD with reliable 
specificity (Bustin, 2002). Real-time detection of the ongoing PCR via the TaqMan assay 
(Heid et al., 1996; Gibson et al., 1996) exploits the nuclease activity of the Taq-polymerase 
(Holland et al., 1991). A probe complementary to the amplified target sequence, labeled 
with a reporter fluorophore at the 5’- end and a quencher fluorophore at the 3’- end 
(Lee et al., 1993; Livak et al., 1995), is added to the PCR. During the extension step Taq- 
polymerase degrades hybridized probes, releasing the 5’ fluorophore. The fluorescence 
from released fluorophores is proportional to the amount of degraded probes, and hence 
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the amplification cycle at which the fluorescence exceeds a threshold value can be taken 
as a measure of the amount of target present in the reaction. Alternative probe designs 
have been developed for real-time detection, such as molecular beacons (Tyagi & 
Kramer, 1996) and scorpion probes (Whitcombe et al., 1999). These probes contain 
reporter fluorophores and quencher molecules as in the TaqMan probes previously 
described, but are constructed so that degradation of the probes is not necessary. 
Furthermore, they can be used to distinguish transcript variants that differ in a single-
nucleotide position (Heid et al., 1996; Gibson et al., 1996). The PCR step renders the 
Taqman method sensitive to false positive results due to contamination of the samples, 
and multiplexing is difficult, demanding labor-intensive optimizations. Biased results 
may arise from the reverse transcription step. This is avoided in the invader technique, 
since RNA is used as the target in the reaction. These assays can also be used for 
quantification of mRNA targets. To achieve proper quantification of mRNA expression by 
RT-qPCR the RNA should be of good quality, internal controls as well as standard curves 
should be included and samples should be normalized against relatively constantly 
expressed genes, so called housekeeping genes (Bustin et al., 2005). RT-qPCR 
experiments that rely on RNA extraction of sometimes complex tissue samples will give 
an average value from numerous variable subpopulations of cells of different lineage at 
diverse stages of differentiation. This average value can be misleading in attempts to 
compare mRNA expression levels between different individuals (Bustin et al., 2005). 
Moreover, comparison of gene expression patterns of housekeeping genes, in 
subpopulations of cells derived from the same individual, revealed differences in mRNA 
levels. This provides evidence that cellular subpopulations of the same origin are highly 
heterogeneous (Goidin et al., 2001). The microarray technology allows simultaneous 
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characterization of expression levels on a genome-wide scale and has been applied for 
not only detection of mature mRNA, but also non-coding RNAs (Pozhitkov et al., 2007). 
For gene expression profiling by microarray technology, transcripts are isolated, labeled 
and hybridized to thousands of probes that are attached to a solid surface. Unreacted 
targets (that are not bound to the DNA probes) are washed away and the remaining 
signals are detected and measured. However, array-based assays suffer from certain 
limitations such as unreliable detection of low abundant genes and cross hybridization 
which gives rise to unspecific signals (Pozhitkov et al., 2007; Draghici et al., 2006). This 
type of hybridization-based approach rely on prior knowledge about the genome 
sequence in contrast to sequence-based approaches that directly can determine the 
expression of novel transcripts, thereby allowing identification of previously 
uncharacterized genes. The limitations associated with traditional sequencing, i.e. 
Sanger sequencing, such as relatively low throughput and high costs, resulted in the 
development of tag-based methods, e.g. Serial Analysis of Gene Expression (SAGE) 
(Velculescu et al., 1995) that offer higher throughput and precise digital gene expression 
levels. However, disadvantages with this approach limit the use of it, such as laborious 
technical procedure and difficulties in resolving similar transcripts (Velculescu et al., 
1995; Morozova et al., 2009). The development of a panel of next-generation sequencing 
technologies (e.g. 454/Roche, Illumina, SOLiD and Helicos) provided new transcriptome 
studies for gene expression profiling as well as for identification of genetic variants such 
as mutations, splice variants and fusion genes and was termed RNA-Seq (RNA 
sequencing) (Wang et al., 2009; Morozova et al., 2009; Edgren et al., 2011). Although it is 
still in the early stage of use, RNA-Seq is believed to have many advantages over 
previously described methods, such as the deep coverage and base level resolution. 
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However, the newly described sequencing technique is associated with some limitations 
or difficulties, such as nonuniformity of transcript coverage and transcript-length bias, 
which will be important to further advance RNA-Seq in becoming an invaluable tool for 
the characterization and quantification of the transcriptome (Wang et al., 2009; Ozsolak 
& Milos, 2011).  
  
Single-cell studies of gene expression 
  
Expression analysis of single genes in single cells is important, for example, for finding 
rare events in a sample (Levsky & Singer, 2003), e.g. cancer cells that are hidden in a 
group of normal cells. Moreover, studies reveal that gene expression can be highly 
diverged, even within a clonal population of cells (Kaufmann & van Oudenaarden, 2007), 
and that genes are transcribed in bursts with long periods of expression inactivity (Raj et 
al., 2006). In these cases, single cell detection techniques that can identify cell-to-cell 
differences within a population become a preferable method of choice. Furthermore, 
multiplex in situ analysis is required to appreciate the interplay between different cells 
in a heterogeneous tissue and the respective transcript expression profiles. A plausible 
risk with bulk measurements is the limitation to see differences at the inter- and 
intracellular level and instead end up with false positives or negatives that represent the 
average value in that sample. Thus, the advantage of studying single molecules in 
individual cells is that it gives the correct frequency distribution of expressed molecules 
for single genes, yielding much more detailed information than can be gleaned from the 
mean value alone. The in vitro techniques described in the previous section use isolated 
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mRNAs from cells or tissues to determine the expression levels. However, the precise 
dissection of tissues might be difficult to attain without inadvertently including some 
irrelevant surrounding cells which can lead to false results. Exact sampling is especially 
important for diagnostic analysis where samples need to be as pure as possible, with no 
contamination from normal cells, to prevent uncertain or incorrect results. One method 
that offers mRNA as well as protein expression analysis is laser-capture microdissection 
(LCM) of single-cells isolated from a certain location in a heterogeneous tissue (Emmert-
Buck et al., 1996). TMA’s are produced by punching out samples from selected tissue-
regions and distributing them on a single slide (Kononen et al., 1998). The TMA 
technology has been widely applied within the field of cancer research for diagnostic 
and drug target discovery (Kallioniemi et al., 2001; Sugimura et al., 2010). However, LCM 
has a number of potential drawbacks. The procedure is expensive, time-consuming and 
limited to amplification-based techniques (Curran et al., 2000). Moreover, another major 
limitation is the need to identify the cells of interest based on morphologic 
characteristics, which in turn, requires a trained histologist or pathologist (Liu, 2010). In 
situ analyses can achieve precise and spatial localization within morphological 
preserved cells or tissues as they occur in their natural situation. Studying tissues can 
also give comprehensive information of the origins of the different cell types and find 
regions containing cells of similar characteristics. A technique for in situ hybridization 
was first described in 1969 for detection of ribosomal DNA. At first radio-labeled probes 
were used, however many non-isotopic labeling variations have been developed. Non-
radioactive hybridization methods can be divided into two groups: direct and indirect.  
 The direct method: the probe is bound directly to the target molecule so the 
resulting hybrid can be visualized in a microscope immediately after 
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hybridization. This can be accomplished by introducing labeled nucleotides 
(fluorophores) to the probes.  
 The indirect method: the labeled probe is not visualized directly. Instead, a 
reporter molecule is bound to the label after hybridization which enables the 
visualization of the target in a microscope. Commonly used labels for indirect 
approaches are streptavidin and digoxigenin.  
The direct method is simple and fast and best suited for detection of repetitive 
sequences and multicopy genes, whereas the indirect method is more labor intensive 
and instead suitable for low-copy target sequences.  
  
Performing an experimental assay 
In order to perform an essay, there are features, that must be considered:  
 Sensitivity is the capability of a method to discriminate between small 
differences in concentration of target molecule in a sample. The assay sensitivity 
is measured by the ability of the assay to recognize all positive cases as such. 
Extending this definition for methods used to detect certain molecules, the 
sensitivity of a method is measured by its ability to detect every molecule present 
in a reaction.  
 Limit of detection (LOD) describes the lowest detectable concentration of 
analyte in a sample. Limit of detection (LOD) is the minimum amount of 
molecules that an assay can detect significantly above background signal. 
Depending on the level of significance that is required, the LOD can be calculated 
as, for example, the concentration of a certain analyte that corresponds to a signal 
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that is two or three standard deviations above background signal.  
 Specificity describes how efficient the assay targets the correct analytes in a 
sample, i.e. that it only detects the molecules of interest. The assay specificity is 
determined by the ability of the assay to recognize all negative cases as such. As 
with sensitivity, specificity in the context of detection methods refers to the 
ability of the method to detect only the correct molecules.  
 Selectivity, defines the method’s ability to distinguish between closely related 
targets.  
 Dynamic range is the ratio between the highest and lowest measureable amount 
of a changeable quantity. The dynamic range of an assay (or the linear dynamic 
range) is the range of protein concentrations that lies between the LOD and the 
point of saturation, at which point the greatest possible amount of protein has 
been detected.  
 Coefficient of variation (CV) is defined as the ratio of the standard deviation(σ) 
to the mean (μ). It applies only for non-zero means.  
 
mRNA in situ detection 
  
To increase the sensitivity of traditional in situ hybridization, target amplification 
strategies involving in situ polymerization have been developed. Over two decades ago, 
in situ PCR was developed for detection of DNA molecules. The method conducts PCR 
directly on cells and tissues with elongation of sequence specific primers and 
amplification in a conventional thermal cycler. The amplified targets can be detected 
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directly with labeled nucleotides or indirectly via in situ hybridization of labeled target 
specific-probes, which is more specific and therefore preferred. The ligase-based 
analysis, is characterized by: 
 High specificity: pairwise hybridization to targets 
 High selectivity: enzymatic substrate recognition 
 Efficient linking: affinity and covalent interaction 
 Amplifiable product: formation of a new strand of DNA 
 Carries information: DNA tags included 
Further modifications of the technique lead to in situ RT-PCR for detection of RNA 
(Figure 1.8). In practice, however, the method is associated with many problems, such as 
low amplification efficiency, poor reproducibility, sensitivity and specificity as well as 
problems with high background, which makes the practical application limited. A similar 
technique, also based on in situ polymerization, is the primed in situ labeling (PRINS) 
procedure in which an unlabeled, target-specific probe is hybridized and used as primer 
for chain elongation in situ using Taq polymerase and labeled nucleotides. Although 
PRINS has the specificity to discriminate between single nucleotide differences it cannot 
detect low copy-number sequences due to low LOD. In situ PCR and PRINS are target 
amplification-based techniques that were developed to address the need to amplify and 
detect targets in situ and represent rapid and relatively inexpensive alternatives to some 
in situ hybridization applications. However, due to the limitations described above none 
of these methods is suitable for detection and visualization of low-copy single nucleotide 
variants in situ. The first application of padlock probes in the in situ setting was for 
detection and genotyping of centromeric sequences in chromosomes 13 and 21 (Lizardi 
et al., 1998). In this study padlock probes labelled with biotin and digoxigenin were 
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detected using labelled streptavidin and antibodies. Detection of ligated padlock probes 
using antibodies suffered from a lack of sensitivity, preventing studies of rare targets due 
to background generated by unspecific binding of the detection reagents. Introduction of 
the rolling circle amplification mechanism increased the specificity of detection by 
increasing the signal strength and decreasing the unspecific background (Nilsson et al., 
1997).  
  
  
 
 
 
 
  
Figure 1. 8 Schematic 
representation of the mRNA in situ detection. cDNA is created using locked nucleic 
acid (LNA)-modified primers and is probed after degradation of mRNA by RNase H. RCPs 
are identified through hybridization of fluorescent detection probes (Larsson et al., 
2010). 
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Locked nucleic acids (LNA) 
 
Locked nucleic acids (LNA) are another type of nucleic acid analogue that has 
exceptional hybridization affinity towards complementary DNA and RNA molecules. The 
synthetic LNA molecule contains a methylene bridge on the ribose ring between the 2´-
oxygen and the 4´-carbon thereby locking the structure into a high binding-affinity 
with reduced conformational flexibility (Figure 1.9).  
  
   
Figure 1.9 The chemical structure and definition of locked nucleic acid (LNA). 
(Petersen & Wengel, 2003).  
An LNA-DNA duplex provides a substantial increase in thermal stability with the ability 
to increase the Tm of an oligonucleotide with +1 to +8 °C for DNA and +1 to +10 °C for 
RNA per LNA monomer introduced. Furthermore, LNA probes have high discriminatory 
power between matched and mismatched sequences which make them well suited for 
sensitive nucleic acid detection. LNA-modified oligonucleotides are fully soluble in water, 
which simplifies experimental implementation. LNA- modified probes have been used in 
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various applications including in vitro discrimination of single-base mismatches, FISH-
studies for detection of repeated genomic sequences and miRNAs and for whole mount 
in situ hybridization detection of mRNAs. In the Nilsson’s work, the effect of LNA base 
incorpaporation in the primer for cDNA synthesis in situ, was evaluated. Primers with 
every second base at the 5’-end substituted with LNA performed better than primers 
with substitutions of every third base. Primers with five, seven or nine LNA bases in total 
were also investigated and it was found that adding nine LNA bases resulted in a small 
decrease in the amount of signals in situ. To ensure that the LNA would not interfere 
with the ability of the reverse transcriptase to synthesize cDNA from the primer, LNA 
bases were placed on the 5’ -side of the primers, leaving the 3’-end unmodified.  
  
The Padlock probe 
 
The concept with padlock probes was invented two decades ago and is an extension of 
the oligonucleotide ligation assay (OLA). Padlock probes have many advantageous 
characteristics and offer highly selective detection of DNA and RNA in solution and in 
situ. Padlock probes can be synthesized using standard solid-phase chemical synthesis 
or via a novel PCR-based method. Padlock probes are linear oligonucleotides of 
approximately 70 to 100 nucleotides in length with target-complementary 5´- and 3’- 
ends which constitute dual target recognition when both probe arms must hybridize 
correctly to the target. This property allows for highly multiplex assays with limited 
cross-reactivity between probes. When the padlock probes hybridize to their correct 
target the ends of the padlock probe are brought together in a head to tail orientation, 
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with only a nick in between. The nicks can be sealed by a DNA ligase creating circles that 
are locked onto the target strands as padlocks. This nick ligation will only occur if there 
is a perfect match between probe and target at the ligation junction, leaving allelic 
probes linear and unamplified. Padlock probes are excellent tools to detect single-
nucleotide variants in RNA and DNA. This is because the simultaneous hybridization of 
the two target-complementary segments ensures a high specificity in recognizing a 
target sequence. The discriminating power of the padlock probes is increased by the fact 
that the ligation reaction is strongly inhibited by any mismatches at the ligation junction, 
especially at the 3’ ends of the hybridized probes (Larsson et al., 2004; Nilsson et al., 
1994; Larsson et al., 2010) (Figure 1.10). Distinction of single-nucleotide sequence 
variants is therefore possible with padlock probes. The catenation of the probes to the 
correct target sequence after hybridization and ligation renders the probe resistant to 
stringent washes if the probes are bound between two points of the target molecule that 
are attached to a solid phase, reducing the background signal from non-specifically 
hybridized probes. After the circularization, the probes can act as template for 
amplification using PCR or rolling-circle amplification (RCA). Moreover, the arising 
probe/target duplex becomes topologically locked and will thereby resist extreme 
washes, which reduce the amount of non-specific signals.  
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Figure 1.10 Schematic rapresentation of padlock probe ligation. Adapted from 
Nilsson et al., 2004.  
 
DNA ligases: Ampligase vs T4 DNA ligase 
 
 DNA ligases were first isolated in the late 1960s (Weiss et al., 1968; Zimmerman et al., 
1967; Gellert, 1967) and applied for molecular cloning (Jackson et al., 1972) and 
synthesis of long oligonucleotides (Agarwal et al., 1970). In their cellular environment 
DNA ligases catalyze the joining of Okazaki fragments produced during the replication of 
genomic DNA, forming the lagging strand, and repair nicks that arise during DNA 
damage repair and DNA recombination. DNA ligases have been isolated from a number 
of organisms, and share general reaction mechanism, but differ in substrate 
requirements and temperature optima. All ligases contain a lysine residue in their active 
site. Depending on the origin of the enzyme, this lysine is adenylated by reaction with 
either ATP or NAD+. The ligation reaction begins when the adenylated ligase enzyme 
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binds to a single-stranded break (with a phosphorylated 5' end) in double-stranded 
DNA. The adenylyl group is transferred to the 5' phosphate, which is in turn attacked by 
the 3' hydroxyl group, releasing the adenylate. The enzyme is released and is ready for 
another ligation after acquiring a new adenlyate charge (Lehman, 1975). Ligases isolated 
from thermophilic organisms have higher optimal reaction temperatures, and can be 
used for thermocycled ligation reactions (Abravaya et al., 1995). Higher reaction 
temperatures also destabilize transiently hybridized imperfectly matched DNA 
complexes, further decreasing the risk of chance ligation events. The substrate 
specificity of DNA ligases ensures that only nicks with correctly matched base pairs are 
closed. This mismatch discrimination is due to the structure of DNA ligases, whose 
footprint covers several bases upstream and downstream of the nick position (Doherty & 
Dafforn, 2000). DNA ligases catalyze the formation of phosphodiester bonds between the 
adjacent 3’-hydroxyl and 5’-phosphate termini at breaks in one or both strands of a 
DNA duplex. DNA ligases can be divided according to the cofactor requirements of the 
enzymes. The known eukaryotic, archebacterial and viral ligases all require ATP as a 
cofactor and are monomeric proteins ranging from 30 to >100 kDa. The eubacterial 
ligases are a more homogenous group of proteins in the range of 70-80 kDa, and they 
require NAD+ as a cofactor (Higgins & Cozzarelli, 1979; Engler & Richardson, 1982; 
Doherty & Suh, 2000). ATP- and NAD+- dependent DNA ligases share six conserved 
motifs involved in building up the active site of the enzymes (Doherty & Dafforn, 2000). 
The ligation reaction mechanism can be divided into three steps. First, the ligase is 
activated through the formation of a covalent protein-AMP intermediate with the 
concomitant release of PPi or NMN, depending on the cofactor. The AMP molecule is 
bound to the ε-amino group on the lysine residue in the conserved KXDG motif. After 
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the recognition of and binding to a nick, the AMP molecule is transferred to the 
phosphorylated 5’ end of the nick. In the third and final step, the enzyme catalyzes a 
nucleophilic attack of the adjacent 3’ hydroxyl group on the pyrophosphate bond 
between the AMP and the 5’ phosphate. The subsequent formation of a phosphodiester 
bond seals the nick, and releases the AMP and the ligase (Higgins & Cozzarelli, 1979; 
Doherty & Suh, 2000; Rossi et al., 1997). There are many commercially available ligases 
for molecular biology, but mainly two DNA ligases are used for padlock probe ligation. 
The first is the bacteriophage T4 DNA ligase, which is an ATP-dependent ligase most 
active around 37 °C. The second ligase is the thermally stable Thermus thermophilus 
(Tth) ligase, also known as Ampligase, which joins DNA nicks in double stranded DNA 
through an NAD+dependent reaction. T4 DNA ligase is derived from bacteriophage T4. 
Tth ligase originates from the eubacterium Thermus thermophilus. T4 DNA ligase has 
two temperature optima for ligation, 28°C and 37°C, while Tth ligase is thermostable and 
has an optimal temperature range between 65-72°C for nick closure. The optimal pH 
for nick closure ranges between 7.2-7.8 for T4 DNA ligase, and 8.5 for Tth ligases (Wu & 
Wallace, 1989; Engler & Richardson, 1982; Tong et al., 1999). Both of these enzymes 
require divalent cations present in the active site during the ligation reaction, probably 
in a similar configuration that has been proposed for T7 and Tfi ligase (Doherty & Suh, 
2000). In general, Mg2+ is used as the divalent metal ion for ATP-dependent and NAD+-
dependent ligases. Slightly increased ligation rates have been observed with the T4 DNA 
ligase when Mn2+ was used (Engler & Richardson, 1982). Tth ligase exhibited about 6 
fold higher mismatch ligation rate with Mn2+ compared to Mg2+ (Tong et al., 1999). DNA 
ligases need a certain length of double-stranded DNA, referred to as a footprint, for nick 
ligation. For the T7 ligase, the footprint has been shown to be asymmetrical, spanning 7-
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9 and 3-5 bases at the 5’and 3’ends of the nick, respectively (Doherty & Dafforn, 
2000). T4 DNA ligase and Tth ligase are more discriminating toward mismatches at the 
3’ end than the 5’ end of the ligation junction (Landegren et al., 1988; Wu & Wallace, 
1989; Pritchard & Southern, 1997). T4 DNA ligase mismatch discrimination can be 
enhanced further by a NaCl concentration of 200 mM in the ligation reaction (Landegren 
et al., 1988; Wu & Wallace, 1989). Some ATP-dependent ligases, such as T4 DNA ligase, 
also have the ability to ligate DNA hybridized to RNA (Kleppe et al., 1970; Fareed et al., 
1971). Ampligase is active at high temperatures, enabling stringent hybridization of 
oligonucleotides, and has been found to have significantly higher ligation specificity than 
T4 DNA ligase (Luo et al., 1996). Although specificity is generally higher with Ampligase, 
T4 DNA ligase has the advantage of working at low temperatures which makes it suitable 
for some padlock probe applications. Ampligase® Thermostable DNA Ligase catalyzes 
the NAD-dependent ligation of adjacent 3’-hydroxyl and 5’- phosphate termini in duplex 
DNA structures. The half-life of Ampligase DNA Ligase is 48 hours at 65°C and more than 
1 hour at 95°C. Ampligase DNA Ligase has no detectable activity on blunt ends or RNA 
substrates. Ampligase DNA Ligase does not replace T4 DNA Ligase in most conventional 
cloning applications because it has: i) no activity on blunt ends; and ii) low activity at 
temperatures where 2- and 4-base cohesive ends form stable duplexes.  
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Rolling-circle amplification (RCA) 
 
The rolling circle replication mechanism is used by many plasmids and bacteriophages 
for replication of their circular genomes. The replication process is isothermal and 
usually requires DNA polymerase, a primer to initiate the replication, DNA nucleotides 
and also DNA binding and unwinding proteins. The rolling circle replication (RCR) 
mechanism, or also called rolling circle amplification (RCA), can also function well with 
small DNA or RNA circles as templates in in vitro reactions, producing many copies in 
tandem of a sequence complementary to the initial circle (Fire & Xu, 1995; Liu et al., 
1996; Daubendick et al., 1995). Fire & Xu used several commercially available DNA 
polymerases and DNA circles as small as 26 nucleotides and generated RCR products 
consisting of many copies of the complementary circular template. RCR products longer 
than 12000 nucleotides were obtained, which means that the enzyme traveled at least 
280 times around the circle before dissociating. This rolling circle replication does not 
require DNA binding or helix-unwinding proteins in the polymerization process. Since 
the contiguous rolling circle products (RCPs) will by nature collapse into micrometer-
sized DNA-bundles, RCA is highly suitable for localized detection. The RCPs become 
detectable in a fluorescence microscope by the local enrichment of short fluorescent 
probes that hybridize to the detection sites of the coiled RCPs. The enzyme used in RCA, 
Φ29 DNA polymerase (Bacillus subtilis), possesses several important features which 
make it most suitable for the efficient amplification of circular DNA molecules (Blanco & 
Salas, 1985; Esteban et al., 1993). The polymerase carries a 3´ to 5´ exonuclease activity 
that enables proofreading of the newly synthesized DNA. This feature also becomes 
handy for initiation of polymerization in cases when no complementary primer is added 
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and should instead be primed by the target (Blanco & Salas, 1985). The Φ29 DNA 
polymerase is a DNA dependent polymerase which synthesizes DNA with high fidelity 
due to efficient proofreading hoice for performing RCA in situ. During polymerization, 
one polymerase molecule can synthesize more than 70 kb DNA in length. The 
polymerase has a strand displacement activity which could be of importance when 
replicating a circular molecule. It has been argued however that it is more likely the 
bending force associated with replication of small circular molecules such as padlock 
probes that cause the strand displacement needed for efficient replication of these 
molecules with RCA. The Φ 29 DNA polymerase can further also use RNA as primer for 
DNA synthesis, which is of special interest in RNA analysis with padlock probes. In order 
for the RCA to begin, the target strand must have a free end close to where the padlock 
probe hybridizes. This is because the reaction is inhibited by the topological link formed 
between the padlock probe and its target sequence. If a nearby free 3´ end is introduced 
close to the padlock probe site at the target DNA strand, this inhibition is circumvented 
and the reaction can proceed efficiently. This variant of RCA has been named target-
primed RCA. Once the appropriate primer is created and in place the Φ29 DNA 
polymerase can then switch its activity and starts incorporating nucleotides in 5´ to 3´ 
direction. After replicating the entire circular padlock probe sequence, the polymerase 
will reach the priming site again. The polymerase then displaces the newly synthesized 
strand and goes on for another round. This strand-displacement activity will keep the 
amplification continuously going, creating longer and longer RCPs, until inactivation of 
the polymerase or change of temperature. After approximately one hour of amplification 
the resulting concatemeric product is roughly one μm in diameter and contains about 
1,000 copies of the original padlock probe (Figure 1.11). This RCP can then be labeled by 
 95 
hybridization of complementary fluorescent detection oligonucleotides and is easily 
detected and visualized as a bright spot in a fluorescence microscope.  
  
  
 
 
 
 
Figure 1.11 A rolling circle product (RCP). Padlock probe amplification with RCA 
creates a long linear molecule that spontaneously coils up to a DNA-bundle. The RCP 
becomes detectable by hybridization of fluorescence labeled probes that is visualized as 
a bright spot (square) in a cell.  
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1.7 IMAGE ANALYSIS TAKES OFF: EXTRACTING RICH 
INFORMATION FROM DIGITAL IMAGES 
The rapid growth in digital imaging techniques associated with light microscopy allows 
researchers from the fields of biology and medicine to produce large amounts of image 
data in a variety of experiments. This sometimes overwhelming amount of image data 
needs to be handled carefully to allow the extraction of the required information in a 
resourceful manner. Thus the role of image analysis is not limited only to the analysis of 
the acquired image. It is always better for the image analysis to start with "good quality 
images" rather than trying to "make them good" for processing later. While numerous 
commercial and free software packages exist for image analysis, many of these packages 
are designed for a very specific purpose, such as cell counting. Other packages are sold 
with accompanying hardware for image acquisition (e.g., yeast colony counters), but 
these are expensive and do not allow measurement of features beyond those that are 
already built-in. Most commercial software is proprietary, meaning that the underlying 
methods of analysis are hidden from the researcher. At the other end of the continuum, 
some software packages are very flexible, especially for interactive analysis of individual 
images (e.g., Image-Pro Plus, MetaMorph®, and the open-source ImageJ/National 
Institutes of Health (NIH) Image). While users can program custom algorithms or record 
macros, these customized routines are challenging to adapt without knowing a 
programminglanguage or interacting directly with the macro code. The CellProfiler™ 
project was developed to address these software challenges by providing the scientific 
community with an easy-to-use opensource platform for automated image analysis. The 
compiled software is freely available for Macintosh®, PC, and Unix platforms at 
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www.cellprofiler. org. It can accommodate adaptation to many biological objects and 
assays without requiring programming, due to its modular design and graphical user 
interface. There are many existing software packages available for specific applications 
in biology, but CellProfiler accomplishes many of the same goals in one open-source 
program (Carpenter et al., 2006).  
 
Fluorescence Microscopy 
 
Cells and the internal structures of the cells can be observed using manydifferent forms 
of light microscopy ranging from the normal bright fieldmicroscopy to advanced systems 
like the Stimulated Emission Depletionmicroscopy (STED) (Davidson & Abramowitz, 
2008; Klar et al., 2001). With the advances of the Green Fluorescent Proteins (GFP) 
(Tsien, 1998; Cantrill, 2008) a whole new color palette becomes available for 
fluorescence microscopy enabling the study of protein dynamics and functioning in 
livingcells. The applicability of this wide range of techniques in a particularsituation 
differs depending on the questions asked and also the availability ofthe techniques. 
Fluorescence microscopy has become an indispensable technique forperforming 
precisely localized detection of interactions within the cells. The microscopy and 
imaging need to be associated with specially designed techniques and the advances in 
both have enabled the study of dynamic processes in living cells (Stephens & Allen, 2003). 
In fluorescence microscopy a sample is irradiated with a specific band of wavelengths. 
These wavelengths are absorbed by fluorophores and light of longer wavelengths are 
emitted. Through optical filters only specific wavelengths of the emitted light reach the 
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detector. In fluorescence microscopy, the use of a fluorophore capable of emitting light in 
the detectable visible range, defined by the filters, is required to visualize the sample 
(Rittscher et al., 2008). In contrast to bright field microscopy, where the sample is 
observed together with the incident light, fluorescence microscopy makes use of the 
difference in excitation and emission wavelengths to block the incident light. This results 
in an image with high contrast between sample and background. Fluorescent molecules 
(fluorochromes) absorb short wavelength light (high energy) and are excited to a higher 
electronic energy state. The duration of the unstable high energy state (fluorescence 
lifetime) before the molecule relaxes by photon emission to the ground state is in 
theorder of nanoseconds. The fluorescence phenomenon is depicted in the Jablonski 
diagram. In ordinary fluorescence microscopy setups the number of photonsreaching 
the detector is very low. This is because the ratio between the number of energy quanta 
emitted by the tissue sample compared to the number of absorbed quanta is very low 
(also known as quantum yield). The fluorescent light is emitted in all directions where 
only a fraction reaches the objective lens. The light also has to pass through a setup of 
filters and dichroic mirrors (beam splitters) that divert the emitted light from the optical 
section, and filters the fluorescence before it reaches the imaging device. To have a large 
number of photons reaching the imaging device, high energy mercury (short 
wavelengths) or xenon (long wavelengths) arc lamps are used. Laser (acronym for ”light 
amplification by the stimulated emission of radiation”) sources are also commonly used 
to achieve the high-intensity illumination needed toimage weak fluorescence signals 
(Denk et al., 1990; Huisken et al., 2004). The type of light source to use dependson the 
wavelengths needed to excite the fluorochromes. A limiting property in using 
fluorescence microscopy is the phenomenonof photobleaching (commonly known as 
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fading). Photobleaching occurs when fluorochromes permanently lose their ability 
tofluoresce. The number of fluorescence cycles that the fluorochromes can perform 
before photobleaching occurs is limited (from a few to millions of cycles), and dependent 
on the molecule and its environment. During the excitation stage the fluorochrome may 
interact with a nearby molecule, and thus form a new configuration for which 
fluorescenceis no longer possible. Increasing the intensity of the exciting light will speed 
up the process of photobleaching. Instead of increasing the laser intensity for imaging 
thick tissue, or having prolonged exposure due to high resolution demands, one may 
have to use lower resolution orswitch imaging technique to more advanced optical path 
setups, single (or selective) plane illumination microscopy (SPIM), or 2photon 
microscopy (Denk et al., 1990; Huisken et al., 2004). The dichroic mirror reflects light 
below a given wavelength while transmitting the light of longer wavelengths. Together 
withthe excitation and emission filters, it is possible to expose the sample to only the 
light of the absorption wavelength and to only let the emitted light of the specific 
wavelength to be captured at the detector.  
 
Fluorochromes 
 
The fluorescence phenomena is inherent to many plants and animal tissues, if 
illuminated by short wavelength light. This is known as primary fluorescence 
(autofluorescence), and has been used in research hand industry. In the study of animal 
tissue the primary fluorescence is usually very faint, and does not always appear where 
wanted. Instead fluorochromes are introduced, allowing for target specificity, and 
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significantly better quantum yield. This is know n as secondary fluorescence, and there 
are several methods to stain a specimen with a fluorescent dye. The use of secondary 
fluorescence has increased due to the development of hundreds of fluorochromes with 
well known excitation (absorption) and emission spectra, and with new techniques to 
increase the specificity for a given biological target. One of the most common 
fluorochromes is 4,6-diamidino-2-phenylindole (DAPI). DAPI is a nucleic acid dye, with 
two highly nucleophilic parts (Kapuscinski, 1995). The dye binds to the adenosine-
thymidine (A-T) base pairs inDNA, and fluoresces in the blue region of visible light when 
excited byultraviolet light. Another common fluorochrome is Rhodamine. The decision of 
which fluorochrome to use for fluorescence microscopy has to be based on that the 
quantum yield should be sufficient given the light conditions, and that the fluorochrome 
can stay attached to the target given the treatment of the specimen and the environment. 
Immunofluorescence is a very important application of fluorescence microscopy based 
on mainly using antibodies specifically targeting an antigen (protein) of interest.  
 Direct immunofluorescence: by chemically attaching a fluorochrome to an 
antibody (also known as a conjugate) and adding many of themin the presence of 
the antigen of interest, they bind to the antigen increasing the local concentration 
of the fluorochrome. The antibody remains bound after the specimen is washed, 
and the presence of the antigen is detected after excitation with specific 
wavelengths.  
 Indirect immunofluorescence: when unstained antibodies are incubated 
together with its related antigen to form an antibody-antigen complex. The 
conjugates attach to the complex, and the complex is then detected by the 
fluorescence after excitation. This usually produces fluorescence with higher 
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signal to noise ratio, since several conjugates are likely to react with the same 
primary antibody.  
Genetic information contained in the DNA (deoxyribonucleic acid) can be specifically 
stained by fluorochrome-conjugated oligonucleotides (short segments of DNA, or RNA) 
that bind to particular DNA sequences.  
 
Point Spread Function 
The resolution, i.e., how close two objects can be within an image and still be resolved as 
two distinct objects, depends on the imaging system properties, particularly on the point 
spread function (PSF). The point spread function (PSF) describes the relationship 
between the point object and the blurred response produced in the microscope. An 
image from a microscope consists of a sum of all PSF from the point objects in the scene. 
A wider PSF will decrease the resolution in the acquired image. The PSF differs between 
different microscopes and microscopy techniques. More blurring is usually seen in the z-
­direction (axial) than in the x−y direction (lateral). Confocal microscopes decrease the 
size of the PSF in all directions, i.e., improving the resolution in all directions. Even 
though the axial resolution is improved, it is still lower than the lateral (Bolte & 
Cordelieres, 2006; Wallace et al., 2001). If the PSF of the microscope is known, 
deconvolution methods can be used to reduce the blurring effect caused by the PSFor a 
given microscopy system the PSF is usually modeled with a Gaussian function (Zhang et 
al., 2007) and the full width at half maximum (FWHM) of the PSF is used to measure 
resolution. The determined PSF can be used to reassign the out-of-focus light 
mathematically (Bolte & Cordelieres, 2006). When the PSFs of wide-field microscopy and 
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confocal microscopy are compared, confocal systems show improved resolution in both 
axial and lateral directions. The z resolution is still poor compared to the xy resolution. 
This has to be taken into account when performing image analysis.  
 
 
Digital image analysis 
 
The image or image volume representations are definied by the spatial domain and by 
the frequency domain where the image content is represented as frequencies. In general, 
slowly varying intensity components in the spatial representation are represented as 
low frequency components while sharp transition in intensity are represented as high 
frequency components. The Fourier transform maps the spatial domain representation 
of an image into the frequency domain representation, where N is the number of 
samples.  
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A digital image is an image represented in a computer, which differs in many aspects 
from the continuous image we perceive through our visual system. Scientific 
visualization is the process of communicating a message based on the images from 
image processing or image analysis/computer graphics (Sonka et al., 2007). The origin of 
digital image analysis dates back to the 1950s and1960s with the establishment of the 
artificial intelligence and robotics branches of the growing field of computer science. The 
precursor for the computer science field is the development of general purpose 
computersduring the 1940s. Pioneers and early  contributions  to  image 
analysis include, e.g., Azriel  Rosenfeld (http://www.cfar.umd.edu/AR), who wrote the 
first textbook (Rosenfeld, 1969) on the subject in 1969 and was a founding member of 
the IEEE Computersociety’s Technical Committee on Pattern Analysis and Machine 
Intelligencein 1965, and King Sun Fu (Kashyap et al., 1986), who was a founding member 
of the International Association for Pattern Recognition (IAPR) in 1978. A digital image 
is generally represented with a square grid consisting of picture elements (pixels) in 2D 
and in 3D the elements are referred to as voxels. Each element has a value that describes 
the content of the position of the imaged object that it represents. In a binary image the 
value is either 1 (part of an object) or zero (part of the non-object or background 
regions). In a gray valued or gray scale image the range of values change depending on 
how the structure that stores the information is defined. If an 8-bit representation is 
used 28 is the upper limit and each element can have a value ranging between 0 and 255. 
This is the most common form of representation but it is not so uncommon to use other 
representations such as the 16-bit representation that gives a value between 0 and 
65535. A color image follows the same structure with the addition that, instead of having 
a single number representing a gray value, each element has a value for each color 
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component. In an RGB (Red, Green, Blue) representation three values represent how 
much red, green and blue are contained in each element. In essence this means that 
instead of one matrix of values (in 2D) we have three matrices of gray values, one for 
each color component. A set of images collected over time will have an additional 
dimension, the time. An important issue in acquiring these time-lapse sequences is the 
temporal resolution that defines the rate at which the images are acquired. A suitable 
rate should be based on the viability of the live cells imaged (Meijering et al., 2008). 
Putting things together more formally, a digital image can be represented as a discrete 
integer-valued function:  
f (x); x = (x,y, z, ) 
x, y,z: spatial coordinates; t: spatial coordinates; λ: the color component.  
 
Pre-processing 
 
The samples may need to be prepared differently depending on the modality that is used 
for imaging. If the specimen is to be imaged several times, possibly in different systems, 
some landmarks may need to be introduced at this stage to facilitate registration of 
images. Image acquisition; the all important imaging step that often makes or brakes a 
project. Great care should be taken to generate the best images possible from an analysis 
point of view (not necessarily the prettiest pictures) at this stage, since the image quality 
reflects the output of the whole project. If noise or errors were introduced in the imaging 
step, they should be taken care of now. Registration of images from different times or 
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modalities can be considered as pre-processing. Each image volume consisted of layers 
that were merged along the z-axis using a maximum intensity projection (MIP). 
However, the MIP is somewhat sensitive to noise, as it will act as maximum filter for each 
1 × 1 × 16 pixel array. To reduce the amount of non-point-like signal before the MIP, the 
background was removed in each focus layer using top-hat filtering (Haralick & Shapiro, 
1992). The top-hat filtering may be described using a rolling ball analogy. Draw a 
squiggly line on a piece of paper, and let an imaginary ball (a structuring element) with a 
certain radius roll along the curve. Every point that the ball manages to touch, being 
small enough to fit in to large holes and grooves, is set to zero. Points that the ball does 
not touch, due to being too large, are given values according to the distance between the 
ball and the line.  
  
 
Segmentation 
The aim of segmentation is to divide the image into different regions that are 
homogeneous with respect to certain criteria. Thresholding is the process of separating 
the image into foreground (objects), and background based on selecting a threshold 
value using global, or local properties of the image intensity distribution. The threshold 
value divides the image such that pixels with gray levels below the threshold belong to 
the background, and pixels with higher, or equal gray level belong to the foreground (or 
the opposite if the image contains dark objects on a bright background). The output from 
the thresholding is a binary image g (x, y) (an image consisting of 0 and 1). A threshold 
value T is defined and pixels with values above T are considered to be part of the object 
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in the image f (x, y):  
 
 
 
 
 
 
The value T can be set manually or selected automatically from certain criteria. The 
image histogram p(f) of the image f (x, y) is the probability density function which gives 
the frequency of the different pixel values in f (x, y). A popular thresholding method 
based on the histogram is Otsu’s (Otsu, 1979) where the automatic selection of an 
optimal threshold is performed based on the class seperability of the histogram. If an 
image contains objects with fairly similar gray values that are significantly different from 
those of the background, the histogram will have two distinct peaks with a valley in 
between. A gray value close to the valley can then successfully be used to separate the 
objects from the background. However, if the objects and background have overlapping 
intensities then the histogram will not have distinct peaks and finding the optimal value 
for thresholding is difficult. Image pre-processing can be useful in reducing the 
variations in the gray values within objects and also within the background to increase 
the between class separability. The watershed algorithm was originally presented by 
Beucher and Lentue joul (1979) (Lantuejoul & Beucher, 1981) and later refined in a more 
efficient implementation by Vincent and Soille (1991) (Vincent & Soille, 1991). The 
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watershed segmentation is a region-based segmentation method and has been 
extensively used in many areas of image analysis, e.g., cell segmentation (Carpenter et al., 
2006; Malpica et al., 1997; Wahlby et al., 2004). The watershed segmentation can be 
understood by seeing the image as a landscape. The watershed algorithm is a region 
growing method commonly explained by a “rain falling on a mountain landscape” 
analogy. The gray-level intensity represents the elevation in this landscape. The 
landscape image can be, e.g., the original gray-level image, a distance transformed image 
(an image containing a distance value to the nearest object pixel or nearest background 
pixel) (Maurer et al., 2003), or a gradient magnitude image. The algorithm can be 
illustrated by letting water enter through the local minima and start to rise. A lake 
around a local minimum is created and referred to as catchment basin. When the water 
fronts from different catchment basins meet they form a dam or watershed that 
separates the catchment basins. All that is left after the watershed segmentation are 
watershed lines separating the objects. If objects of interest are bright rather than dark, 
the image is inverted before applying watershed segmentation. Beside bilevel 
thresholding, multilevel thresholding techniques also exist, where the problem lies in 
selecting two or more thresholds for dividing the image. The probability function gives 
the likelihood of a certain gray level to occur in the image. In Otsu’s method (Otsu, 1979), 
an optimal threshold is reached by minimizing the variance between classes 
(background and foreground), over the total image variance (three equivalent 
formulations exist). The threshold that produces the smallest variance ratio is selected. 
This approach was used in the signal segmentation project. In minimum error 
thresholding (Kittler & Illingworth, 1986) the gray level histogram is viewed as two 
mixed normally distributed populations. An optimal threshold is the value that 
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minimizes a criterion function introduced to avoid estimating the mean and variance of 
the two populations. The method was used with good results in the testicle project, after 
some interactive treatment of parts of images lacking tissue.  
 
1.7.1 CELLPROFILER: DIGGING DEEP AND WIDE INTO SINGLE CELLS 
 
CellProfiler is freely available, open-source software that enables researchers without 
training in computer programming to measure biological phenotypes quantitatively and 
automatically from thousands of images. With an interface designed by biologists and 
underlying algorithms developed by computer scientists, CellProfiler bridges the gap 
between advanced image analysis algorithms and scientists who lack computational 
expertise. (Carpenter et al., 2006; Lamprecht et al., 2007). CellProfiler was initially 
designed for high-throughput image analysis but is often used for small-scale projects. 
This highlights the trend toward quantifying information in images regardless of 
experiment size.CellProfiler's interface lets researchers build customized chains of 
interoperable image analysis modules to identify and measure biological objects and 
features in images (Figure 1.12).  
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Figure 1.12 An example of CellProfiler’s pipeline on web interface.  
 
  
 
 
CellProfiler has been used to measure individual cells, colonies of cells and whole 
organisms in a wide range of assays (e.g. counting cells, measuring staining intensities 
and scoring complex phenotypes with machine learning) and at many experimental 
scales (from a few to hundreds of thousands of images). A variety of cell types have been 
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analyzed, including budding yeast, Drosophila, mouse, rat and dozens of human cell 
types. The diverse measurements generated by CellProfiler provide raw material for 
machine-learning algorithms that can identify challenging phenotypes (Jones et al., 2009; 
Misselwitz et al., 2010; Ramo et al., 2009). The first MATLAB (MATLAB version 7.5.0 2007) 
language was redesegned to the open-source Python language, making use of the high-
performance scientific libraries NumPy and SciPy (Oliphant, 2007). Cython 
(http://www.cython.org) is used to implement computationally intensive algorithms, as 
well as bridge to precompiled libraries including Java via the Java Native Interface. The 
Java/Python bridge allows CellProfiler 2.0 to load nearly 100 image formats via the Open 
Microscopy Environment  Consortium's Bio-formats library 
(http://www.loci.wisc.edu/software/bio-formats). A bridge with ImageJ was built in 
order to run ImageJ (http://rsbweb.nih.gov/ij), macros in the context of a CellProfiler 
pipeline. CellProfiler can be run in batch mode: sets of images are partitioned between 
CellProfiler instances running on separate computing cores or cluster nodes in a 
distributed environment. In CellProfiler 2.0, images can be loaded via HTTP or located 
based on a comma-delimited text file containing image file locations, which might be 
generated by automated microscopes or laboratory information systems. Metadata 
about the images can also be loaded similarly. CellProfiler 2.0 has enhanced database 
capabilities and is now able to upload directly to MySQL or SQLite databases during 
image processing. CellProfiler 2.0's FlagImage module can exclude images from analysis 
based on measurements of image quality, such as blurriness and presence of debris. 
Images can be grouped for aggregate operations, such as illumination correction of 
images on a per-plate basis or analysis of multiple time-lapse movies or three-
dimensional image stacks. Illumination often varies more than 1.5-fold across the field of 
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view, even when using fiber optic light sources, and occasionally even when images are 
thought to be already illumination-corrected by commercial image analysis software 
packages (TRJ, AEC, DMS, and PG, unpublished data). This adds an unacceptable level of 
noise, obscures real quantitative differences, and prevents many types of biological 
experiments that rely on accurate fluorescence intensity measurements (for example, 
DNA content of a nucleus, which only varies by two-fold during the cell cycle). 
CellProfiler contains standard methods plus our new methods (Jones et al., 2006) to 
address illumination variation, allowing various methods to be compared side by side 
and, ultimately, providing less noisy quantitative measures.  
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Figure 1.13 Schematic representation of a typical CellProfiler pipeline. The original 
image is processed, in order to apply the modules of illumination correction. Then, the 
subsequent step is the identification of primary and secondary objects (nuclei and cells).  
 
The final step is the analysis of data (Figure 1.13). Object identification (also called 
segmentation) is the most challenging step in image analysis and its accuracy 
determines the accuracy of the resulting cell measurements. In most biological images, 
cells touch each other, causing the simple, fast algorithms used in some commercial 
software packages to fail. The first objects identified in an image (called primary objects) 
are often nuclei identified from DNA-stained images, although primary objects can also 
be whole cells, beads, speckles, tumors, and so on. After primary objects (often nuclei) 
are identified, the edges of secondary objects that surround each primary object (often 
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cell edges) can be found more easily. Measuring cell size in Drosophila was not 
previously feasible because the commonly used watershed method (Meyer & Beucher, 
1990) often fails to find the borders between clumped cells (Jones et al., 2005). Other 
subcellular compartments can also be identified, including the cytoplasm (the part of 
each cell excluding the nucleus) and the cell or nuclear membrane (the edge of the cell or 
nucleus).  
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2. MATERIALS AND METHODS 
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2.1 SAMPLE COLLECTION 
 
 
In Beghini et al., work, bone marrow (BM) mononuclear cells were collected from 33 
newly diagnosed, unselected non-promyelocytic AML patients according to standard 
procedures, after obtaining the informed consent, according to Niguarda Hospital’s 
Ethical Board approved protocols. AML samples were classified according to the French-
American-British (FAB). According to the revised Medical Research Council risk group 
stratification, based on cytogenetic and molecular markers, samples included 14 
adverse, 13 intermediate and 6 favorable risk patients. Human adult BM cells obtained 
from 10 healthy donors were derived from the posterior iliac crest, after obtaining 
informed consent, according to the Niguarda Hospital's institutional review board 
guidelines (Table 2.1). The subsequent gene expression analysis, was performed on 
n=112 AML patients, 1 idiopathic myelofibrisis and n=3 healthy donors, including some 
samples recruited in Beghini et al., work (Table 2.2). Bone marrow tissue sections of 
AML patients, were obtained from Niguarda Hospital. 
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TABLE 2.1 Clinical characteristics of AML patients 
 
 
AML FAB CYTOGENETICS 
AML 1 M2 45, XY, -7 
AML 2 M1 Complex karyotype 
AML 4 M4 46, XY, del(20)(q11;q13) 
AML 5 M4 46, XX 
AML 6 M4 46, XX, +11 
AML 9 M0 46, XY 
AML 10 M5a 46, XX 
AML 13 M1 46, XY, t(6;9)(p23;q34) 
AML 14 M2 46, XX 
AML 16 M2 46, XX 
AML 17 M1 46, XY 
AML 19 M1 46, XX, del (11)(q23) 
AML 21 M1 46, XY 
AML 23 M1 46, XY 
AML 24 M1 46, XY 
AML 25 M1 46, XX, del (11)(q23) 
AML 30 M5a 46, XY 
AML 32 M2 46, XX 
AML 34 M0 46, XY, del (11)(q13;q23) 
AML 38 M1 46, XX 
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AML 39 N.A Complex karyotype 
AML 40 M2 Complex karyotype 
AML 41 M4 46, XX 
AML 42 M4 46, XX 
AML 44 M2 46, XX,t(8;21)(q22;q22) 
AML 46 M2 46, XY 
AML 47 M2 46, xx, +21 
AML 48 M5a 46, XY 
AML 49 Biphen 45, XX, -7,t(9;22)(q34;q11) 
AML 50 M4 Complex karyotype 
AML 51 M5b 46, XX 
AML 52 M2 46, XY 
AML 53 M1 46, XX 
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TABLE 2.2 Clinical characteristics of AML patients. 
 
 
AML FAB CYTOGENETICS 
AML 1 M2 45, XY, -7 
AML 2 M1 Complex karyotype 
AML 4 M4 46, XY, del(20)(q11;q13) 
AML 9 M0 46, XY 
AML 10 M5a 46, XX 
AML 11 AREB-T 46, XY, +8 
AML 12 M2 46, XX 
AML 13 M1 46, XY, t(6;9)(p23;q34) 
AML 14 M2 46, XX 
AML 16 M2 46, XX 
AML 17 M1 46, XY 
AML 18 M5a 46, XY 
AML 19 M1 46, XX, del (11)(q23) 
AML 21 M1 46, XY 
AML 25 M1 46, XX, del (11)(q23) 
AML 30 M5a 46, XY 
AML 39 N.A. Complex karyotype 
AML 40 M2 Complex karyotype  
AML 42 M4 46, XX 
AML 43 M0 46, XY, t(4;12)(q21;p13) 
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AML 44 M2 46, XX,t(8;21)(q22;q22) 
AML 46 M2 46, XY 
AML 49 Biphen. 45, XX, -7,t(9;22)(q34;q11) 
AML 53 M1 46, XX 
AML 57 M1 47, XX, +4 
AML 58 M1 47, XX, +4 
AML 59 N.A 47, XX, +8 
AML 61 M1 46, XY 
AML 62 M5a 46, XX 
AML 63 M5b 46, XX 
AML 64 M2 46, XX 
AML 65 M2 46, XX,t(8;21)(q22;q22) 
AML 67 M1 47, XX, +8 
AML 200 M2 45,X,-Y,t(8;21)(q22;q22) 
AML 201 M4 48,XY,inv(16),+22,+9 
AML 202 M4 46,XY,inv(16) 
AML 203 M4 46,XY,inv(16) 
AML 204 M4 46,XX,inv(16) 
AML 205 M4 46,XY,inv(16) 
AML 206 M4 46,XX,inv(16) 
AML 207 M4 46,XX,inv(16) 
AML 208 M4 45,X0,inv(16) 
AML 209 M4 46,XY,inv(16) 
AML 210 M4 46,XY,inv(16) 
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AML 211 M4 46,XY,inv(16) 
AML 212 M2 45,X, -Y,t(8;21)(q22;q22) 
AML 213 M2 49,XY,t(8;21)(q22;q22),+4,+6,+19 
AML 214 M4 46,XX,inv(16 
AML 215 M2 45,X,-Y,t(8;21)(q22;q22) 
AML 216 M4 46,XY,inv(16) 
AML 217 M2 46,XY,t(8;21)(q22;q22) 
AML 218 M2 46, XX,t(8;21)(q22;q22) 
AML 219 M2 47,XY,t(8;21)(q22;q22),+13 
AML 220 M2  46,XX 
AML 221 M2 45,X, -Y,t(8;21)(q22;q22) 
AML 222 M2 46, XX,t(8;21)(q22;q22) 
AML 223 M2 46, XY,t(8;21)(q22;q22) 
AML 224 M2 46, XX,t(8;21)(q22;q22) 
AML 225 M1 45,X,-Y 
AML 226 M2 47,XY,+11 
AML 227 M2 46,XX 
AML 228 M2 46,XY 
AML 229 M4 46,XX 
AML 230 M1 46,XY 
AML 231 M1 46,XY 
AML 232 M1 46,XX 
AML 233  M1 46,XX 
AML 234 M4 46,XX,inv(16) 
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AML 235 M4 46,XX,inv(16) 
AML 236  M1 46, XX 
AML 237 M2 46,XY,inv(16) 
AML 238  M4 46,XX,inv(16) 
AML 239  M2 45,X, -Y,t(8;21)(q22;q22) 
AML 240  M2 46,XY,t(8;21)(q22;q22),+4 
AML 241 M2 45,X,-X,t(8;21)(q22;q22),add(4)(p16),-9,+mar 
AML 242  M4 46,XY,inv(16) 
AML 243  M4 46,XY,inv(16) 
AML 244  M4 47,XY,inv(16),+6 
AML 245  M1 47, XX, +4 
AML 246  M4 46, XY 
AML 247 M2 Complex karyotype 
AML 248 M1  46, XY 
AML 249 M4 46, XX 
AML 250 M0 46, XY 
AML 251 M1 46, XX 
AML 252  M1 46, XY 
AML 253  M4 46, XY 
AML 254  M1 46, XY 
AML 255 M4 46, XY 
AML 256 M4  46,XX,inv(16) 
AML 257 M1 46, XX 
AML 258 M1 46, XY 
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AML 259 M4 46, XY 
AML 260 M1  46, XX 
AML 261 M4  46, XY 
AML 262 M1 46, XX 
AML 263 M4 46, XY 
AML 264  M0 46, XX 
AML 265 M1 46, XY 
AML 266 M4 46, XX 
AML 267 M2 46, XX,t(8;21)(q22;q22) 
AML 268 M2  46, XY,t(8;21)(q22;q22) 
AML 269 M1 46, XX 
AML 270 M1 46, XX 
AML 271 M4 46,XX,inv(16) 
AML 272 M4 46,XY,inv(16 
AML 273  M4 46,XX,inv(16) 
AML 274  M1 46, XX  
AML 275  AREB-T 46, XX 
AML 276 M4 46, XY,t(8;21)(q22;q22)  
AML 277 M5 46,XX 
AML 278 M1 46, XX 
I.M. 66 - 46, XX 
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2.2 CELL SORTING AND FLOW CYTOMETRY 
 
The mononuclear cells were obtained by a density gradient centrifugation using "Ficoll-
Hypaque" (Lymphoprep, AXIS-SHIELD, Oslo, Norway d = 1.077 g/m), a mixture of 
polysaccharides of high molecular weight, which allows the separation of different 
hematopoietic components. This procedure allows the separation of two cellular 
fractions: I) erythrocytes and polymorphonuclear granulocytes, which precipitate to the 
bottom of the tube, II) mononuclear cells (MNC) which are collected at the interface 
between Ficoll and serum. 
The AC133+ cell fraction was isolated by immunomagnetic separation after labeling with 
CD133/1 (AC133)-biotin antibody and anti-biotin MicroBeads on LS columns and Midi 
MACS separator (Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of the 
AC133+ fraction, evaluated by flow cytometry analysis, was greater than 97%. 
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 Figure 2.1 AC133 positive selection.     
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2.3 MICROARRAY EXPRESSION ANALYSIS 
 
Microarrays have evolved from Southern Blotting, a technique which is used to identify a 
specific DNA sequence in DNA samples (Southern, 1975). The first studies that involved 
microarrays were published in 1980s, but the real microarrays take-off began with a 
publication by Fodor et al. (Fodor et al., 1991) from Affymax, a company which later 
changed its name to Affymetrix and became the market leader for microarray 
technology. 
Typically, a microarray consists of a large number microscopic DNA spots attached to a 
solid surface. Each of the spots contains many short DNA sequences called probes. All of 
the probes inside one spot have the same sequence. Also, all of the probe sequences are 
complementary to a part of the gene from an organism which is being analyzed.  
The HG-U133 arrays use as few as 11 probes in a probeset (Bolstad, et al., 2003). The size 
of a standard GeneChip is 1.28 cm x 1.28 cm; and over 6.5 million squares, or features 
are present on each chip. In each feature, there are millions of identical probes. The 
design of Affymetrix probes is not usually in the hands of the researchers. A probe 
consists of a short oligonucleotide sequence containing 25 nucleotides, called a 25-mer; 
and all the probes are synthesised on the chip one base at a time, and in parallel at all 
locations. A paired probe is composed of: a) a perfect match (PM), which is the exact 
sequence of the chosen fragment of the gene, b) a mismatch (MM), which is same as PM 
but contains a mismatch nucleotide in the middle of the fragment. The mismatch probe 
contains a single mismatch located directly at the 13th position in the 25-mer probe 
sequence . This mismatch probe is used as a background control and also to overcome 
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the low specificity of the short oligonucleotide used. While the perfect match probe 
provides measurable fluorescence when the sample binds to it, the paired mismatch 
probe is used to detect and eliminate any false or contaminating fluorescence within that 
measurement.  
 
   
Figure 2.2 Microarray technology overview.  
 
The mismatch probe serves as an internal control for its perfect match partner because 
it hybridizes to nonspecific sequences about as effectively as its counterpart, allowing 
misleading signals, from cross hybridization for example, to be efficiently quantified and 
subtracted from a gene expression measurement or genotype call. Affymetrix anticipates 
that the MM probe does not hybridize well to the target transcript, but hybridizes to 
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many transcripts to which the PM probe cross-hybridizes (Simon et al., 2004). Therefore, 
the intensity difference between PM and MM paired probe is considered to be a better 
estimate of the hybridization intensity to the true target transcript.  
The value that is usually taken as representative for each gene‘s expression level is the 
average difference between PM and MM. Ideally, this average value is expected to be 
positive because the hybridization of the PM is expected to be stronger than the 
hybridization of the MM. However, many factors, including non-specific hybridizations 
and a less than optimal choice of the oligonucleotide sequences representative of the 
gene, might result in an MM hybridization stronger than the PM hybridization for certain 
probes. The calculated average difference might be negative in such cases, and these 
negative values introduce noise into the dataset. 
The outputs of microarray experiments require processing before they can be used for 
extracting meaningful information. Image processing and normalization are the two 
preliminary microarray data processing stage. Regardless of the technology, the arrays 
are scanned after hybridization and independent, 16 bit, digital, grey-scale TIFF images 
are generated for query and control samples (Causton et al., 2003). Analysis of a cDNA 
image seeks to extract intensity for each spot or feature on the array, and it involves 
various image processing stages that can be carried out through different microarray 
image analysis software. Affymetrix has integrated its image processing algorithms into 
the experimental process of GeneChip software, and thus, there are no decisions to make 
for the end users (Stekel, 2006). 
Affymetrix GeneChip experiments are managed with the Affymetrix GeneChip Operating 
Software (GCOS). Once the fluorescent-tagged nucleic acid sample is injected into the 
hybridization chamber, and hybridization takes place to the complementary 
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oglionucleotides on the chip, the hybridized chip is scanned and the laser excited 
fluorescence across the chip is converted to a 2D image. This image data file (.DAT) can 
be exported as a .TIFF image. The image data file is used by the software to generate 
a .CEL file that gives the position and intensity information of each probe for one 
GeneChip, in addition to the position of masks and outliers. The Affymetrix output result 
file is the .CHP file, where the average signal intensities are linked to gene identities. The 
report file (.RPT) is generated from the .CHIP file, and it summarizes the quality control 
information about expression analysis settings and probe set hybridization intensity 
data. Besides, there are two more files that are used in the actual analysis process - 
Experiment File (.EXP) and Chip Description file (.CDF). The former contains parameters 
of the experiment such as probe array type, experiment name, equipment parameters 
and sample description. The .CDF file is provided by Affymetrix and describes the layout 
of the chip. 
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Data normalisation is an important aspect, and plays an important role in the early stage 
of microarray data analysis as the subsequent analytical results are very much 
dependent on it. The normalization methods rely on the fact that gene expression data 
can follow a normal distribution, and the entire distribution can be transformed about 
the population mean and median without affecting the standard deviation. The objective 
of normalization is to eliminate the measurement variations and measurement errors, 
and to allow appropriate comparison of data obtained from the expression levels of 
genes so that the genes that are not really differentially expressed have similar values 
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across the arrays. Normalization is also used to identify and eliminate questionable and 
low quality data. Normalization approaches typically use either a control set of genes or 
the entire genes from an array. The use of a control set requires only one assumption, i.e., 
the control genes are detected at constant levels in all of the samples being compared. 
For GeneChips, Affymetrix Inc. claims to have integrated the housekeeping genes and 
spiked-ins, or spiked controls in the chips after supposedly testing them on a large 
number of various tissue types with the resultant low variability in those samples (Wang 
et al. 2002). For cDNA microarrays, normalization involves determining the amount by 
which the genes of the red channel are over- or under expressed relative to the green 
channel. Approaches to calculate the normalization factor can be divided into three 
categories: global normalization, intensity-based normalization and location-based 
normalization as well as a hybrid of intensity- and location-based normalization. The 
Affymetrix data normalization was performed using the Robust Multi-Array Average or 
RMA (Irizarry et al., 2003) based on quantile normalization, and is used for normalizing 
the chips. RMA is largely the work of Terry Speed‘s group at University of California at 
Berkeley, and only uses PM probes as the method assumes that including the MM probes 
introduces more variability than the correction is worth. In RMA, the expression 
measure is obtained using three steps: convolution background correction, quantile 
normalization, and a summarization method based on a multi-array model fit that uses 
the median polish algorithm (Tukey, 1977). Starting with the raw probe-level data from a 
set of GeneChips, the perfect-match (PM) values are background-corrected, quantile 
normalized, and then finally the linear model is fit to the normalized data to obtain an 
expression measure for each probe set on each array. 
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PROCEDURE 
RNA isolation 
 
Total RNA for expression profiling analysis was extracted using RNAqueus 4PCR kit 
(Ambion, Austin TX) from AC133 selected cells. 500 μL of Lysis/Binding Solution was 
added to a sample and vortexed vigorously; an equal volume of 64% Ethanol was added 
to the lysate and the tube was inverted several times. The samples were applied to 
columns, spun for 30 seconds at 10,000 RCF, and the flow through was discarded. 700µL 
of Wash Solution #1 was added, centrifuged, the flow through was then discarded. Then 
500µL of Wash Solution #2/3, was added and centrifuged and the flow thought was 
subsequently discarded. This process was repeated with another 500 µL of Wash 
Solution #2/3. RNA was eluted with 50µL of preheated Elution Solution, and centrifuged 
at 10,000 RCF for 30 seconds, and eluted again with 15 µL of Elution Solution. Solution 
was then treated with 7.5µL of 10x DNase1 buffer and 1.0 µL of DNase1 enzyme to 
destroy residual DNA. The product was then incubated for 30 minutes at 37ºC before 8.0 
µL of DNase1 inactivation reagent was added and incubated for 2 minutes at room 
temperature. The tube was then spun down at 10,000 RCF for 1 minute to pellet the 
inactivation reagent. 
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RNA quality evaluation 
 
Integrity of RNA samples extracted from dried blood spots was checked using Experion™ 
(Bio-Rad, USA). Experion system was included with automated electrophoresis station, 
priming station, vortex station for RNA analysis and RNA std sens analysis kit which 
included with chips and reagents for standard-sensitivity RNA. Following procedure 
performed for RNA analysis using the Experion system. In order to avoid any 
contamination during RNA integrity analysis, electrodes of the Experion system were 
cleaned using Experion electrode cleaner (800 μl) in the first step. After repeating this 
step for one more time, electrodes were rinsed with DEPC treated water (500 μl) for 5 
minutes using electrode cleaning chip. At the end lid was kept open for 60 second to 
evaporate remaining water on electrodes. RNA stain, RNA loading buffer and RNA gel 
from the RNA std sens kit were removed from 4˚ C and equilibrated at room temperature 
for 20 minutes. RNA stain was wrapped in aluminum foil to avoid its light sensitive 
degradation. RNA gel was filtered from filter tube at 2000 RPM for 10 minutes. Filtered 
gel (65 μl) was taken into RNase-free microfuge tube and mixed with RNA stain (1 μl). 
RNA ladder was removed from -20˚ C and thawed it on ice for 10 minutes. RNA ladder (1 
μl) and RNA samples (3 μl) was taken into RNase-free microfuge tube. RNA ladder and 
RNA samples were denatured at 70˚ C for 2 minutes. Ladder and samples were 
immediately placed on ice for 5 minutes, spun down for 2-5 seconds and stored on ice 
until needed. Gel-stain solution (9 μl) was taken in well labeled as GS on RNA std sens 
chip without forming any air bubble. Chip was primed by setting appropriate pressure 
for sufficient time on priming station. Chip was inspected for any air bubbles in micro 
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channels and for incomplete priming. Gel-stain solution (9 μl) was taken other well 
labeled GS. Filtered gel (9 μl) was taken to well labeled as G. Loading buffer (5 μl) was 
taken to each sample well 1-12 including ladder well. RNA ladder (1 μl) was taken to the 
well labeled as L. RNA samples were taken to all wells numbered as 1-12. Chip was 
placed tightly and vortexed for 60 seconds on vortex station. Primed chip loaded with 
RNA samples and ladder was then kept on electrophoresis station for 5 minutes and 
electrophoresis run was started. The use of a RNA ladder as a mass and size standard 
during electrophoresis allows the estimation of the RNA band sizes. After completion of 
the run, electrodes were cleaned using DEPC water (800 μl) filled in a cleaning chip. 
Electropherograms generated were analyzed by Experion software version 3.2. Integrity 
of the RNA may be assessed by visualization of the 18S and 28S ribosomal RNA bands 
(Mueller et al., 2004). The intact RNA preparation shows high 18S and 28S rRNA peaks as 
well as a small amount of 5S RNA. 
 
Microarray 
 
The samples are hybridized to GeneChip HGU133plus 2.0, using the Two Cycle Target 
Labeling protocol, according to the manufacturer’s procedures.  
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TOTAL RNA PROTOCOL 
1 μg- 15 μg One-cycle target labeling 
10 ng-100 ng Two-cycle target labeling 
 
For using as target, the total mature, spliced, poly-A tail added RNA isolated from the cell 
being studied is turned into a double stranded cDNA through reverse transcription. At 
the time of running the array, the cDNA is allowed to go through in vitro transcription 
back to RNA (now known as cRNA), and labelled with biotin. The labelled cRNA is then 
randomly fragmented in to pieces anywhere from 20 to 400 nucleotides in length, and 
the cRNA fragments are added to GeneChip for hybridization. The hybridization occurs 
at a 45°C, 60 rpm for 16 hours. After hybridization, performed in fluidic station 400, the 
difference in hybridization signals between PM and MM, as well as their intensity ratios, 
was detected by scanning the array with a laser serves as indicators of specific target 
abundance. After hybridization, the chips were scanned by a scanner directly connected 
to the computer, which also manages the fluid through the GCOS software. The image 
captured by the scanner is a .DAT file, where the pixels in a feature are then grouped into 
a single value. CEL. The file .CEL is created by the algorithm Cell Analysis Algoritm of 
GCOS and contains the light intensity measured for each probe cell. The GCOS software 
then transformed the .CEL files into .CHP file, in order to obtain qualitative and 
quantitative analysis.The file. CHP can then be exported to a file. TXT. In our study we 
used the method of the logarithmic transformation, used in the pre-processing and 
normalization of gene expression data. For the pre-processing of the data was used 
package Affy, defined as Affymetrix oligonucleotide Methods for Arrays. The system used 
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in our study provides data normalization using RMA (Robust Multy-Array Average) in R 
environment, a programming language for bioinformatics derived from S, a program 
developed by John Chambers and colleagues in the 80s at the Bell Labs. R is an Open-
Source Bioconductor initially developed by Ross Ihaka and Robert Gentleman at 
University of Auckland (New Zealand), which operates through the web: 
www.rproject.org. Background correction used in RMA is aimed at correcting only PM 
values, and is a nonlinear correction using a probabilistic model, done on a per-chip 
basis. It involves a convolution of an exponentially distributed (with mean, α) signal, X 
and normally distributed (with mean, μ and standard deviation, σ) noise, Y caused by 
optical noise and non-specific binding. Therefore, the observed PM intensity, S = X + Y. 
To evaluate the effect of normalization on the Affymetrix arrays, an assessment is carried 
out evaluating MA plots, Array intensity distribution and Nuse plot. 
 
Data mining  
 
Hierarchical clustering (Johnson, 1967) is useful to find the closest associations among 
gene profiles under evaluation where it seeks unsupervisedly to build a hierarchy of 
clusters based on relatedness. Whether any unwanted change has been caused to the 
microarray data through the process of ratio-transformation can be evaluated through 
hierarchical clustering. The method when applied to the pre- and post- transformed 
microarray data would highlight if any change has occurred to the overall state of the 
data. 
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In our study, In order to evaluate the genes that are differentially expressed between all 
patients and healthy subjects, we set up parametric and non-parametric analysis. 
The statistics used are as follows: 
 
 t-Test: standardized difference in the mean absolute or relative gene expression 
(fold changes). They are constructed by dividing the difference between two 
parameters (usually two means) to the standard error of their difference (usually 
estimated by the variances of the two samples from which the averages are 
calculated). Under the assumption that the two samples are drawn randomly 
from the same distribution eindipendente and that this is Gaussian (normal), the 
test follows the Student's t distribution. 
 
 
 
 Mann-Whitney U, Wilcoxon W-test. The nonparametric tests have the 
advantage of not requiring assumptions about the distribution of the parameter 
of interest and dedicated software 
 
Microarray data have been deposited in ArrayExpress 
(http://www.ebi.ac.uk/arraexpress/), with accession number E-MTAB-220. 
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2.4 BIOINFORMATIC ANALYSIS 
 
The Gene Ontology (GO) (Ashburner et al., 2000) was created in 1998 by the Gene 
Ontology Consortium in an effort to address the need for a controlled, structured and 
unified vocabulary for genome annotation. The Gene Ontology Consortium is a 
collaborative project whose founding members are the model organism databases 
Flybase (Tweedie et al., 2009), Mouse Genome Informatics (MGI) (Blake et al., 2011) and 
the Saccharomyces Genome Database (SGD) (Cherry et al., 1998). In the last ten years, 
the list of member projects has more than quintupled and now includes, among others, 
dictyBase (Fey et al., 2009), Gene Ontology Annotation @ EBI (GOA) (Barrell et al., 2009), 
Gramene (Jaiswal et al., 2006), Rat Genome Database (RGD) (Twigger et al., 2006), 
Reactome (Croft et al., 2011), The Arabidopsis Information Resource (TAIR) (Swarbreck 
et al., 2008), WormBase (Harris et al., 2010) and Zebrafish Information Network (ZFIN) 
(Bradford et al., 2011). 
The GO consists of three orthogonal structured vocabularies or “sub-ontologies”, namely: 
• Molecular function (MF), i.e. the activity, at molecular level, of a gene product; 
• Biological process (BP), i.e. the larger overall process that a gene product is involved 
in; 
• Cellular component i.e. the component of the cell that a gene product acts in. 
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Genome wide analysis 
 
We performed a genome-wide analysis in order to select genes differentially expressed 
between AML AC133+ patients and AC133+ healthy donors (Welch t-test, 0.05 
significance level). The resulting set of differentially expressed genes has been analyzed 
for functional enrichment with respect to the terms of the Biological process (BP) 
branch of the Gene Ontology (GO) and the pathways of the KEGG database. We 
performed the functional enrichment analysis using: 
 GOStats: version 2.12.0 of the Bioconductor package 
(http://www.biocunductor.org/packages/release/bioc/html/GOstats.html); 
 DAVID (Database for Annotation, Visualization and Integrated Discovery): 
http://david.abcc.ncifcrf.gov/home.jsp ; 
 Dysregulated pathway analysis: iterative procedure, based on non parametric 
test proposed by Majeti et al. 
The first two tests are based on the hypergeometric distribution, whereas the last one is 
based on a non-parametric test and on iterative procedure. All tests were applied to all 
genes of the Hgu133plus2 gene chip, considering all the genes included in the Affymetrix 
platform as Universe with p-value < 0.05. 
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Generation of an evolutionarily conserved human transcriptional regulators 
dataset 
 
The entry point of our selection procedure was the extraction from Pfam 
(http://pfam.sanger.ac.uk/) of all the domains involved in transcription regulation. Next, 
we used the set of 400 Pfam domains to query the entire set of ensemble human genes 
using the BioMART web interface (http://www.ebi.ac.uk/biomart/). This produced an 
initial set of 2,971 non redundant genes associated to a unique HGNC symbol. In order to 
extract all the one-to-one orthology relationships , we thus adopted a direct SQL access 
to the ensembl_compara_51 database (hosted at ensembldb.ensembl.org) occurring 
between the genes in the initial set and the complete gene set of the following 
organisms: Bos taurus, Canis familiaris, Danio rerio, Drosophila melanogaster, Equus 
caballus, Gallus gallus, Loxodonta africana, Mus musculus, Saccharomyces cerevisiae, 
Takifugu rubripes and Xenopus tropicalis. We then compiled an evolutionarily conserved 
set of TRs by arbitrarily requiring the presence of at least 5 one-to-one orthology 
relationships disregarding the involved species. This produced a set composed by 1,989 
non redundant genes. We finally tested each of the 1,989 gene symbols obtained through 
the orthology filtering for the association with at least 1 Affymetrix HGU 133 Plus 2 
microarray platform (according to the content of BioMART). This produced a final set of 
conserved putative transcriptional regulators composed by 1,919 genes. We thus check 
our conserved TRs set for the overlap with annotated NCBI’s UniGene clusters. Again, 
the required annotations were obtained using the BioMART web interface using the 
whole human ensembl known gene set (version 51) and limiting the extraction to the 
genes set produced by the orthology 1-to-1 filter. 1,620 conserved TRs genes were found 
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to be overlapped with at least 1 NCBI UniGene cluster. We thus removed from our 
transcriptional regulator set all the gene symbols lacking an annotation in the 
Bioconductor annotation package associated with the Affymetrix HGU 133 Plus 2 
platform. This filtering procedure produced the reference conserved TRs set composed 
by 1,611 evolutionarily conserved genes. The genes comprised in the conserved TRs set 
were tested for differential expression in AC133+AML cells by mean of a standard t-test. 
In order to identify a set of genes suitable for ontology driven functional enrichment 
investigations we applied a standard hypergeometric test. We followed this approach 
and we selected a set of overexpressed conserved TRs by mean of a standard Welch t-
test with statistical cutoff of 0.05 (upper tail). This procedure identified a set of 734 (out 
of 1,611 TR genes) conserved putative TRs overexpressed in AC133+AML cells. The TR 
overexpressed genes were then tested for functional enrichment using the Bioconductor 
GOstats package (function: hyperGTest). 
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2.5 CELL COLTURE 
 
Selected AC133+ cells from A46 BM at AML diagnosis were cultured for 16 weeks, using 
synthetic medium StemSpam H3000 (StemCell Technologies, Vancouver, Canada) in the 
absence of serum and cytokines.  
 
2.6 IMMUNOSTAINING 
Indirect immunostaining 
 
Indirect immunostaining was performed following standard procedures. Bone marrow 
biopsies of AML patients, previously embedded in paraffin blocks were cut in 5 μm thick 
sections and mounted on slides. Slides were loaded into glass slide-holders and dewaxed 
as follows: twice in 100% xylene (Carlo Erba Reagents, Rodano, Italy) 15min and 10min, 
twice in 100% EtOH (Panreac, Quimica Sau, Castellar del Valle s, Spain) for 5min, once in 
95% EtOH for 5min, once in 85% EtOH for 5min, once in 65% EtOH for 5min, once in 
30% EtOH for 5min and three times in water for 5min each. Epitope retrieval was 
performed using the boiling method with buffer citrate (10mM, pH6). Slides were 
dipped into already boiling buffer citrate for 20min and then brought to room 
temperature in water. The blocking procedure was performed overnight using 
Phosphate Buffered Saline (PBS) plus 5% Bovine Serum Albumin (BSA) (Sigma Aldrich, 
St. Louis, US) and 0.05% Tween 20 (Roche, Mannheim, Germany). The day after, slides 
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were incubated with primary antibodies such as mouse anti-Active-β-Catenin (1:100, 
Millipore, Billerica, MA, US), rabbit anti-WNT10B (H70) (1:100, Santa Cruz 
Biotechnology, Santa Cruz, CA, US), for 5h and then washed three times with PBS plus 
5% BSA and 0.05% Tween 20.  
 
PRIMARY ANTIBODIES DILUITION SECONDARY ANTIBODIES DILUITION 
Mouse anti-Active- 
β-Catenin 
1:100 Donkey anti-mouse Alexa Fluor 488 1:500 
Rabbit anti-WNT10B 1:100 Donkey anti-rabbit Alexa Fluor 568 1:500 
 
 
Samples were incubated with the secondary antibodies donkey anti-mouse Alexa Fluor 
488 (1:500, Life Technologies, Carlsband, CA, US), and donkey anti-rabbit Alexa Fluor 
568 (1:500, Life technologies). Exposure times for slides images were 600-620 ms for 
DAPI; 450-480 ms for Alexa Fluor 568 and 370-400 ms for Alexa Fluor 488. Nuclei were 
counterstained with 100ng/ml DAPI (Sigma-Aldrich). Cells were analyzed using the 
upright microscope (Leica, DM 4000B). 
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FLUOROPHORES λ ABSORPTION λ EMISSION 
DAPI 360/40 nm 470/40 nm 
488 nm 495 nm 519 nm 
568 nm 578 nm 603 nm 
 
 
 
 
 
Figure 2.3 Image from Fluorescence Spectra Viewer (Life Technologies). DAPI 
emission is shown in green, 488 nm emission is shown in blue and 568 nm emission is 
shown in red. 
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Direct immunostaining 
 
Direct immunostaining was performed following standard procedures. Bone marrow 
biopsies of AML patients, previously embedded in paraffin blocks were cut in 5 μm thick 
sections and mounted on slides. Slides were loaded into glass slide-holders and dewaxed 
as follows: twice in 100% xylene (Carlo Erba Reagents, Rodano, Italy) 15min and 10min, 
twice in 100% EtOH (Panreac, Quimica Sau, Castellar del Valle s, Spain) for 5min, once in 
95% EtOH for 5min, once in 85% EtOH for 5min, once in 65% EtOH for 5min, once in 
30% EtOH for 5min and three times in water for 5min each. Epitope retrieval was 
performed using EDTA (0.5M, pH 8.0) at 37°C for 30 min. The blocking procedure was 
performed overnight using Phosphate Buffered Saline (PBS) plus 5% Bovine Serum 
Albumin (BSA) (Sigma Aldrich, St. Louis, US) and 0.05% Tween 20 (Roche, Mannheim, 
Germany). Primary antibodies mouse anti- CD133.1 (AC133) ( Milteny Biotech, Bergisch 
Gladbach, Germany) and mouse anti-Active-β-Catenin ( Millipore, Billerica, MA, US), 
were direct labeled using and Mix-n-Stain™ CF™ 647A Antibody Labeling Kit (5-20μg 
Sigma Aldrich, St. Louis, US). The day after, slides were incubated with primary 
antibodies for 3h and then washed three times with PBS plus 5% BSA and 0.05% Tween 
20. Exposure times for slides images were 300-350 ms for DAPI; 550-660 ms for 488 nm 
dye and 470-490 ms for 647 nm dye. Nuclei were counterstained with 100ng/ml DAPI 
(Sigma Aldrich, St. Louis, US). Cells were analyzed using the upright microscope (Leica, 
DM 4000B). 
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FLUOROPHORES λ ABSORPTION λ EMISSION 
DAPI 360/40 nm 470/40 nm 
488 nm 495 nm 519 nm 
647 nm 650 nm 668 nm 
 
 
 
Figure 2.4 Image from Fluorescence Spectra Viewer (Life Technologies). DAPI 
emission is shown in green, 488 nm emission is shown in blue and 647 nm emission is 
shown in red. 
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2.7 PROBE DESIGN: MFOLD 
 
The concept of RNA secondary structure began with the work of Doty and Fresco (Doty 
et al., 1959; Fresco et al., 1960). The prediction of RNA secondary structure (folding) by 
energy minimization using nearest neighbor energy parameters began with Tinoco and 
colleagues (Borer et al., 1974; Tinoco & Uhlenbeck, 1971; Tinoco et al., 1973; Uhlenbeck et 
al., 1973) and also with Delisi and Crothers (Delisi & Crothers, 1971). Efficient algorithms 
for RNA secondary structure prediction using dynamic programming methods borrowed 
from sequence alignment were developed independently by a number of people 
(Waterman & Smith, 1978; Waterman, 1978; Nussinov et al., 1978; Nussinov & Jacobson, 
1980; Zuker & Stiegler, 1981; Sankoff et al., 1983; Zuker, 1989; Devereux et al., 1984). The 
‘mfold’ software for RNA folding was developed in the late 1980s (Salser, 1977; Freier et 
al., 1986; Zuker, 1989). The ‘m’ simply refers to ‘multiple’. The core algorithm predicts a 
minimum free energy, ΔG, as well as minimum free energies for foldings that must 
contain any particular base pair. Any base pair, ri-rj , between the i th nucleotide and the 
j the nucleotide that is contained in a folding no more than δδG from the minimum, is 
plotted in a triangular plot called the ‘energy dot plot’. The base pair ri-rj is plotted in 
row i and column j of this matrix. The free energy increment, δδG , is chosen a priori by 
the user, who selects a ‘percent suboptimality’, P . From this, δδG is computed to be P / 
100 |ΔG| . Base pairs within this free energy increment are chosen either automatically, 
or else by the user, and foldings that contain the chosen base pair are computed. They 
have minimum free energy conditional on containing the chosen base pair. The 
description and use of the mfold package has appeared in a number of articles (Jaeger et 
al., 1989; Jaeger et al., 1990; Zuker, 1994; Zuker, 1999). The closely related ‘RNAstructure’ 
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program has also been described (Mathews et al., 1998; Mathews et al., 2000). The 
Turner group has published numerous articles over the years that detail the 
development of the RNA folding parameters. A subset of these articles are what I would 
call ‘major works’ that summarize the current state of the art. Version 1 of the mfold 
package used free energies that were described by Freier et al.. Versions 2.1 to 2.3 used 
the parameters from Walter et al. (Walter et al., 1994), although the incorporation of 
coaxial stacking parameters into the minimization algorithm has not been accomplished. 
The current version 3 software uses free energy data from Mathews et al. (Mathews et al, 
1999). DNA folding prediction with the mfold software began in 1996, when DNA 
specific parameters were added to the mfold package through a collaboration with the 
SantaLucia group (John SantaLuica Jr., Department of Chemistry, Wayne State University, 
Detroit, MI). 
 
The mfold web server comprises a number of separate applications that predict nucleic 
acid folding, hybridization and melting temperatures (Tm s). 
 Sequence name. A sequence name may be typed or pasted (entered) within the 
‘Enter a name for your sequence:’ text field. Long names are truncated to 40 
characters. 
 Sequence. A sequence must be entered into the sequence text area box. All 
characters except for ‘A–Z’ and ‘a–z’ are removed. Lower case characters are 
converted to upper case. For RNA folding, ‘T’ or ‘t’ are converted to ‘U’, while ‘U’ or 
‘u’ are converted to ‘T’ in DNA folding. The letter ‘ N’ should be used for an 
unspecified base. 
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 Multiple constraints of any form are allowed in any order. Force a specifi c base 
pair or helix to form.  
 will force the formation of the helix (single base pair if k=1). 
 
 
 
The triple (i , j , k ) refers to k consecutive base pairs, where ri -rj is the exterior closing 
base pair. If any of these base pairs cannot exist, then an error will be generated and the 
job will fail. 
 
RNA and DNA sequences may be linear or circular. 
 The folding temperature is fixed at 37°C for RNA folding using version 3.0 energy 
rules. For RNA folding with the version 2.3 parameters, or for DNA folding, any 
integral temperature between 0 and 100°C may be chosen. 
 Ionic conditions may be altered for DNA folding only. For RNA, the ionic 
conditions are fi xed at [Na+ ]= 1M and [Mg++ ]= 0 M. For folding, these are 
equivalent to physiological conditions. The following constraints apply: [Na+ ]= 
0.01 M, [Mg++ ]= 0.1 M, and [Na+ ]= 0.3M if [Mg++ ]> 0M. For the purposes of 
folding, Na+ may be considered equivalent to Li+, K+ and NH4+, while Mg++ is 
equivalent to Ca++. 
 
PROCEDURE 
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We evaluate our three padlock probes, using MFold: 
 
 
 
 
 
 
 
 
    
Figure 2.5 MFold output for β-actin, WNT10B, WNT10BIVS1 padlock probes.  
The mRNA in situ detection is performed in denaturing conditions, without secondary 
structures of probes. 
 
 
 
 
2.8 IN SITU mRNA DETECTION 
 
In situ detection of individual mRNA molecules was performed as described. Bone 
marrow biopsies of AML patients, previously embedded in paraffin blocks, were cut in 5 
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µm thick sections and mounted on slides. Slides were dewaxed as follows: twice in 100% 
xylene for 15 min and 10 min, twice in 100% EtOH for 2 min, twice in 95% EtOH for 2 
min, twice in 70 % EtOH for 2 min, and washed in DEPC-H2O for 5 min and in DEPC-PBS 
for 2 min. Tissue fixation was performed in 3.7% (w/v) paraformaldehyde in PBS for 10 
min at RT. After a wash in DEPC-PBS for 2 min, the tissue sections were then 
permeabilized with 2 mg/ml pepsin (Sigma Aldrich, St. Louis, US) in 0.1 M HCl at 37 °C 
for 2 min. Slides were washed in DEPC-H2O for 5 min, in DEPC-PBS for 2 min and then 
fixed in 3.7% (w/v) paraformaldehyde in PBS for 10 min at RT. Tissue sections were 
then dehydrated through a series of 70%, 85% and 100% ethanol for 1 min each. 
Molecular reactions were carried out with a reaction volume of 100 μl in secure-seals 
(13 mm in diameter, 0.8 mm deep; Grace Bio-Labs) mounted over the tissue. One μM of 
locked nucleic acid (LNA)-modified cDNA primer was added to the slide with 10 U/μl of 
M-MULV reverse transcriptase (Fermentas), 500 nM dNTPs (Invitrogen), 0.2 μg/μl BSA 
(New England Biolabs, NEB) and 1 U/ μl RiboLock RNase Inhibitor (Fermentas) in the 
M-MULV reaction buffer. Slides were incubated for 3h at 37°C. After incubation, slides 
were washed in PBS-T (DEPC-PBS with 0.05% Tween20), followed by a post-fixation 
step in 3.7% (w/v) paraformaldehyde in DEPC-PBS for 30 min at RT. After post-fixation 
the sample were washed twice in DEPC PBS-T. To make the target cDNA strands 
available for padlock probe hybridization, the RNA portion of the created RNA-DNA 
hybrids was degradated with RNaseH (Fermentas). Ligation was then carried out with 
0.1 μM of the WNT10b padlock probe and β-actin padlock probe in a mix of 0.5 U/μl 
Ampligase (Epicentre), 0.4 U/μl RNase H (Fermentas), 1 U/μl RiboLock RNase Inhibitor 
(Fermentas), Ampligase buffer, 50 mM KCl and 20% formamide. Incubation was 
performed first at 37 °C for 30 min, followed by 45 min at 45 °C. After ligation reaction, 
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the slides were washed twice in DEPC-PBS with 0.05% Tween20. Rolling Circle 
Amplification (RCA) was performed with 1 U/μl ф29 DNA Polymerase (Fermentas) in 
the supplied reaction buffer, 1 U/μl RNase Inhibitor (Fermentas), 250 μM dNTPS 
(Invitrogen), 0.2 μg/μl BSA (NEB) and 5% glycerol. Incubation was carried out for 5h at 
37°C, and it was followed by a twice wash in PBS-T. Rolling Circle Particles (RCPs) were 
visualized using 100 nM of detection probe in 2X SSC and 20% formamide at 37°C for 20 
min. Slides were then washed in DEPC-PBS. . Nuclei were counterstained with 100ng/ml 
Hoechst 33258 (Sigma-Aldrich). The Secure-seals were removed and the slides were 
dehydrated using a series of 70%, 85% and 99.5% ethanol for 3 min each. The dry slides 
were mounted with Invitrogen Slowfade. Images of bone marrow tissue slides were 
acquired using an Axioplan II epifluorescence microscope (Zeiss) equipped with a 100 
W mercury lamp, a CCD camera (HRM, Zeiss), and a computer-controlled filter wheel 
with excitation and emission filters for visualization of DAPI, Cy3, and Cy5. A ×20 (Plan-
Apocromat, Zeiss) and ×40 (Plan-Neofluar, Zeiss) objective were used for capturing the 
images. Images were collected using the Axiovision software (release 4.3, Zeiss). 
Exposure times for slides images were 520–680 ms (at ×20 magnification), 320–480 ms 
(×40) for DAPI; 300 ms (x20), 650 ms (×40) for Cy3; 250 ms (×20), 580 ms (×40) for 
Cy5. Images were collected as z-stacks to ensure that all RCPs were acquired, with a 
maximum intensity project created in Axiovision. For quantification, the numbers of 
RCPs and cell nuclei in images were counted digitally using CellProfiler 
(www.cellprofiler.org) on three x20 microscope images . The total number of RCPs was 
divided by the number of nuclei for each image. The average for each sample was then 
calculated from the result of the five images and is reported as RCPs per cell. The 
threshold for different color channels was set with ImageJ 1.41 .  
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FLUOROPHORES λ ABSORPTION λ EMISSION 
HOECHST 33258 346 nm 460 nm 
CY3 550 nm 570 nm 
CY5 622/36 nm 667/30nm 
 
 
 
Figure 2.6 Image from Fluorescence Spectra Viewer (Life Technologies). Hoechst 
emission is shown in red, CY3 emission is shown in green and CY5 emission is shown in 
blue. 
 
β- ACTIN LNA PRIMER 
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5’-C+TG+AC+CC+AT+GCCCACCATCACGCCC-3’ 
WNT10B LNA PRIMER 
5’-C+A+G+G+C+CGGACAGCGTCAAGCACACG-3’ 
β- ACTIN PADLOCK PROBE 
5’-[Phos]GCCGGCTTCGCGGGCGACGATTCCTCTATGATTACTGACCTATGCGTCTATTTAGTGGAGCCTCTTCTTTACGGCGCCGGCATGTGCAAG-3’ 
WNT10B PADLOCK PROBE 
5’-[Phos]-ACCGTGCCTGTCTCGGACCCCTCCTCTATGATTACTGACCTAAGTCGGAAGTACTACTCTCTTCTTCTTTTAGTGAAGCCCAGGCAACCCA3’ 
WNT10BIVS1 PADLOCK PROBE 
5’-[Phos]AGTCTCCCGTCCCGCAGGTCTCCTCTATGATTACTGACCTATGCGTCTATTTAGTGGAGCCTCTTCTTTCTATTCCTGAACCCGCATCA-3’ 
CY3 DETECTION PROBE 
5’-[Cy3]TGCGTCTATTTTAGTGGAGCC -3’ 
CY5 DETECTION PROBE 
5’-[Cy5]AGTCGGAAGTACTACTCTCT-3’ 
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2.9 MICE AND TRANSPLANTATION PROCEDURE 
 
The RAG genes encode two recombination activating proteins, RAG-1 and RAG-2, whose 
cellular expression is restricted to lymphocytes during their developmental stages and is 
fundamental for the development of mature B and T lymphocytes. In 1992, Shinkai and 
colleagues developed a RAG-2-deficient murine model characterized by the absence of 
functional B and T cells, similarly to scid mice (Shinkai et al., 1992). Unlike scid mutation, 
due to the specificity of RAG function and its involvement in the initial phases of VDJ 
rearrangement, the resulting phenotype is completely stable and affects only 
lymphocyte maturation. The deletion of RAG-2 activity caused several alterations in the 
physiology of the immune system: mice showed decreased or occasionally absent 
thymus, and a reduction of the cellularity of other lymphoid organs as spleens and 
lymph nodes. Crossing of RAG-2- and γ- common chain-deleted mice led to the 
generation of a completely genotipically defined immunodepressed murine model 
named Rag2
-/-
γc
-/- 
mice. As previously reported, the common cytokine receptor γ- chain 
is a high and median affinity component of the receptors for several cytokines, such as 
IL-2, involved in the activation of T and NK cells and in control of the peripheral 
tolerance, IL-7 responsible for the development and functionality of lymphocytes, IL-9 
that acts as a growth factor for mast cells, IL-15 involved in the regulation of the 
development and maturation of NK cells and the homeostasis of memory lymphocytes, 
IL-4 and IL-21 that act on immunoglobulin production and regulate the isotypic switch. 
Rag2
-/-
γc
-/- 
mice show a combined immunodeficiency characterized by the complete 
absence of B, T and NK cells and share all the properties described for NOG mice, with 
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the exception that they are completely resistant to radiations (Shultz et al., 2007). 
 
 
PROCEDURE 
 
Rag2
-/-
γc
-/- BALB/c mice were bred and maintened under specific pathogen-free 
conditions in the mouse facility of Istituto Oncologico Veneto. Rag2
-/-
γc
-/- 
mice at 6 
weeks were sublethally irradiated with 5Gy and transplanted via the tail vein with 1x106 
of A46 AC133+ AML cells. Three weeks after transplantation, recipient mice were 
sacrificed and BM cells were harvested by flushing femurs and tibias. BM engrafment 
was evaluated using human antibodies CD34, CD38, AC133 and CD45 (BD Biosciences 
Bedford, MA and Miltenyi Biotec GmBH). The cell engraftment was evaluated by the 
human panleukocyte CD45 marker expression. 
 
 
 
 
 
 
2.10 ZEBRAFISH MODEL AND TRANSPLANTATION 
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PROCEDURE 
 
Zebrafish (Danio rerio) was first pioneered as an animal model system by George 
Streisinger at the University of Oregon at Eugene in the 1970s (Stahl, 1985; Westerfield, 
1995). In recent years, the zebrafish has become one of the most important vertebrate 
model organisms to study biological processes in vivo. This is due to a combination of 
advantages making it an ideal organism for the researchers in many aspects of 
embryonic development, physiology and disease. 
Zebrafish is a teleost fish of the cyprinid family in the class of ray-finned fishes. The 
lineage leading to the cyprinds and mammals split about 450 million years ago 
(Nusslein-Volhard, 2002). The teleosts include other model organisms such as medaka 
(Oryzias latipes), the pufferfish (Takifugu ruripes, Tetraodon nigrovirdis) and the three 
spined stickleback (Gasterosteus aculeatus) (Nusslein-Volhard, 2002). The zebrafish 
genome is about 1.7 gigabases in size, which is just more than half of tetrapods, such as 
human and mice and is divided into 25 chromosomes (Nusslein-Volhard, 2002). The 
absolute number of genes in zebrafish is currently unknown, however, a large number of 
gene has been cloned and analyzed to date. 
As a vertebrate, it has many of the strengths of invertebrate model systems, such as 
small size, easy maintenance, a large number of offspring and a short generation time. 
Its transparent, easily accessible embryos, as well as their large size make it ideally 
suited to micromanipulation and in vitro observations (Nusslein-Volhard, 2002). 
Moreover, its very rapid and synchronous embryonic development greatly facilitates 
phenotypic analysis and large-scale experimental approaches. During the first 24 hours 
 157 
of development, the embryos are completely transparent, allowing the visualization of 
developing organs. After about 2 days all common vertebrate specific body features can 
be seen, including compartmentalized brain, eyes, ears and all internal organs 
(Westerfield, 1995). In comparison to higher vertebrates, the organs in zebrafish are like 
a minimalist version, using far fewer cells to fulfill the equivalent function in the 
organism. For instance, the kidney of the larval zebrafish consist of a single glomerulus 
which runs most of the body length, in comparison to the tens of thousands of glomeruli 
in the mammalian kidney (Nusslein-Volhard, 2002). The zebrafish larvae have hatched 
and are able to swim and search food as soon as 5 days after fertilization. The zebrafish 
reaches sexual maturity in approximately 2-3 months (Nusslein-Volhard, 2002). 
With the community of zebrafish researchers growing worldwide, new techniques and 
methodologies are becoming available at an ever-increasing rate and adaptation of 
techniques from other model organisms. In addition, the zebrafish genome has been 
sequenced to facilitate disease and orthologous gene identification 
(http://www.sanger.ac.uk/modelorgs/zebrafish.html). 
 
PROCEDURE 
 
Embryos were handled according to relevant guidelines. Fish of the AB strain were 
maintained at 28°C on a 14-hr light/10-hr dark cycle. Embryos were collected by natural 
spawning and staged according to Kimmel work. Zebrafish embryo cells transplantation 
was performed as previously reported in Hatta et al. work. Briefly, fluorescently labeled 
A46 cells were resuspended in 1x PBS and injected into zebrafish blastulae (between 
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100 and 200 cells per injection) at 3 hpf. Injected live embryos were immediately 
observed under a fluorescent microscope to ensure for the presence of labeled A46 cells. 
Embryos were collected at the desired developmental stages and immediately fixed and 
processed for whole-mount in-situ hybridization (WISH) according to Thisse and 
colleagues using gsc, ntl, and pax2a DIG-labeled riboprobes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.11 RAPID AMPLIFICATION OF cDNA (RACE PCR) 
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The Rapid Amplification of cDNA (RACE PCR) is a procedure for amplification of nucleic 
acid sequences from a messenger RNA template between a defined internal site and 
unknown sequences at either the 3' or the 5' -end of the mRNA. This method is used to 
extend partial cDNA clones by amplifying the 5′ sequences of the corresponding mRNAs. 
The technique requires knowledge of only a small region of sequence within the partial 
cDNA clone. During PCR, the thermostable DNA polymerase is directed to the 
appropriate target RNA by a single primer derived from the region of known sequence; 
the second primer required for PCR is complementary to a general feature of the target, 
in the case of 5′ RACE, to a homopolymeric tail added (via terminal transferase) to the 3′ 
termini of cDNAs transcribed from a preparation of mRNA. This synthetic tail provides a 
primer-binding site upstream of the unknown 5′ sequence of the target mRNA. The 
products of the amplification reaction are cloned into a plasmid vector for sequencing 
and subsequent manipulation. 
In general, PCR amplification of relatively few target molecules in a complex mixture 
requires two sequence-specific primers that flank the region of sequence to be amplified.  
In this procedure, mRNAs are converted into cDNA using reverse transcriptase (RT) and 
an oligo-dT adapter primer. Specific cDNA is then directly amplified by PCR using a gene-
specific primer (GSP) that anneals to a region of known exon sequences and an adapter 
primer that targets the poly(A) tail region. This permits the capture of unknown 3'mRNA 
sequences that lie between the exon and the poly(A) tail. 5' RACE, or “anchored” PCR, is 
a technique that facilitates the isolation and characterization of 5' ends from low-copy 
messages. The method has been reviewed by both Frohman (Frohman, 1990) and Loh 
(Loh, 1991). 
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PROCEDURE 
 
1μg of total RNA derived from AML46 sample, was used to prepare 5’RACE ready cDNA 
using 5´ RACE System for Rapid Amplification of cDNA Ends, Version 2.0 amplification 
kit (Invitrogen) and following the protocol supplied. 
First strand cDNA is synthesized from total or poly(A)+ RNA using a gene-specific 
primer (GSP1) that the user provides and SuperScript™ II, a derivative of Moloney 
Murine Leukemia Virus Reverse Transcriptase (M-MLV RT) with reduced RNase H 
activity. This permits cDNA conversion of specific mRNA, or related families of mRNAs, 
and maximizes the potential for complete extension to the 5' -end of the message. 
Following cDNA synthesis, the first strand product is purified from unincorporated 
dNTPs and GSP1. TdT (Terminal deoxynucleotidyl transferase) is used to add 
homopolymeric tails to the 3' ends of the cDNA. After first strand cDNA synthesis, the 
original mRNA template is removed by treatment with the RNase Mix (mixture of RNase 
H, which is specific for RNA:DNA heteroduplex molecules, and RNase T1). 
Unincorporated dNTPs, GSP1, and proteins are separated from cDNA using a S.N.A.P. 
Column. A homopolymeric tail is then added to the 3'-end of the cDNA using TdT and 
dCTP. Since the tailing reaction is performed in a PCR-compatible buffer, the entire 
contents of the reaction may be directly amplified by PCR without intermediate organic 
extractions, ethanol precipitations, or dilutions. PCR amplification is accomplished using 
Taq DNA polymerase, a nested, gene-specific primer (GSP2) that anneals to a site located 
within the cDNA molecule, and a novel deoxyinosine-containing anchor primer  
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provided with the system. 
 
 
PRIMER GSP1 5’-CCCAGAATCTCATTGCTTAGAG-3’ 
PRIMER GSP2 5’-CTCCTCCAGCATGTCGAAGC-3’ 
 
 
 
Conventional agarose gel electrophoresis was used to analyze DNA fragments. The 
electrophoretic mobility of DNA fragments mainly depends on the fragment size and to a 
lesser extent on the conformation of the DNA, type and concentration of agarose used as 
well as applied voltage and electrophoresis buffer used. Agarose gels have greater range 
of separation and can resolve DNAs from 50 bp to 20 kbp in length. For separating 
smaller sized PCR fragments 2% and 3% gels were used. Agarose gels were prepared by 
dissolving agarose powder in Tris-Boric Acid-EDTA buffer (TBE). 1-2 % (m/v) agarose 
gels were used depending on the size of the PCR amplicon. 
 
 
PCR products were cloned into pCR®II-TOPO® plasmid using the TOPO TA Cloning® kit 
(Invitrogen). 2μl PCR Product was mixed with 1μl salt solution (1.2 M NaCl; 0.06 M 
MgCl2), 1μl sterile H2O, and 1μl TOPO®vector. For each transformation, 1-50 μg of DNA 
was added to 25-50 ml of chemically competent cells. The reaction was incubated at 
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room temperature for 5-30 minutes, and subsequently chilled on ice for 5 minutes. 0.5-
2μl of the ligation reaction was transformed into Escherichia Coli strains Top10F 
(Invitrogen). Incubated on ice for 30 min, the cells were next subjected to heat shock at 
37 or 42 °C for 1 min and next incubated on ice for 2 min. The cells were recovered in 
SOC (2% bacto-tryptone, 0.5% bacto-yeast extract, 10mM NaCl, 2.5mM KCl, 10mM 
MgCl2, 20mM glucose) broth and then incubated for 1 h at 37°C with shaking (200-250 
rpm). Cells were plated on LB-agar containing appropriate antibiotics (ampicillin 
100μg/ml) with an incubation at 37°C overnight. 
To allow blue/white screening of bacterial colonies 40μl of 40mg/ml X-gal (Genespin), 
and 40μl 100μg/μl IPTG (Genespin) were applied to plates, and left to dry before plating. 
White colonies were selected for restriction analysis of miniprep DNA. Miniprep DNA 
was performed using a boiling method. 
DNA sequencing was carried out using the dideoxy nucleotide chain-termination method 
(Sanger et al., 1977) with dye terminator labelling of purified plasmids or PCR products. 
Specific forward and reverse primer for PCR products and universal M13 forward and 
reverse primer for purified plasmids were used. The DNA samples were precipitated 
using ethanol and the pellets were washed twice with 75% ethanol. The purified 
templates were dissolved in sterile water and the Applied Biosystems Big-Dye ver 3.1 
chemistry kit was used to set up the sequencing reactions. Sequences were analysed on 
ABI 3130XL automatic sequencers (Applied Biosystems). 
 
PRIMER M13 FW 5’-TTGTAAAACGACGGCCAGT-3’ 
PRIMER M13 REV 5’-CAGGAAACAGCTATGACC-3’ 
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2.12 RT-PCR 
First strand cDNA was synthesised from total RNA using IMPROMTM Reverse 
Transcription (Promega) system following the manufactures procedure. 
For primer design, genomic sequences were retrieved from the University of California 
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Santa Cruz (UCSC) Genome Browser (http://genome.ucsc.edu/cgi-bin/hgGateway, 
version February 2009) and primers were designed by the use of the publicly available 
software Primer3 (http://frodo.wi.mit.edu/primer3/input.htm). 
RNA was denatured with GAPDH and WNT10B primer for the gene-specific 
retranscription and random primers at 70 ˚C for 5 min. Then single strand cDNA was 
synthesised for 1hr in a mix containing 1.0 ul of reverse transcriptase, 0.5 mM dNTPs, 
20U of RNase inhibitor and 5X reverse transcription buffer, 1.5 mM MgCl2. The reaction 
was performed at 42˚C for 1 h, followed by heating at 70°C for 15 min.  
The WNT10B gene-specific reaction was puriefied by using 2.5M of Sodium Acetate 
(pH 5.2) and 2 volumes of EtOh 100%; 30 min at -20°C followed by 30 min in a 
centrifuge at 4°C. 
Nucleic acid sequences of interest were amplified by RT-PCR using cDNA as the 
template. The standard mixtures (20.0 μl) for the regular PCR reaction in this work were 
prepared by the following recipe: 
1 μl cDNA (RT-PCR), 1.25 U of EuroTAq DNA polymerase (EuroClone), 2.5 μl of the 
supplied 10 x buffer (EuroClone), 1.50 μl 50 mM MgCl2 (EuroClone), 0.5 mM 
dNTPs ,0.5 μM of forward and reverse primer. 
Reactions were carried out in microcentrifuge tubes in a themocycler MJ Mini™ 
Personal Thermal Cycler (Bio-Rad). 
with a range of cycling conditions, specific to each primer set.  
The reactions were performed by the following cycling parameters: initial 
denaturation, amplification, elongation and final extension. 
 
 GAPDH: 94°C 1 min, 94°C 20 sec, 60°C 15 sec, 72 °C 12 sec (30 cycles), 72°C, 5 
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min, 4°C forever. 
 WNT10B: 94°C 2 min, 94°C 20 sec, 61°C 20 sec, 72 °C 30 sec (30 cycles), 72°C, 
5 min, 4°C forever. 
 WNT10BIVS1: 94°C 2 min, 94°C 20 sec, 63°C 20 sec, 72 °C 30 sec (30 cycles), 
72°C, 5 min, 4°C forever. 
 WNT10A: 94°C 2 min, 94°C 20 sec, 58°C 20 sec, 72 °C 30 sec (30 cycles), 72°C, 
5 min, 4°C forever. 
 WNT2B: 94°C 2 min, 94°C 20 sec, 57°C 20 sec, 72 °C 30 sec (30 cycles), 72°C, 5 
min, 4°C forever. 
 WNT6: 94°C 2 min, 94°C 20 sec, 59°C 20 sec, 72 °C 30 sec (30 cycles), 72°C, 5 
min, 4°C forever. 
 
 
 
 
PRIMER RT WNT10B 5’-ATCTCATTGCTTAGAGCCCGAC-3’ 
PRIMER WNT10B EX1 FW 5’-GCAGCACTAGTGAAGCCCAG-3’ 
PRIMER WNT10B IVS1 FW 5’-CCTGAACCCGCATCAAGTCTC-3’ 
PRIMER GSP2 5’-CTCCTCCAGCATGTCGAAGC-3’ 
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2.13 IMMUNOBLOT 
 
 
 
The lysates were applied with the same volume of 12 μl to one slot of a 10% stacking gel. 
The samples were run for approximately 30 min at 30 V, and subsequently for 45 min at 
100 V. The stacking gel was removed from the separating gel.  Thereafter, the gel was 
applied followed by the PDVF membrane (PVDF Transfer Membrane, Thermo Scientific) 
PRIMER WNT10A FW 5’-GTGCTCCTGTTCTTCCTACTG-3’ 
PRIMER WNT10A REV 5’-GATCTTGTTGCGAGTCTCCA-3’ 
PRIMER WNT2B FW 5’-GACAACTCTCCAGATTACTGTG-3’ 
PRIMER WNT2B REV 5’-AATTGGAGGGATGAGTGAGG-3’ 
PRIMER WNT6 FW 5’-CAACAGGACATTCGGGAGAC-3’ 
PRIMER WNT6 REV 5’-ATAAGAGCCTCGACTTCTCGT-3’ 
PRIMER GAPDH FW 5’-ACCTGCCAAATATGATGACATC-3’ 
PRIMER GAPDH REV 5’-CAGTGTAGCCCAGGATGC-3’ 
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which was activated by dipping into methanol. Tha transfering step, was performed in 
Biorad instruments Trans Blot® Turbo Transfer System, with transfer buffer (192 mM 
glycine, 25 mM Tris-base, 0.05% SDS, and 20% methanol). The electroblotting was done 
for 10  min h with a voltage of 25 V. As the protein transfer was finished, the membrane 
was separated from the sandwich and washed three times with TBST (20 mM Tris-base, 
140 mM NaCl, and 0.05% Tween® 20; adjusted to pH 7.6 with NaCl) for 5 min at RT. 
Afterwards, bound proteins were blocked with 5% BSA (Sigma-Aldrich) powder 
dissolved in TBST under continuous shaking O/N at 4°C. The incubation with the 
primary antibody occurred over night at 4 °C. Protein expression was assessed by 
immunoblot analysis using standard procedures, applying anti–active β -catenin (ABC) 
monoclonal mouse (anti-ABC clone 8E7; Millipore, Billerica, MA), anti–WNT10B 
monoclonal mouse (5A7; Abcam), anti– glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) polyclonal rabbit (ab97626; Abcam), antibodies. Secondary antibodies used 
were anti– mouse HRP, and anti– rabbit HRP (Thermo Fisher Scientific, Waltham, MA). 
The detection of the HRP conjugated antibodies on the membrane was done after three 
washing steps with the help of the ECL™ Western Blotting Detection Reagents 
(EuroClone).  
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3. Results 
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3.1 AC133+ CELL FRACTION IS HIGHLY EXPANDED IN AML 
 
 
According to literature’s data, the AC133 antigen expression is restricted to a rare cell 
population with long-term reconstituting activity, ranging from 20% to 60% of all CD34+ 
cells, and resulting barely detectable in CD34-Lin- cells. In Brioschi et al., we evaluated 
the ability clonogenic of AC133 + selected cell in qualitative terms as capacity to produce 
colonies granulocyte / macrophage (CFU-GM) and / or erythroid (BFU-E Burst-Forming 
Units-Erythroid) in the presence of appropriate stimulation and in term quantitative by 
comparing the results with those obtained from the seeding of mononuclear cells in toto. 
We previously shown in Brioschi et al. work, through the comparative analysis of the 
data of clonogenicity, that AC133+ LT-HSCs being also highly enriched in colony forming-
units (CFU) and have a stronger granulocyte/macrophage (CFU-GM) differentiation 
potential relative to the unsorted bone marrow mononuclear cells (BM-MNCs). 
Conversly, their BFU-E forming potential is lower (Brioschi et al., 2010).  
The first step of our work is the descriptive assessment of AML and control cell 
populations, represented by mononuclear cells separated by density gradient and the 
fractions obtained for positive and negative immunomagnetic separation. In order to 
determine the dynamic range of expansion of AC133+ cell fraction in AML, flow 
cytometric quantification of CD133.1 (AC133) expression either in single staining or in 
combination with the pan-hematopoietic marker CD45 was performed on 25 primary 
AML bone marrow human samples and 10 age-matched healthy volunteer adult donors. 
We then proceeded to the statistical analysis defining the P value (α=0.001) by the non-
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parametric test of Mann-Whitney test. 
The resulting CD133.1+ cell fraction was expanded among AML patients by an average of 
31.5% (interquartile range (IQR): 16.5%-53.4%) with respect to normal donors (median 
0.54%, IQR: 0.17%-1.14%, P<0.0001) (Figure 3.1).  
 
 
 
Figure 3.1 Human AC133+ cell fraction is highly expanded in AML. 
Dot plots of the immunophenotype analysis from bone marrow of healthy donor (A) and 
an AML patient (B). The CD45/CD133.1 co-staining was perfomed on BM MNCs and 
percentages on cellularity are shown for gated normal and AML populations. (C). Flow 
cytometry analysis of the AC133 antigen in BM MNCs of healthy donors (n=10) and AML 
patients (n=25).  
 
 
 
 
 
 171 
3.2 THE WNT SIGNALING IS DYSREGULATED IN AC133+ AML 
CELL FRACTION 
 
In order to highlight the de-regulated pathway that characterize AC133+ AML cell 
fraction versus normal long-term reconstituting AC133 HSC cells, we performed a 
genome-wide functional enrichment analysis. The identification of differentially over-
represented pathways in AC133+ AML cells is based on the functional enrichment 
analysis through three computational tools: GOstats (version 2.12.0 of the Bioconductor 
package), DAVID (Database for Annotation Visualization and Integrated Discovery; 
http://david.abcc.ncifcrf.gov/home.jsp) and dysregulated pathway analysis, employing 
the pathway information from GO BP (Gene Ontology Biological Processes) and KEGG 
databases (Falcon & Gentleman, 2007; Huang et al., 2009; Majeti et al., 2009). We 
identified: 
 212 GO BP terms functionally enriched with GOStats (p-value <0.01); 
 284 GO BP terms with DAVID (p-value <0.05); 
 616 GO BP terms with the non-parametric test (p-value<0.05).  
Moreover, GOStats selected 16 KEGG pathways (p-value < 0.05), DAVID 24 KEGG 
pathways (p-value < 0.05) and the dysregulated pathway analysis 3 KEGG pathways (p-
value < 0.05). Thus, the three computational types of analysis applied to all genes, 
selected the term “Wnt receptor signaling pathway” (p-value= 0.022) as the most specific 
de-regulated pathway (Figure 3.2).  
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Figure 3.2 Schematic representation of expression profiling analysis and 
identification of de-regulated pathway. The microarray data, obtained from the gene 
expression profiling study, are used as query for functional enrichment analysis through 
three computational tools: GOstats, DAVID and dysregulated pathway analysis, 
employing GO BP (Gene Ontology Biological Processes) and KEGG databases. 
 
 
 
 
Since the accepted role of transcriptional factors (TFs) in myeloid leukemogenesis, we 
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performed also the same functional enrichment analysis focusing on genes annotated as 
transcription regulators (TRs), employing the evolutionarily conserved human 
transcriptional regulators data set (http://homes.dsi.unimi.it/~re/TRdataset/). The 
first step of our analysis consisted in the definition of a set of genes annotated as 
transcriptional regulators (TRs) and conserved in a broad range of organisms, from 
yeast to human. The entry point of our selection procedure was the extraction from Pfam 
of all the domains involved in transcription regulation, which resulted in a set of 400 
Pfam domains. Next, we used this list to query the entire set of ensemble human genes 
using the BioMART web interface. This produced an initial set of 2,971 non-redundant 
genes associated to a unique HGNC symbol. We thus adopted a direct SQL access to the 
ensembl_compara_51 database (hosted at ensembldb.ensembl.org) in order to extract all 
the one-to-one orthology relationships occurring between the genes in the initial set and 
the complete set of genes in the following organisms: Bos taurus, Canis familiaris, Danio 
rerio, Drosophila melanogaster, Equus caballus, Gallus gallus, Loxodonta africana, Mus 
musculus, Saccharomyces cerevisiae, Takifugu rubripes and Xenopus tropicalis. We then 
defined an evolutionarily conserved set of TRs by requiring the presence of at least 5 
one-to-one orthology relationships disregarding the involved species. This produced a 
set composed of 1,989 non redundant genes. We finally tested each of the 1,989 gene 
symbols obtained through the orthology filtering for the association with at least 1 
probe set in the Affymetrix hgu133plus2 array. This defined a final set of conserved 
putative transcriptional regulators composed of 1,919 genes. We can perform a first 
comparison with the study conducted by Messina et al., in which the analysis was carried 
out starting from 479 genes, present in the TF TRANSFAC database and integrated with 
the 852 genes in the InterPro database (Messina et al., 2004). The data obtained, 
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followed by an orthology test with the FlyBase database of the Gene Ontology, were 
further analyzed, in manual mode, in order to combine the data present in the literature 
with the role played by TF and then confirm that each mRNA emerged from the analysis 
was associated with a regulator of transcription (Hunter et al., 2008; Levine & Tijan 
2003). One feature that differentiates the two studies is the analysis of orthology, 
performed against only one animal species, in the work of Messina et al. and instead 
made against eleven different species in our study; the test of orthology multi-species 
executed following analysis of comparative genomics, through the orthology and 
paralogy proposed by Ensembl (version 51) and by alignments with WU-BLAST, has 
allowed us to greatly enhance the data obtained, as it allowed the selection of only those 
proteins that, subject to evolutionary pressure, have retained their biological role in the 
species compared. Besides, the pipeline adopted by the authors resulted in the definition 
of a set of 1,468 human TFs. In order to explain the difference in size, we compared our 
pipeline with the procedure presented in Messina et al., work. After considering the 
absence of a comparative genomics filtering, the most relevant difference between the 
compared approaches is the absence in our pipeline of a filtering aimed at providing 
strong support for the expression of our set of TRs. We thus check our conserved set of 
TRs for an overlap with annotated NCBI’s UniGene clusters. Moreover, the required 
annotations were obtained using the BioMART web interface and the whole human 
known Ensembl gene set (version 51) and limiting the extraction to a set of genes 
produced by the orthology 1-to-1 multi-species filter. One thousand, six hundred and 
twenty conserved TRs genes were found to overlap with at least 1 NCBI UniGene cluster. 
Therefore we removed from our set of TRs all the gene symbols lacking an annotation in 
the Bioconductor annotation package associated with the Affymetrix Hgu133plus2 array. 
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This filtering procedure produced the reference conserved TRs set composed of 1,611 
evolutionarily conserved genes (http://homes.dsi.unimi.it/~re/TRdataset/). We tested 
genes comprised in the conserved TRs set for differential expression in AC133+ AML 
cells. In this stage of the analysis our goal was to isolate a set of genes highly or 
moderately overexpressed in the leukemic condition in order to identify genes suitable 
for ontology driven functional enrichment investigations using a standard 
hypergeometric test. We selected a set of overexpressed conserved TRs by means of 
Welch t-test (α=0.05, one-tailed).  
This procedure identified a set of 734 conserved putative TRs overexpressed in AC133+ 
AML cells (http://homes.dsi.unimi.it/~re/TRdataset/) (Figure 3.3). 
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Figure 3.3 Schematic representation of definition of transcription factors dataset 
and functional enrichment analysis. Construction of conserved human transcriptional 
regulators (TRs) data set, obtained after the bioinformatic tools interrogation; this 
dataset was used as a filter for gene expression profiling data in order to define the 
transcriptional program differentially expressed between AML and healthy donors. The 
“Wnt signaling pathway” (GO:0016005) term is the most specific de-regulated Go term 
in AML. 
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The overexpressed TR genes were then tested for functional enrichment using the 
Bioconductor GOstats package (www.rproject.org function: hyperGTest). All the 
functional terms retrieved are associated with regulatory processes because of the 
nature of the universe set, which is entirely composed of TRs. Among the selected 
functional terms the most specific one, with respect to the GO Biological Process 
ontology, is the term ‘GO:0016055’, associated with the “Wnt receptor signaling 
pathway” and composed of 38 genes, 26 of which resulted significant by the Welch t-test 
(http://homes.dsi.unimi.it/~re/TRdataset/). 
If we consider the study conducted by Majeti et al., our microarray analysis has not been 
simply adopted to evaluate the differences in gene expression between the normal and 
pathological hematopoietic stem cell, but the data set of transcription factors has 
allowed to evaluate the differences between the two types of cells as a function of the 
transcript (Majeti et al., 2009). Besides, unlike the study of Majeti et al., the gene 
expression analysis was performed on fractions AC133 + obtained and not on the CD34 + 
cell population, using microarray technology, Affymetrix platform® and followed by 
analysis of pre-processing for the validation data. 
Thus, the two independent types of analysis applied to all genes and to transcription 
regulators, selected the term “Wnt receptor signaling pathway” as the most specific 
dysregulated pathway in AML. 
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The ligand-dependent activation of the regeneration-associated Wnt pathway 
 
In order to look insight into the Wnt signaling in AC133+ leukemia cells, we performed a 
second step analysis of microarray data by using all the WNT probe sets annotated to GO 
class ‘GO: 0016055’ or to any of its children GO terms. The total list of analyzed WNT 
genes includes 480 probe sets, mapping to 193 different genes 
(http://homes.dsi.unimi.it/~re/TRdataset/).  
In order to assess differential expression of WNT genes we employed Welch t-tests (two-
tailed) on the 480 probe sets, thus identifying 103 differentially expressed genes 
(http://homes.dsi.unimi.it/~re/TRdataset/).  
The bioinformatics analysis defined the differentially expressed WNT ligands (WNT10B, 
WNT10A WNT2B and WNT6), the Wnt/β-catenin signaling agonists, the antagonists and 
deregulated targets within the canonical Wnt/β-catenin pathway with the lower P value 
as evaluated by the Bonferroni correction. Considering this data our results are define 
the ligand-dependent activation of the regeneration-associated Wnt pathway (Beghini et 
al., 2012) (Figure 3.4). 
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Figure 3.4 Heatmap of the differentially expressed WNT-associated genes. The 
names, accession numbers as well as P values for the differentially overexpressed and 
underexpressed genes are shown in the right panels. The double analysis of clustering, 
that is shown in the heat-map of probe-sets differenzially expressed, makes the 
distinction between patients and controls.  
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3.3 THE WNT10B HEMATOPOIETIC REGENERATIVE 
MOLECULE IS EXPRESSED IN AML 
 
 
According to our previously data indicating transcriptional activation of canonical WNTs, 
we investigated how expression of WNT10B is related to AML phenotype through new in 
situ approaches (Beghini et al., 2012). 
The ability to study individual transcripts in single cells has been sought after for a long 
time, but existing methods have limitations in selectivity or efficiency. For single-cell 
analysis, technologies must be very sensitive. Gene expression is a highly stochastic 
process, with substantial cell-to-cell variations in mRNA levels. Thus, the concept of the 
average cell is considered a myth and cellular biomolecules and genetic varations should 
instead be studied on a single-cell level (Levsky and Singer, 2003). The mRNA in situ 
detection is initiated by in situ reverse transcription using LNA containing primers, 
followed by digestion of the mRNA part of the mRNA/cDNA duplex for creation of a 
single-stranded target. Padlock probes are thereafter hybridized to the cDNA transcripts 
and circularized upon complete match with the correct targets. Finally, RCA is primed 
from the cDNA creating long concatemeric DNA molecules that will be visualized by 
labeling with fluorescence tagged oligonucleotides. 
Using this approach, we detected WNT10B related transcript in bone marrow sections 
obtained at diagnosis from two randomly selected patients. In order to set up the 
experiment, we first tested the method to detect WNT10B transcripts in cultured human 
cells, in order to evaluate the correct ligation of the specific padlock probe. According to 
the literature’s data (Kirikoshi & Katoh, 2002), WNT10B mRNA is relatively highly 
expressed in HeLa cell line; therefore we tested our padlock probe on Hela cells seeded 
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and fixed on slides, with β-actin as as a reference transcript. In the figure 3.5, we can 
observe abundant, bright, spot-like β-actin signals localized to the cytoplasm of cells. 
 
 
 
 
Figure 3.5 In situ detection of β-actin in cultured human HeLa cells. mRNA in situ 
detection of β-actin, visualized by green Rolling Circle Particles (A and B right). In the 
left panel are shown images acquired in gray scale. Cell nuclei are shown in blue. Scale 
bar 10 μm. 
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We acquired the RGB images, but also the gray scale images in order to segment all cell 
nuclei in the image and count the RCPs for single cell through the CellProfiler pipeline 
(http://www.cellprofiler.org/). Most gray level image segmentation techniques can be 
extended to color images as well. However, when a color image is separated to the three 
color components R, G and B, the color information is scattered and the information that 
humans can perceive is lost. When compared to gray scale images, color images have 
additional information that can sometimes be useful or even necessary in image analysis 
tasks. In the last step of the analysis, through Human Cell CellProfiler’s pipeline we 
counted the detected signals inside each cytoplasm and nucleus. In order to consider all 
signals, we acquired the images by the Maximum Intensity Projection (MIP), considering 
x, y and z axes. Through the Human Cells CellProfiler’s pipeline, we counted 110 β-actin 
RCPs for each HeLa cell. We can observe the distribution of RCPs around the nuclei, and 
we also can observe the presence of the signals on different focal planes. Following the 
β-actin detection, we performed the same experiment in order to test the WNT10B 
padlock probe on HeLa cells. As we can see in the figure 3.6 and 3.7, we found expression 
to vary widely among the cells. Using the same image pipeline of β-actin counting, we 
counted 120 bright RCPs around the cell nuclei, without any aspecific signal. The 
CellProfiler output data, were subsequently analyzed through R (http://www.rproject. 
org/), a language and environment for statistical computing and graphics. 
We observed an average ratio close to 1 between the houskeeping gene and the 
hematopoietic regenerative-associated Wnt ligand (WNT10B) expression, indicating an 
high expression of WNT10B in a tumor context (Figure 3.8). 
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Figure 3.6 WNT10B mRNA in situ detection in HeLa cells. WNT10B RCPs are shown 
in green. In the figure are shown five different fields (A,B,C,D,E), acquired at X20. In the 
left panel are shown the same images acquired in a grey scale. Cell nuclei are shown in 
blue. Scale bar 10 μm. 
 
 
 
 
 185 
Figure 3.7 Highlits of WNT10B mRNA in situ detection. WNT10B RCPs are shown in 
green. In the figure are shown three different fields (A,B,C,), acquired at X40. In the left 
panel are shown images acquired in a grey scale. Cell nuclei are shown in blue. Scale bar 
10 μm. 
 
 
 
 
Figure 3.8 β-actin and WNT10B RCPs counting. CellProfiler output, that define the 
number of β-actin (red) and WNT10B (green) RCPs in each cell. The ratio between β-
actin and WNT10B is close to 1. 
 
 
Therefore, following the experiment’s set up, we further investigated WNT10B related 
transcript in bone marrow sections obtained at diagnosis from two randomly selected 
patients, with β-actin as reference transcript in consecutive sections (Figure 3.9). 
Considering the presence of the β-actin mRNA, we acquired 24 fields of the AML63 bone 
marrow biopsy, in order to visualize the complete distribution of β-actin RCPs (Figure 
3.10). The DAPI and Cy3 signals, were acquired with the same parameters in each field. 
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Then we performed the WNT10B mRNA in situ detection. We can note in the Figure 3.11 
that the WNT10B RCPs are spread on the entire area, with an omogeneous distribution. 
This data suggests that the hematopoietic regenerativeassociated Wnt ligand (WNT10B) 
is expressed at mRNA level on both leukemic blasts and stromal-like cells, indicating a 
possible autocrine/paracrine involvement of Wnt in the bone marrow 
microenvironment. 
 
 
 
 
Figure 3.9 β-actin mRNA in situ detection on bone marrow biopsies. β-actin RCPs 
are shown in red. Cell nuclei are shown in blue. Scale bar 20 μm. 
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Figure 3.10 A scan of β-actin mRNA in situ detection. β-actin RCPs are shown in red. 
In the scan, were acquired 24 fields on x and y axes at X20. Cell nuclei are shown in blue. 
 
 
 
 
 
 
 
Figure 3.11 WNT10B mRNA in situ detection. WNT10B RCPs are shown in green 
(Cy5). In the figure are shown mRNA in situ detection performed on two AML patents 
biopsies, AML9 and AML63. The fields were acquired at X40. Cell nuclei are shown in 
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blue. Scale bar 20 μm. 
 
 
If we compare the mRNA in situ detection performed on HeLa cells and on bone marrow 
biopsies, we can note that there are differences about number and distribution of RCP 
signals. Infact, working with FPPE sections, we must consider that: first of all, the 
permeabilization step is a crucial step, becouse allow the contact between target and 
reagents; second of all, we must consider the thickness of the bone marrow section (5-7 
μm). Considering the thickness of the section, we can found RCPs distributed in five focal 
planes, and then we can’t detect every signal in the image. In order to solve this problem, 
we used CellProfiler software as the automated system of image analysis. 
 
 
 
Figure 3.12 Quantification of RCPs. The CellProfiler quantification of β-actin RCPs 
(red) and WNT10B RCPs (green) for five slide fields. In the panel A, is shown the ratio 
WNT10B/ β actin RCPs, considering the CellProfiler data output (B). 
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Finding cells, finding molecules 
 
In the signal segmentation project, the collected image stacks of relatively flat cells 
contained point like signals in focus in different layers. However, the MIP is somewhat 
sensitive to noise, as it will act as maximum filter for each 1 X 1 X 16 pixel array. To 
reduce the amount of non-point-like signal before the MIP, the background was removed 
in each focus layer using top hat filtering. The top-hat filtering may be described by a 
rolling ball analogy. Draw a squiggly line on a piece of paper, and let an imaginary ball (a 
structuring element) with a certain radius roll along the curve. Every point that the ball 
manages to touch, being small enough to fit in to large holes and grooves, is set to zero. 
Points that the ball does not touch, due to being too large, are given values according to 
the distance between the ball and the line. In the top-hat transform the imaginary ball 
has been replaced with a structuring element with a flat top, like a hat. Performing the 
MIP of the filtered layers results in a single layer image with high contrast between 
signals and background. The flattened images contain the fluorescent signals from the 
fluorochromes and some noise. A Distance Transform (DT) of a binary image results in a 
gray level image where the value of each object pixel denotes the distance from that 
object pixel to the background. For a 2D or 3D binary image this can be computed by two 
passes through the image with a filter mask (typically of size 3X3, or 3X3X3). To separate 
cell nuclei from image background Otsu’s method of thresholding, which minimizes the 
variance of the foreground and background, is used. The nuclei are often clustered and 
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have to be separated in order to identify individual cells. A distance transform is applied 
to the binary image obtained from the previous step. This will create a landscape like 
image where the intensity represents the height in the landscape. Once the nuclei are 
separated an area defining the cytoplasm belonging to each cell has to be delineated. 
Since it often is the case that no cytoplasmic stain is present, cytoplasm delineation is 
purely based on the distance from the nuclei. A distance transform is performed on the 
background of the image of the nuclei. A user-defined threshold, representing the 
maximum distance from cell nucleus to cell border, is thereafter applied, defining the 
outer border of each cytoplasm. A watershed algorithm is then used to label and 
separate touching cytoplasms. Nuclei touching the border will be flagged in the results, 
this way the user can chose to omit these cells in the final results (Figure 3.13). 
 
 
 
 
 
Figure 3.13 The cell nuclei segmentation process. The distance shells for signal 
concentration measurements. The segmented nucleus in xy, yz and xz views respectively 
(A). The negative distance shells overlaid on the nucleus (B). The segmented nucleus 
with pseudo-colors after the segmentation process (C). 
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When each cell nucleus and cytoplasm is labeled correspondingly we detected and 
assigned each signal to a particular cell, and thereafter projected into a 2D image by a 
maximum intensity projection (MIP). In the pre-processing step we set up a filter with a 
variable sized kernel, defined by us, enhancing local maxima in the image. There are two 
measurements of signals made; a signal count and an intensity measure. The signal 
count measures all detected signals as while the intensity measure looks at a 5X5 
neighborhood around the center of a detected signal and measures the total intensity in 
that neighborhood. Working with the formalin-fixed paraffin-embedded (FFPE) tissue 
sections, we must solve a lot of problems about the background fluorescence, the RCP’s 
counting, and at least the correct segmentation between nuclei and cytoplasm, because 
the bone marrow section is characterized by a high number of closer blast. Beside, 
another problem is the thickness of the sample, that determine questions about the z-
axes analysis and the Point Spread Function (PSF) definition of RCPs signals. Large scale 
intensity variations and shading effects in the image caused by uneven illumination and 
other variations over the field of view are undesirable, as they may introduce problems 
for the segmentation step as well as position dependence for features such as integrated 
pixel intensity. Given that the uneven background is due to uneven illumination and the 
intensity of the fluorescence in each cell is a linear function of the light illuminating the 
cell, the usually accepted illumination correction is: (Iraw −Idark)/(Iblank−Idark), where 
Idark is an image without the illumination and Iblank is an image from a blank part of 
the slide with illumination. Whether it is feasible to acquire good images of the shading 
situation directly in conjunction with the imaging procedure, or not, is very much 
dependent on the imaging environment. Considering these image’s feature, we 
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decreased the background fluorescence, through the illumination correction. A method 
inspired by the watershed algorithm was used for initial separation of clusters of cells 
and segmentation of the image into cells and background in one step. Color, as humans 
perceive it, is the response from the three different spectral sensitivity ranges of the 
cones in the eye. Therefore most imaging devices are designed to optimize, red, green 
and blue colors (RGB). In order to localize the point-like signals in relation to the nuclei 
membranes, a nucleus is considered as a set of shells based on the Eucliedian distance 
transform. The shells have negative values inside the nuclei, zero at the border and 
positive values outside. In order to identify the RCPs’ signals, using x, y and z axes, we 
considered the point-like signals using a property of Fourier transform, i.e., computing 
the coefficients as dot products between the signal and sines and cosines. The idea is 
based on a method called Stable Wave Detector (SWD) (Dupaˇc and Hlav.ˇc, 2006) that is 
used for landmark detection on 2D images. 
We considered the image as a sequence of frames that should overlap more than T/2, the 
signal width. Sine and cosine Fourier coefficients, bi and ai, of the first harmonic wave of 
the Fourier series are computed using 
 
ai = FiC 
bi = FiS 
C(t) = cos(2π(t/T)) 
S(t) = sin(2π(t/T)) 
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Figure 3.14 Point-like signal detection. A. The mid slice of a simulated point like 
signal, considering the point spread function of a RCP signal. B. The signal as a surface 
plot. C. Definition of a single point signal of the RCP, after the image processing. 
 
In order for a pixel to be classified as a true signal, the image is first convolved with the 
cosine filter C of period T and a threshold is used to identify the potential signals (Figure 
3.14). Then, after this pre-processing of the images, we can detect the single RCP signal, 
in a bone marrow biopsy through CellProfiler pipeline. We applied the Human Cell 
CellProfiler pipeline, using .tif images acquired at fluorescence microscope and saved in 
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a folder, as Imput Images. After the images loading, we defined nuclei as Primary Objects 
and RCPs as Secondary Objects, defined by Otsu’s and Waterhshed thresholding 
methods. The definition of blobs and nuclei, followed the illumination and background 
correction, is the last step of the image analysis (Figure 3.15). 
 
 
Figure 3.15 CellProfiler analysis. The.tif images were loaded as input image (A), and 
then the nuclei were labeled (B). In the panel C and D, are shown the Primary and 
Secondary objects. The overlay between Primary and Secondary Objects (E), is followed 
by background correction (F, G). The results are shown in panel H and I. 
 
In order to better elucidate the impact of the diffuse WNT10B overexpression on the 
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leukemic microenvironment, we examined its expression in histological preparations of 
bone marrow from five randomly selected AML patients at diagnosis. The double 
immunostaining for WNT10B and ABC, evidenced that WNT10B is expressed by a high 
proportion of leukemic cells, and its presence correlates with cytoplasmic accumulation 
of active-β-catenin in a proportion of eight percent of cells. WNT10B antibody staining 
was also detectable in interstitial spaces, suggesting the secretion and release in the 
bone marrow microenvironment. Besides, the slides revealed that WNT10B is diffusely 
expressed but that only a few small cells (8-10 μm diameter of the nuclei), with a clonal 
appearance and increased N:C ratio, shared the Wnt signaling activation signature 
represented by cytoplasmic accumulation of the active form of β-catenin, likely induced 
through an autocrine/paracrine mechanism (Figure 3.16). 
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Figure 3.16 β-catenins activation in AML cells expressing WNT10B. Representative 
bone sections of an AML patient (AML9) were costained for expression of (A) active β-
catenin (green), and (B) WNT10B (red). The image was acquired at X40 objective. Scale 
bar 10 μm. 
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3.4 AC133 IS EXPRESSED ON A46 AML CELLS SECRETING 
WNT10B 
 
According to the idea that primary cells cultures closely mimic the in-vivo state and 
generate relevant data, we established a primary AC133+ cell culture (A46). A46 cells, 
with diploid karyotype, were selected from a 66 years old male at diagnosis of AML-M2. 
The immunophenotype of unselected cells revealed a dominant CD133.1+CD34+CD38-
CD45+CD117+ blast population (59%), representing an optimal source to establish a 
LICs-enriched primary culture. In order to investigate whether the endogenous WNTs 
production had any paracrine effect, A46-CM was used to evaluate β-catenin-mediated 
transcriptional activation. To this aim, HEK293T cells (H293T), transfected with 
Super8XTOPFlash β-catenin/TCF transcription-based reporter construct, were exposed 
either to pBA-Wnt10b H293T-Collected Medium as control or A46-Collected Medium. 
This construct could be efficiently expressed in a dose-dependent manner when 
transiently exposed to A46-CM for 12h (Figure 3.17). 
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Figure 3.17 Immunoohenotyoe analysis from AML46 BM MNCs at the diagnosis an 
after selection. (A) Patterns of CD38/CD133.1, CD117/CD45, CD34/CD38 co-staining 
was gated on BM AML cells before selection. Representative CD34 and CD38 expression 
on Ficoll™-selected MNCs (below center) and AC133 sorted cells prior to culture is 
shown in the central part of figure. Percentages on total cellularity are shown for gated 
AML populations. 
 
In order to clarify the relationship between the abnormal Wnt activation in AC133+ 
population and the LIC activity we translplanted A46 cells into sublethally irradiated (5 
Gy) six weeks old Rag2-/-γc-/- mice via the tail vein. We set up the experiment using Rag2-
/-γc-/- mouse, becouse this immunodeficient mouse strain lacks mature B, T and NK cells, 
supporting efficient engraftment of human AML.  
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Table 3.1. Immunophenotype analysis of transplanted Rag2-/-γc-/- mice. 
 
 
 
Transplanted mice were killed at 3 to 8 weeks after transplantation and analyzed for 
engraftment of human leukemia cells in BM. The AC133+ A46 cells showed engraftment 
of human CD45 (hCD45)+ cells. Then, we evidenced that engrafted hCD45+ cells were 
human myeloid leukemia blasts by measuring CD34/CD38/CD133 expression. 
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Figure 3.18 AC133+ A46 cells transplantation in Rag2-/-c-/- mice. (A) Represetation 
of overview of the experimental design: 1*106 AC133+ A46 cells were injected into 
sublethally irradiated Rag2
-/-
c
-/-
 mice through the tail vein. Three weeks after 
transplantation BM cells were collected and analyzed by flow cytometry. (B) Expression 
profiles of three recipient mice (M#1-3) are shown. 
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3.5 THE TRANSPLANTATION OF A46 CELLS INDUCED ECTOPIC 
AXIAL STRUCTURES FORMATION IN ZEBRAFISH EMBRYO BY 
WNT SIGNALING ACTIVATION 
 
In order to define the physiological relevance of WNT factors expression and release and 
the tumor-linked signals, we used the developing zebrafish model as a biosensor. Wnt 
pathway is among the most evolutionarily conserved signalings, and Wnt ligands have 
been strongly implicated in body axis formation in Xenopus and Danio Rerio. In this 
models Wnt ligands represents the maternal dorsal determinants necessary to induce 
the nuclear translocation of β-catenin in the prospective dorsal region of the blastula. 
Additionally, the Wnt signaling activation in zygotic state of zebrafish development, is 
required for proper tail development, and its overexpression induces ectopic tail buds. 
Considering this evidences, we transplanted A46 cells fluorescently labeled with 
Hoechst 33342, into developing zebrafish embryos (Figure 3.19). We observed that 
embryos grafted at or before the mid blastula transition stage (~3 hours post 
fertilization, hpf) A46 cells (Figure A) developed secondary axial structures, ranging 
from additional tail tissues (Figure E-H) to an almost fully-formed ectopic head (Figure 
I). Control embryos grafted with normal bone marrow-derived AC133+ cells, did not 
show any alterations of the normal phenotype. In order to identify the additional tail 
structures we performed in-situ hybridization staining for the notochord and tail bud 
marker ntl. We can observe the emergence of ectopic head structures through the pax2a 
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lstaining that abeling optic stalk, midbrain-hindbrain boundary, and otic vesicles. These 
results imply that A46 cells might determine the establishment of an additional source 
of signal, with a Nieuwkoop center-like activity, inducing an extra dorsal organizer. We 
can underline that this results are similar to the endogenous situation at mid-blastula 
transition, when maternal Wnt/β-catenin signaling initiates the formation of the dorsal 
organizer. In consideration of this evidence, we analyzed, in cell-grafted embryos, the 
expression of the organizer-specific gene goosecoid (gsc), strictly linked with the nuclear 
translocation of maternal b-catenin triggered by the activation of the Wnt signaling. We 
can observe that normal AC133+ cells did not alter the normal expression of the gene 
(Fig B), approximately 30% of the embryos grafted with A46 cells (n=208) displayed 
both the expansion of the gsc endogenous domain and the activation of the gene in 
ectopic positions (Fig. C, D). Besides we can note in the figure that the endogenous (n) 
and ectopic (*n) ntl signals run parallel along the axis of the embryo, indicating the 
presence of additional axial structures. We also underlined in 24hpf embryo that 
developed an ectopic head the expression of the brain- marker gene pax2a. The optic 
stalk (OS) in close vicinity to the eye (e), the midbrain-hindbrain boundary (MHB), and 
the otic vesicles (OV) of the embryo are stained with the pax2a riboprobe, as well as 
several areas of the ectopic head. This data, underlines that A46 cells retain a dorsal-
organizer inducing activity possibly correlated with their strong Wnt signaling 
activation. In our work we also investigated the possible involvement of the Nodal 
signaling pathway in the dorsal-organizer induction mediated by A46 cells, considering 
that the secondary axis can be also induced by Nodal, a highly evolutionarily conserved 
morphogen able to activate gsc expression. The microarray data and qualitative RT-PCR 
in A46 and samples from 13 different AML patients exluded any Nodal contribution s to 
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the formation of the secondary axis and induction of gsc expression. 
 
 
 
 
 
Figure 3.19 A46 AML cells induce ectopic gene expression and secondary body axis 
formation upon transplantation in zebrafish embryos. (A) Fluorescence microscopy 
of a live zebrafish embryo at 30% of epiboly (from lateral view) transplanted at 3hpf at 
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the animal pole region with A46 cells previously blue-stained with Hoechst 33342. (B-D) 
Dorsal side view of 70% epiboly-stage embryos hybridized with a gsc-specific probe. 
The arrowheads indicate the gsc-endogenous signal, and arrows specify the position of 
zebrafish cells expressing ectopic gsc. (E) Brightfield microscopy of a 24hpf zebrafish 
embryo injected with A46 AML cells (lateral view). The arrowhead and the dotted line 
indicate the secondary trunk/tail induced by A46 cells. (F,G) The embryo in (E) has been 
hybridized with a probe specific for the notochord and tail bud marker ntl. (F) The probe 
labels the notochord (n) in the endogenous trunk and the chordoneural hinge (cnh) in 
both tails (G, higher magnification). (H) Tail of a 24hpf embryo hybridized with ntl-
specific probe. (I) Dorsal view of a 24hpf embryo that developed an ectopic head on the 
side of the endogenous one, as indicated by the expression of the brain- marker gene 
pax2a. The dotted lines indicate the main (M) and secondary (S) axes. The image is 
composed by different pictures corresponding to several focal planes, since the embryo 
is not flat, and a single focal plane cannot comprise all the labeled structures belonging 
to the main and secondary axes. Scale bars represent 125 μm (A-D), 150 μm (E), 40 μm 
(F), 15 μm (G and I), or 25 μm (H). 
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3.6 THE AC133BRIGHT POPULATION SHARED THE WNT 
SIGNALING ACTIVATION SIGNATURE 
 
Thirteen years ago, a novel cholesterol (Ch)-interacting, pentaspan membrane 
glycoprotein, named prominin-1 (CD133) has been identified as a surface marker of both 
neural (Weigmann et al, 1997) and haematopoietic (Yin et al, 1997) stem and progenitor 
cells. Since numerous somatic stem cells and cancer stem cells originating from different 
organ systems have been demonstrated to express it, prominin-1 might become a 
biological tool for stem cell. In our work, we noted that the signature of WNT signaling 
activation, is defined by the cytoplasmatic accumulation of the active form of β-catenin 
in AML cells. Thus, in order to characterize the activation of the WNT regenerative 
pathway in AC133+ cellular fractions, we investigated how the expression of WNT10B is 
related to AML phenotype, through in situ approaches. In order to look and observe the 
AML context, we performed direct immunostaining in histological preparations of bone 
marrow from AML patients at diagnosis. Double immunostaining for WNT10B and active 
β-catenin (ABC), confirmed that WNT10B was expressed by a high proportion of 
leukemic cells (Beghini et al., 2012). We noted that the “responsive” phenotype, defined 
by expression of the dephosphorylated β-catenin was restricted to only restricted to a 
rare population of cells, in an estimated proportion of eight percent of cells. Then we 
performed a direct AC133 immunolabeling on a closer serial section of AML bone 
marrow biopsy, considering WNT10B/ABC staining, in order to compare the different 
cell subpopulation distribution (Beghini et al., 2012). 
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In order to clarify the relationship between the responsive phenotype and the AC133 
positive cells, we performed series of immunofluorescences followed by image analysis. 
The first step of our work, was focused on the resolution of the hematopoietic tissue 
autofluorescence. The formalin-fixed paraffin-embedded (FFPE), show a lot of technical 
problems as autofluorescent properties of specific tissue constituents, for example 
lipofuscin granules, collagen fibers and porfirins with a broad-band blue excitation (Del 
Castillo et al. 1989; Noonberg et al. 1992; Edwin & Jackman 1981; Verbunt et al. 1992; 
Belichenko et al. 1996; Banerjee et al. 1999). On the other hand, autofluorescence, either 
intrinsic or induced by fixation media and tissue processing may either mask specific 
fluorescent signals or be mistaken for fluorescent labels (Del Castillo et al. 1989; 
Noonberg et al. 1992). Besides, using a long-pass green emission filter on FFPE sections, 
the fluorescence results dull and not bright. When we performed immunofluorescences 
we also must considered that aldehyde fixatives react with amines and proteins to 
generate fluorescent products. These tissue-bound free aldehyde groups will combine 
covalently with any amino group offered to them, including terminal and side-chain 
(lysine) amino groups of antibodies. Besides, small organic fluorophores are powerful 
research tools in biological imaging that have enabled unprecedented insights into both 
cellular and molecular processes. However, their performance can be compromised by 
undesirable photophysical properties that limit both the fluorescence quantum yield and 
the total number of photons emitted before photobleaching. Such issues include both 
transient (blinking) and irreversible (photobleaching) light-induced transitions to dark 
states. Dark state transitions are particularly limiting in single-molecule studies that 
demand high illumination intensities. Therefore we performed our in situ studies, by the 
direct immunolabeling, in order to decrease the autofluorescence, avoiding the aspecific 
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binding of secondary antibodies. First of all, we set up a series of experiments, in order 
to define the background of bone marrow sections. We evaluated the fluorescence 
background after the antigen retrival, followed by the excitation at 460 nm, 488 nm and 
647 nm (see Figure 3.1 A, B,C). 
 
 
 
Figure 3.20 Evaluation of fluorescence background of bone marrow section. 
Following the antigen retrival, evaluation the fluorescence properties of bone marrow 
section after the excitation at 460 nm (A), 488 nm (B) and 647 (C). Scale bar 10 μm. 
 
In the figure 3.20. we can observe how there are autofluorescent spots, maybe due to 
granular cells. Besides, at 488 nm emission (see Figure 3.20 B), we can observe, an 
higher background then the 647 nm emission, own because using a long-pass green 
emission filter on FFPE sections the hematopoietic tissue has a fluorescent background. 
The background visualization is useful for the subsequent image analysis, in order to 
specify the signals and define the parameters for the nuclei segmentation. Then, we 
examined by immunostaining a number of bone marrow biopsy sections from five 
randomly selected cases. In all the analyzed samples the AC133 direct immunostaining 
revealed the islands of highly AC133bright positive cells in an estimated proportion of 
eight/ten percent of cells, amid AC133dim or negative tumor blasts (Beghini et al., 2012) 
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(Figure 3.21 A and B). The multiple approach to image analysis through ImageJ and 
CellProfiler Analyst reveals that 70% of cells are AC133 positive cells, but only a 10% of 
cells present the bright signal positivity in the AML environment. Each cellular image 
generated in a high-throughput screening experiment contains a tremendous amount of 
information. In order to analyze the high-content screening (HCS), defined as the high 
information content inherently present in cell images (Carpenter, 2009), we performed 
the image analysis through ImageJ, CellProfiler, and CellProfilerAnalyst. The cell 
segmentation is a crucial step in a pre-processing of single cell analysis. The main goal of 
the segmentation is to, in the end, accurately define signals per cell rather than achieving 
a perfect delineation of the cytoplasm. In order to define nuclei and cytoplasmatic 
signals, we performed an image segmentation through two thresholding method: for the 
nuclei we applied a popular thresholding method based on the histogram named Otsu’s 
(Otsu, 1979) where the automatic selection of an optimal threshold is performed based 
on the class seperability of the histogram. From the histogram, Otsu’s algorithm selects a 
threshold that minimizes a weighted intra-class variance of the background and 
foreground.  
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3.21 Detection of AC133brightcells. The AC133 direct immunostaining on two bone 
marrow sections derived from AML patients, AML9 (A) and AML63 (B). The green 
signals, obtained with hybridization antibody labeled with dye 488nm define the AC133 
positive cells. In both cases, we can observe two types of AC133 postivive cells: a rare 
group of cells is characterized by the high bright positivity, and other cells showed a dim 
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cytoplasmatic signal. Cell nuclei are shown in blue. Scale bar 10 μm. 
 
 
 
 
 
 
Figure 3.22 The cell nuclei segmentation process. In the figure is shown a cell 
nucleus MATLAB representation after the Watershed segmentation, through a 
magnitude gradient representation. In blue is shown the nucleus center, and the AC133 
staining is represented as perimeter around the nucleus according to the pixel gradient 
intensity from low intensity (yellow) to high intensity (red). 
 
In order to define the cytoplasmatic’s area and signals, we applied the Watershed 
segmentation: the general idea is to consider the image as a landscape where the 
magnitudes of the gray values form the hills and valleys of the landscape. The Watershed 
segmentation starts by submerging the landscape in water, and water is allowed to rise 
from each minimum. By these thresholding methods, we divided the image into a set of 
meaningful regions, nuclei and cytoplasm, reducing the background signal. The digital 
image processing algorithms, were implemented in MathWorks™ technical computing 
environment Matlab® (Figure 3.22). This small group of positive cells, are characterized 
by the nuclei diameter of 6-8 μm and the particular double DAPI emission signal, defined 
by the integrated intensity of 0.4. Besides, we can note that the green signals are specific 
and localized around the membrane perimeter. There are rare group defined by bright 
 212 
signals, amid AC133dim or negative tumor blasts (Figure 3.23). 
 
Figure 3.23 β-catenins activation in the subpopulation of AC133bright AML cells 
expressing WNT10B. A. The double immunostaining of bone marrow section from the 
AML9 for expression of active β-catenin (green), and WNT10B (red). Cell nuclei are 
shown in blue (DAPI). B. Direct immunolabeling in order to detect the AC133 positive 
cells (green). The immunostainings were performed on adjacent serial section Cell 
nuclei are shown in blue. Scale bar 10 μm. 
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We can observe that the β-catenin positive cells are also defined by the positivity for 
AC133bright signal. Besides, if we compare this two cell populations, we can note that 
nuclei dimater and DAPI intensity are the same. In order to define the spatial 
relationship between AC133 and ABC positive cells, in AML bone marrow cell 
population, we performed a double immunostaining AC133/ABC (Figure 3.24). In the 
Figure 3.24 we can observe the perfect correlation between AC133 and ABC signal, 
suggesting that the WNT signal responsiveness function is strictly associated to 
AC133bright cells. Using ImageJ, we noted that there are two types of signal positivity: 
the AC133 signals are localized around the membrane perimeter, while the ABC signals 
define the cytoplasmatic area. 
 
 
 
 
Figure 3.24 AC133bright a marker of WNT signaling activation. Double 
immunostaining for AC133 and ABC detection, on bone marrow section derived from 
AML9 patient. Cell nuclei are shown in blue. Scale bar 10 μm. 
 
In order to classify the cell populations that characterize the AML bone marrow 
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microenvironment, we performed a classification of AC133bright and AC133/ABC cells, 
through CellProfiler Analyst. Image-based data is tremendously valuable in that multiple 
single-cell measurements are available. In many cases, a single measured feature (e.g., 
the total intensity of green stain or DAPI stain for the nucleus) can be used to score 
individual cells and the only challenge is to identify a suitable threshold for scoring 
positive cells. Cell image analysis allows accurate identification and measurement of 
cells’ features, enabling automated analysis of certain phenotypes that were previously 
intractable. However, many interesting phenotypes require the assessment of several 
measured features of cells. Machine learning methods that select and combine multiple 
features for automated cell classification have been used to score many phenotypes. This 
can be accomplished in CellProfiler Analyst using plot of individual cell data (Jones et al., 
2008; Jones et al., 2009). For complex phenotypes, several features of each cell may be 
required for effective scoring. We considered, the double intensity signal of DAPI and the 
6-8-μm nuclei diameter as common parameters. Then we performed and image analysis 
using CellProfiler Analyst, and defining two gates, called AC133 and AC133/ABC positive 
cells. The first step is the classification of ‘‘interesting’’ phenotype, followed by the 
scoring of the co-expression signals (Figure 3.25). The samples are scored with 
sequential gates following this approach: (1) score the entire population of cells from an 
experiment, defining the AC133 and AC133/ABC subpopulations (2) draw a gate around 
the data points representing potential cells of interest, (3) adjust the gate to include 
nearly all positive cells and exclude as many negative cells as possible, (4) plot the 
resulting gated subpopulation in a new density plot with two new measurement features 
as axes, (5) gate the subpopulation again based on these new features, and (6) calculate 
the percentage of each image's cells that fall within the final gate, with p-values. 
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Figure 3.25 Definition of cell subpopulations. Samples can be scored for the number 
of gated cells and total cells in each sample, the enrichment of that percentage relative to 
the overall percentage of positive cells in the entire experiment and the left- and right-
tail log10 p-values statistical significance of the enrichment, based on the number of 
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cells in the sample). 
 
In these cases, a density plot showing individual cells can be useful for identifying 
interesting cell subpopulations, by delineating a section of the plot, called "gating". 
Whether the gate contains the cells of interest can be tested using two features: the 
"Show Object Montage" feature to see what individual cells within the gate look like, and 
the "Show Image" feature to see whether cells within a particular sample are 
appropriately marked as inside or outside the gate. Once the final, desired subpopulation 
of cells is gated, the number of cells that fall within that subpopulation is calculated for 
each image, for further statistical analysis. We considered two gates: one gate is based on 
the definition of AC133bright cells, and the other gate is established on the double 
positivity for AC133/ABC. The common gate is the double integrate signal for DAPI 
staining and the nuclei diamater. In the Figure 3.25 we can observe that AC133bright /ABC 
positive cells are valued as 8-10% of cells in AML bone marrow environment and are 
characterized by 6-8 nm of nuclei diameter, and double DAPI integrated signal. Finally, 
through immunostaining followed by a cytometry image analysis, we underlined that 
AC133bright cells correlated with accumulation of active-β-catenin, demonstrating that 
activation of Wnt regenerative signaling marked by expression of the dephosphorylated 
β- catenin was restricted only to the smaller population of AC133bright leukemic cells. 
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3.7 IDENTIFICATION OF A WNT10BIVS1 VARIANT: A WNT-WNT 
SITUATION  
 
In order to understand the cause of the highly WNT10B regenerative molecule 
expression in the leukemia environment, we performed a deeply characterization of the 
WNT10B mRNA. For the identification of the 5’ end of a particular transcript, 5’ Rapid 
Amplification of cDNA Ends (5’RACE) is a successful tool (Frohman et al., 1988). A gene-
specific oligonucleotide that hybridises to a known sequence within a characterised 
coding region is used to prime reverse transcription. As the first step, we set up the 5’ 
RACE that was carried out on RNA extracted from AML46 patient. Using a GSP2 primer, 
designed on WNT10B exon2, we obtained a product that is approximately 120bp long. 
To characterize the RACE product generated, the product was cloned into the 
pCR®IITOPO ® vector (Invitrogen), and inserts were analysed by EcoRI restriction 
digest. Inserts that correlated in size with the PCR products generated by 5’RACE were 
sequenced. We obtained three different results (Figure 3.26): 
 Clones 8-11: the correct WNT10B sequence 
 Cones 1-4 and clone 31: after the sequencing reaction, we noted the presence of 
21bp at the beginning of the WNT10B transcript 
 Clones 18-27: we sequenced clones 18 and 27, using universal primer M13 Fw 
and M13 Rw. Using BLAST and ASAPII, publicly available at 
http://blast.ncbi.nlm.nih.gov and http://www.bioinformatics.ucla.edu/ASAP2, 
we observed that the WNT10B transcript, has an Intron Retention IVS1 region of 
77nt, and after the IVS1 sequence, there is a stop of cDNA, with the absence of 
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exon 1. 
Using BLAST and ASAPII, publicly available at http://blast.ncbi.nlm.nih.gov and 
http://www.bioinformatics.ucla.edu/ASAP2, we observed that the WNT10B transcript, 
has an Intron Retention IVS1 region of 77nt, and after the IVS1 sequence, there is a stop 
of cDNA. 
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Figure 3.26 Scheme of 5’ region of WNT10B. 
 
 
In order to characterize the WNT10BIVS1 region, we performed in silico analysis using 
free software as ASPIC (http://www.caspur.it/ASPIC/) and ESEFInder 
(http://exon.cshl.edu/ESE/). The in silico analysis, using our region as a “query”, 
demonstrate that the Exon2-IVS1 splicing junction is correct, and that the end of the 
WNT10BIVS1 region corresponds with the end of the transcript. It’s interesting to note 
that the ATG site, is localized in the exon 2, suggesting that this alteration doesn’involve 
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the protein expression. Then, the nature of the WNT10BIVS1 transcript remain unclear, 
but it will be the object for the future perspectives. In order to define the distribution 
and localization of WNT10BIVS1, we performed the mRNA in situ detection on AML46 
spotted and fixed cells, and on AML9 bone marrow biopsy. In our work Beghini et al., we 
demonstrated through establishment of a primary AC133+ AML cell culture (A46), that 
leukemia cells synthesize and secrete WNT ligands, increasing the levels of 
dephosphorylated β-catenin in vivo. Besides, the results of our experiments indicate that 
AC133 is expressed on AML-LSC in the A46 primary cells, suggesting that regeneration-
associated Wnt expression signature is enriched in primary human AML LSC-containing 
fraction. In order to test the hypothesis that regeneration- associated Wnt signaling is 
involved in AML-LSC expansion, zebrafish embryonic model has used as a tool by 
examining the ability of A46 primary leukemia cells to modulate embryonic 
microenvironment. Therefore we used zebrafish embryos to show that A46 cells prompt 
secondary axis development inducing the formation of a dorsal-organizer-like structure, 
possibly via the secretion of different Wnt ligands. Considering this background data, we 
performed the mRNA in situ detection on A46 cells, derived from AML46 patient (Figure 
3.27, β-actin mRNA in situ detection). In order to define tha ratio between WNT10B and 
WNT10BIVS1, we set up the double detection in situ for both molecules. Using one 
common LNA primer for retrotranscription, we detected WNT10B and WNT10BIVS1, 
through two specific padlock probe (Figure 3.28) 
 
 221 
  
Figure 3.27 β-actin mRNA in situ detection on AML46 cells. β- actin RCPs are shown 
in green. Nulclei are shown in blue. Scal bar 10 μm. 
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Figure 3.28 WNT10B and WNT10BIVS1 detection in situ. mRNA in situ detection of 
WNT10B and WNT10BIVS1 molecules on A46 cells. There are represented four fileds 
(A,B,C,D). Cell nuclei are shown in blue. WNT10B RCPs are shown in green and 
WNT10BIVS1 are shown in red. Scale bare 10 μm. 
 
 
 
 
 
Figure 3.29 RCPs counting of WNT10B and WNT10BIVS1. Data representing of 
CellProfiler output. The ratio between WNT10B RCPs (green) and WNT10BIVS1 (red) is 
close to 1. 
 
 
We can note that the ratio between WNT10B (green) and WNT10BIVS1 (red) RCPs is 
close to 1, suggesting the balance expression of this two expressed isoforms of 
transcript. 
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3.8 THE WNT10B EXPRESSION BY AML PATIENTS: CLINICAL 
RELEVANCE 
 
We previously revealed the ligand-dependent Wnt pathway activation in AML and 
showed a diffuse expression and release of WNT10B, a hematopoietic stem cells 
regenerative- associated molecule. According to the results presented in Beghini et al., 
the gene expression microarrays and pathway nalysis evidenced that the Wnt/β-catenin 
signaling is diffusely activated in the AC133+ AML population, with a specific 
transcriptional signature involving overexpression of the Wnt pathway agonists and 
down-modulation of the major antagonists. Besides, we noted that WNT2B, WNT6, 
WNT10A, and WNT10B, WNT ligands promoter of hematopoietic tissue regeneration 
(Congdon et al., 2008; Katoh and Katoh, 2008) are the WNT mediators specifically 
upregulated in the AC133+ AML cells. Considering this background data, we performed a 
gene expression analysis through RT- PCR on n= 112 AML samples and n=3 healthy 
donors, in order to define the profiling of WNT ligands for AML patient. We set up the 
detection of WNT10B, WNT10BIVS1, WNT10A, WNT2B and WNT6 molecules, through 
RT-PCR using GAPDH, the housekeeping gene, as internal reference. In particular, we 
detect the WNT10B and WNT10BIVS1 transcripts, using one common RT primer, 
designed on Exon2-Exon3 junction. In the Figure 3.30 we can note that only WNT10B is 
expressed by all AML patients; conversly it’s not expressed by AML11 and AML 275, 
diagnosed as AREB-T, by AML 40 a therapy related AML and by I.M.66 a myelofibrosis 
syndrome and the. These data suggest that the WNT10B ligand expression, is strictly 
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associated to the AML condition. Besides, we can note that WNT10B is espressed also by 
two AML cell lines, KASUMI1 and SKNO. It’s important to observe that WNT10BIVS1 is not 
expressed by Core Binding Factor Leukemia patients (n=42), but it is a signature of only 
dyploid kariotype leukemia. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30 RT-PCR for WNT ligands WNT10B, WNT10BIVS1, WNT10A, WNT2B and 
WNT6. n=120 AML samples and n=3 healthy donors were analyzed by RT-PCR. Product 
size: WNT10B 120 bp, WNT10BIVS1 80 bp, WNT10A 180 bp, WNT2B 260 bp, WNT6 
300 bp. AML11* and AML275* are AREB-T, AML40** is a therapy related AML. 
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In order to analyze the gene expression analysis, as the first step we used the Jaccard 
index for correlation; using GenMAPP (http://www.genmapp.org), a computer 
application designed to visualize gene expression and MappFinder module 
implemented in R envronment, we defined the correlation 1:1 between WNT ligands 
(see Figure 3.31). We defined a binary matrix of lecture, based on index ranges from 0 to 
1 with 0=variables completely different, 1 =variables identical. 
 
 
 
 
Figure 3.31 Heat color map for WNT ligands correlation. Using Jaccard index for 
correlation, we linked the WNT expression through the binary matrix. The results are 
represented through a gradient color map (high correlation: red, low correlation: blue). 
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We can observe that WNT10B and WNT10A ligands expression, are strictly correlated 
among AML samples. This parameter defines that, the AML signature profile is 
characterized by the associated expression of WNT10B and WNT10A ligands. Then, in 
summary, we can report that: 
 AML patient are defined by the WNT10B molecule expression, strictly correlated 
with WNT10A ligand expression; 
 Core Binding Factor Leukemia are defined by the assence of WNT10BIVS1. 
 
This data suggest that, the WNT10B/WNT10BIVS1 ligand expression are a potential 
marker of dyploid kariotype AML evidence, showing the role of WNT10BIVS1 as a marker 
of Non Core Binding Factor Leukemia. In order to observe and evaluate the localiztion 
and distribution of WNT10BIVS1 in the AML bone marrow context, we performed the 
mRNA in situ detection of WNT10B and WNT10BIVS1 mRNA molecules. We planned the 
experiments using only one LNA primer, mapped to WNT10B exon3 and two Padlock 
Probes: the WNT10B mRNA was detected by a Padlock probe designed on the exon 1 
while WNT10BIVS1 was detected with a Padlock probe designed on IVS1-exon2 junction. 
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Figure 3.32 WNT10B and WNT10BIVS1 mRNA in situ detection. mRNA in situ 
detection. mRNA in situ detection on AML9 bone marrow biopsy. WNT10B RCPs are 
shown in green, WNT10BIVS1 RCPs are shown in red. Cell nuclei are shown in blue. Scale 
bare 20 µm. 
  
 
 
Figure 3.33 RCPs counting. The ratio between WNT10B RCPs (green) and WNT10BIVS1 
(red) is close to 0.8. 
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Comparing the WNT10BIVS1 with the WNT10B mRNA distribution, we can note that the 
ratio results equal to 0.8, suggesting that there is a blance between WNT10B and 
WNT10BIVS1 expression. The quantitative comparative analysis between these two 
isoforms, is on going through the digital PCR, in order to define the ratio between 
WNT10B and WNT10BIVS1 in AML patients. 
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3.9 MOLT4: A WNT10BIVS1-EXPRESSING CELL LINE  
 
In order to define a model for the WNT10B and WNT10B IVS1 molecules 
characterization , we studied their expression in hematopoietic cell lines of myeloid and 
lymphoid lineages. The expression analysis, conducted by RT-PCR following the 
experimental plan used In the WNT profiling expression analysis, reveals that the 
MOLT4 cell line expresses only WNT10B IVS1 (Figure 3.34). 
 
 
     
 
Figure 3.34 RT-PCR for WNT ligands WNT10B, WNT10BIVS1, WNT10A, WNT2B and 
WNT6 performed on cell lines. 
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We can note in the figure 3.34 , that KASUMI and SKNO, two Core Binding Factor 
Leukemia cell lines, shared the same expression WNT ligands profile, characterized by 
the expression of WNT10B, WNT10A, WNT2B and WNT6 ligands, and by the 
WNT10BIVS1 absence. Only the MOLT4 cell line, a human cell line of acute lymphoblastic 
leukemia, is characterized by the WNT10BIVS1 expression, showing a “complementary” 
pattern profiling respect other cell lines. In order to define also the in situ distribution of 
the WNT10B IVS1..molecules, we performed the mRNA in situ detection on MOLT4 cells, 
spotted on slides (Figure 3.35). 
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Figure 3.35 mRNA in situ detection on MOLT4 cells. β- actin and WNT10BIVS1mRNA in 
situ detection . RCPs are shown in red. Nuclei are shown in blue. Scale bar 10 μm.  
 
 
 
In the figure 3.35 we can note a diffuse expression of WNT10BIVS1mRNA, similar to the 
housekeeping gene mRNA expression. The WNT10B mRNA in situ detection will be the 
next experiment, in order to support the RT-PCR result. 
In order to evaluate the transcription and traduction processes, we also evaluate the 
WNT10B protein derived from WNT10BIVS1, through a Western Blot analysis. 
 
 
 
Figure 3.36 Western Blot analysis. Immunoblot analysis of ABC and WNT10B protein 
expression in  cell fractions from 7 AML samples, 1 healthy donor introduced as control 
and three human cell lines. 
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We can observe that healthy donors doesn’t present the WNT10B protein expression, as 
the signature of WNT signaling activation. We can underline that I.M.66 sample, a 
idiopathic myelofibrosis doesn’t express WNT10B protein and ABC protein, confirming 
the RT-PCR results and evidencing that the activation of WNT signaling is restricted to de 
novo AML condition. Conversly, all AML patients and all cell lines analyzed shown the 
WNT10B protein expression and β-catenine expression as the signature of Wnt pathway 
activation. It’s interisting to note, that also MOLT4 cell line, characterized by only the 
presence of WNT10BIVS1 transcript in RT-PCR analysis, presented the same pattern of 
other AML samples. This preliminary data, suggests that this alteration is defined at the 
transcriptional level, with the finally correct protein production.  In the future, we will 
try to identify the reason of this variant generation and also transcriptional and 
traductional regulation machanism.  
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4. DISCUSSION 
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According to recently evidences, the leukemia-initiating cell (LIC) properties occur in a 
self-renewing non-HSC progenitor cell population, preceded by the expansion of a 
preleukemic long-term hematopoietic stem cell (LT-HSC). 
Recently, Wnt/β-catenin pathway requirement for LIC development in AML has emerged 
in mouse model, but the molecular function responsible for the preleukemic LT-HSC 
expansion and the acquisition of self-renewal ability in AML remain unclear. Although 
the long-term reconstituting human hematopoietic stem cell marker AC133 has been 
detected in a majority of CD34+ AML, no extensive data concerning the role of AC133 in 
AML had been available. 
Taking into consideration that the AC133 antigen is the most specific marker available 
for the enrichment of rare hematopoietic stem component / progenitor population we 
provided in our project the initially purification through this marker of cell populations, 
obtained at diagnosis from 33 patients with AML and 10 healthy subjects. 
The descriptive analysis of positive and negative fractions obtained by immunomagnetic 
separation of patients and healthy donors, followed by statistical analysis of comparative 
data, showed that CD133.1+ cell fraction was dramatically expanded among AML with 
respect to normal donors. In order to define the transcriptional programs induced in the 
AC133 + cell fraction, we performed a gene profiling analysis on the AC133 + fractions 
obtained from patients with AML and healthy subjects, took advantage of the Affymetrix 
platform (GeneChip ® system). 
Unlike the study performed by Majeti et al., the gene expression analysis was performed 
on fractions AC133+ and not on the CD34+ cell population, using microarray Affymetrix 
platform ® technology, and followed by analysis of pre-processing for the validation data. 
In order to eliminate the bias intensity, the data obtained from the array were 
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normalized. The normalization of the signal intensity of arrays considered in our study 
was performed using an alternative algorithm than the one proposed by Affymetrix ®, 
the RMA (Robust Multy-Array Average) implemented in R environment. Unlike the non-
parametric algorithm proposed by Affymetrix ®, RMA is instead parametric and based 
on a mathematical model capable of considering the intensity of each probe cell as the 
summary of a component of the useful signal, defined by an exponential distribution, 
with a noise component, molded, instead, by a Gaussian distribution. The analysis of Pre-
Processing, allowed the comparison of different amount of samples used ensured the 
validity of the data obtained by eliminating the experimental errors. 
The gene expression analysis of microarray data, was followed by the functional 
enrichment analysis through three computational tools: GOStats, DAVID and 
dysregulated pathway analysis according to Majeti et al (Majeti et al., 2009). 
The results presented in this thesis and in our work Beghini et al., using gene expression 
microarrays followed by pathway enrichment analysis provide direct evidence that the 
Wnt/β-catenin signaling is diffusely activated in the expanded AC133+ AML population, 
with a specific transcriptional signature involving overexpression of the Wnt pathway 
agonists and down-modulation of the major antagonists (Beghini et al., 2012). 
Taking into consideration that the transcription factors (TF), represent the primary 
executors of transcriptional programs with the function of establishing and maintaining 
certain cell phenotypes, we performed a bioinformatic analysis of gene profiling data 
using a set of genes defined for the function of transcriptional regulators. The entry 
point of our selection procedure was extraction of a set of 400 Pfam domains involved in 
transcription regulation. Next, we identified an initial set of 2,971 non redundant genes 
associated to a unique HGNC symbol, using this gene list to query the entire set of 
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ensemble human genes using the BioMART web interface. As the second step of a 
bioinformatics analysis, we then compiled an evolutionarily conserved set of TRs by 
arbitrarily requiring the presence of at least 5 one-to-one orthology relationships 
disregarding the involved species. We finally tested each of the 1,989 non redundant 
gene symbols obtained through the orthology filtering for the association with at least 1 
Affymetrix HGU 133 Plus 2 microarray platform. This produced a final set of conserved 
putative transcriptional regulators composed by 1,919 genes, followed by the removal of 
all the gene symbols lacking an annotation in the Bioconductor annotation package 
associated with the Affymetrix HGU 133 Plus 2 platform. This filtering procedure 
produced the reference conserved TRs set composed by 1,611 evolutionarily conserved 
genes.  
We found that at 0.05 significance level for all functional enrichment analysis, the term 
GO:0016055 associated with the function of “Wnt receptor signaling pathway”, results 
the most specific dysregulated biological process. Thus, the three independent types of 
analysis, applied to all genes and to transcriptional regulators, selected the term “Wnt 
receptor signaling pathway” as the most specific self-renewal associated dysregulated 
pathway. We can note that WNT10B, WNT10A WNT2B and WNT6, known to promote 
the hematopoietic tissue regeneration, are the WNT mediators upregulated in the 
AC133+ AML cells. According to the literature’s evidence, in the hematopoietic system 
WNT10B is significantly upregulated following an injury, increasing the growth of HSCs 
(Angers & Moon, 2009). Taking this issues into consideration, we showed a dramatic 
increase of WNT10B expression and protein release within the microenvironment in the 
large majority of samples from AML patients recruited to this study. Analysis of freshly 
fractionated cells from AML patients showed that active Wnt signaling was predominant 
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in population highly enriched for the AC133 HSC marker. The hematopoietic 
regenerative-associated Wnt ligand WNT10B is expressed on both leukemic blasts and 
stromal-like cells, indicating a possible autocrine/paracrine involvement of Wnt in the 
bone marrow microenvironment. Conversely, we noted that the activation of Wnt 
signaling marked by expression of the dephosphorylated β-catenin has restricted to a 
smaller proportion of leukemic cells. The reasons for these results remain unclear, but it 
is possible that Wnt-induced β-catenin-activation, conferring a “responsive” phenotype, 
restricted to a rare population of cells.  
In this thesis was presented an application of a new in situ technique using padlock 
probes and RCA for detection and genotyping of individual mRNA molecules in cells and 
tissues. The mRNA in situ detection allows selective and multiplex detection of individual 
transcripts and will serve as an important tool within gene expression studies (Larsson 
et al., 2010). 
The mRNA in situ detection, performed on AML bone marrow sections and on AML cells, 
allowed to detect and visualize the WNT10B mRNA molecules at their exact location in a 
tissue and in a single cell. The CellProfiler pipeline, used for a RCPs quantification 
referred to the housekeeping gene expression, showed a β-actin: WNT10B ratio close to 
1.0 suggesting a diffuse constitutive activation of WNT10B transcription in the bone 
marrow. 
It is worth to note, that we used image analysis software as Cellprofiler and ImageJ with 
a MATLAB bridge, in order to reduce the backgoround signals and to detect every RCPs 
in FPPE sections.  
Since activation of WNT signaling can increase the HSC’s ability to reconstitute the 
hematopoietic system of lethally irradiated mice, we transplanted the AC133+ A46 cells 
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into irradiated Rag2-/-γc-/- mice. The results of our experiments evidenced that AC133 is 
expressed on AML-LSC in the A46 primary cells, suggesting that regeneration-associated 
Wnt expression signature is enriched in primary human AML LSC-containing fraction. 
According to Lu et al., the maternal Wnt ligands are fundamental for the establishment of 
the embryonic body plan, a milestone in the development of vertebrates. The Wnt factors 
induce the nuclear translocation of β-catenin, which triggers the formation of the dorsal 
organizer through the activation of zygotic dorsal-specific genes and they are recquired 
for proper tail development. In addition, Bowman et al., evidenced that developmental 
signal transduction pathways, such as Wnt, are often reactivated during regeneration. 
Taking this issues into consideration, we used zebrafish embryos to show that A46 cells, 
possibly via the secretion of different Wnt ligands, prompt secondary axis development 
inducing the formation of a dorsal-organizer-like structure. The mechanisms promoting 
organizer formation are known to involve cooperation between Nodal and Wnt 
signaling. In our paper Beghini et al., we demonstrated that the A46-dependent 
alteration of zebrafish development and activation of the organizer-specific gene gsc are 
not reliant on Nodal activity (Beghini et al., 2012). The results of the first part of my phD 
program, provided a compelling evidence that regeneration-associated Wnt signaling 
exceeds the homeostatic range in human AML and affects responsive cells whose 
renewal is promoted by Wnt pathway activity. 
Taking this results into consideration, during the second part of my phD project we 
focused our attention on a characterization of a regenerative function associated to WNT 
pathway induction. First of all, we detected in situ a AC133 bright subpopulation, that 
shared the WNT signaling activation signature. 
In order to better characterize the LICs, we performed a series of direct immunolabeling 
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on AML bone marrow biopsies.  
First of all, we evidenced that the activation of WNT signaling marked by the expression 
of active β-catenin was restricted to the smaller subpopulation of AC133bright leukemic 
cells. We performed an interactive observation of the original cellular images using 
CellProfilerAnalyst, a new method for image-based screening and machine learning-
based phenotype scoring, in order to define cell phenotypes. For complex phenotypes, 
several features of each cell may be required for effective scoring, measure nuclear 
features, staining’s intensity and AC133/ β-catenin positivity. The multiple single-cell 
measurements analysis, define that only 8-10% of cells, are defined by a double 
AC133bright/ β-catenin positivity, suggesting that only a small AC133bright subpopulation 
shared the WNT signaling activation signature. 
Focusing our attention on the major locus associated to the regenerative function, we 
performed a 5’RACE analysis on WNT10B mRNA, evidencing the presence of an 
alternative expressed WNT10BIVS1 variant. We evidenced in situ that the ratio between 
WNT10B and WNT10BIVS1 is close to 1, but the potential role and the mechanism of 
WNT10BIVS1 expression, will be the object of future studies. 
In order to evaluate the expression of WNT ligands specifically up-regulated in the 
AC133+ AML cells and that promote hematopoietic tissue regeneration evidenced in our 
work (Beghini et al., 2012), we performed the unsupervised expression analysis profiling 
on n=112 AML samples and n=3 healthy donors. 
The first result, of this ongoing project, evidences that the WNT10B ligand is expressed 
by all AML patients, suggesting the potential role of WNT10B as a marker of AML 
condition. It is worth to note, that the regenerative WNT signaling associated function 
marks just AML condition, while myelodisplastic syndroms and AML therapy related are 
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completely negative for WNT regenerative ligands expression. Infact, performing the 
unsupervised expression analysis, in order to remove the biases, we had the possibility 
to re-evaluate the WNT regenrative ligands cases, as not AML conditions, suggesting the 
possible role of WNT profiling as a putative tool of diagnosis. 
It’s interesting to note that the expression of WNT10BIVS1 variant, marks only the Non 
Core Binding Factor Leukemias, suggesting its possible role as a biomarker of a diploid 
karyotype AML. 
Taking this issues into consideration, as the future plan we will perform a WNT-
regenerative-ligands profiling, in order to define a signature of AML patients, using WNT 
ligands expression as putative biomarkers. The first step in the WNT10BIVS1 molecule 
characterization, is the identification of the MOLT4 human cell line, that expressed only 
WNT10BIVS1 variant, , allowing the future characterization experiments. In summary, the 
findings we report in this thesis and in our work Beghini et al., define for the first time 
the regeneration-associated ligand-dependent WNT signaling induction in human AML 
cases. These studies suggest that the regenerative WNT signaling is an altered stem cell 
function, in AC133bright AML leukemia stem cell fraction. The data presented, evidence 
that the WNT10B molecule is strictly associated to the de novo AML condition, 
suggesting its role as a putative disease biomarker and addressing the future 
experimental plans. As the future perspective, we are defining the quantitive ratio 
between WNT10B/ WNT10BIVS1molecules in AML patients, through a Droplet Digital 
PCR technology that provides absolute quantification of nucleic acids,.  
Future studies will be focused on a demonstration of a pathogenic association of 
AC133bright LIC regeneration response with AML, as tumorigeicity, clinico-pathologic 
features and also patient outcomes. 
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